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Abstract 
 
Despite the abundance of the templates, both human and rodent SINEs are 
normally expressed at a very low level. DNA methylation-mediated silencing has 
been proposed as a possible cause of their transcriptional repression. The effect 
of DNA methylation and the effect of DNA methylation-dependent methyl-CpG-
binding domain proteins (MBD proteins) on SINE transcription were studied here. 
It was shown that both human and rodent SINEs are bound by MeCP2, MBD1 and 
MBD2. Both human and rodent SINEs were also shown to be occupied by HDAC1, 
HDAC2 and a component of SWI/SNF complex, Brahma. Human Alus were also 
found to be occupied by components of two corepressor complexes, SIN3 and 
NuRD. Whether MBD proteins repress SINE transcription in a DNA methylation-
dependent manner was further investigated using systems with low or near 
absent DNA methylation and, in the case of MeCP2 protein, by its direct 
removal.  
MeCP2 was found to have no repressive effect on B1 and B2 expression. RT-PCR 
analysis showed no increase in B1 and B2 RNA levels in MeCP2 null mice kidneys. 
ChIP analysis of Dnmt1
n/n p53
-/- embryonic fibroblasts, which have less than 5% 
of the normal DNA methylation level, showed significant reduction in MeCP2 and 
MBD2 binding, confirming that their presence is DNA methylation-dependant. RT-




-/- cells, however, detected 
no increase in B1 or B2 RNA levels. This was consistent with results obtained 
from MeCP2 null mice, where lack of MeCP2 did not result in increased B1 and B2 
expression and with a previous study involving human Alus (Yu et al., 2001). 
MBD2 also does not seem to repress SINE activity, as its release following loss of 
DNA methylation did not result in increased SINE RNA levels.  
Strikingly, all human and rodent SINEs studied here were found to be bound by 
transcription factors TFIIIB and TFIIIC at comparable levels with actively 
transcribed genes. Some RNA polymerase III was also detected, but at levels 
significantly lower than on active genes, suggesting a defect in RNA polymerase 
III loading onto SINEs. This occupancy of the transcriptional complex was 
comparable in cells with normal levels of DNA methylation and in cells with 3 
significantly reduced levels of DNA methylation, suggesting that the occupancy is 
not affected by methylated DNA or DNA methylation-dependent components of 
chromatin. Indeed, removal of 50% of histone H1 did not result in increased B1 
or B2 expression in this study. The fact that all tested SINEs are occupied by 
TFIIIB and TFIIIC also brings an unprecedented insight into the number of these 
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1  Chapter 1- Introduction 
1.1 Class III genes 
In all eukaryotes, transcription of nuclear genes is shared by three RNA 
polymerases and each of them is essential for viability. In addition, two new RNA 
polymerases have been described recently, RNA polymerase IV in plants (Herr et 
al., 2005) and single-polypeptide nuclear RNA polymerase (spRNAP-IV) in 
mammals (Kravchenko et al., 2005). RNA polymerase I is dedicated exclusively to 
transcribing the rRNA genes, of which there are around 400 copies in the human 
genome. RNA polymerase II produces mRNAs from the protein-encoding genes, as 
well as transcribes many genes that encode small nuclear RNA molecules (snRNA) 
(White, 2005). Transcription of some mRNAs in humans and rodents is mediated 
by a newly described spRNAP-IV (Kravchenko et al., 2005). RNA polymerase III is 
responsible for 10-20% of all nuclear transcription (Moss and Stefanovsky, 2002), 
and synthesizes a variety of small, untranslated RNAs with essential roles in 
metabolism, including transfer (t)RNAs, 5S rRNA and 7SL RNA and can also 
transcribe a great number of pseudogenes derived from tRNA and 7SL (White, 
2005). Tight regulation of these polymerases, and their respective transcription 
machineries, dictates gene expression patterns, and hence cell function. 
Although the proteins encoded by class II genes (genes transcribed by RNA 
polymerase II) function in a diverse array of processes, the untranslated RNAs 
produced by RNA polymerase I and RNA polymerase III are more specialised and 
primarily involved with biosynthesis. This thesis is specifically concerned with 
RNA polymerase III transcription of short interspersed elements (SINEs) and this 
introduction emphasizes aspects of RNA polymerase III transcription related to 
SINEs. 
Although greatly out-numbered by RNA polymerase II-transcribed, mRNA 
encoding genes, RNA polymerase III genes (class III genes) are transcribed at very 
high frequencies. Confocal and electron microscopy of HeLa cells revealed that 
RNA polymerase III transcription occurs at around 2000 sites within the nucleus. 
Each site has a radius of around 20nm and contains, on average, five molecules 
of active RNA polymerase III (Pombo et al., 1999).  Jana Vavrova, 2008    Chapter 1, 16 
1.1.1 RNA polymerase III-transcribed genes 
 
5S rRNA 
Together with approximately 80 proteins (Doudna and Rath, 2002), and the 5.8S, 
18S and 28S rRNAs produced by RNA polymerase I, 5S rRNA is an essential 
component of ribosomes in every eukaryotic organism, and therefore is vital for 
protein synthesis (Wool, 1979). At approximately 120 nucleotides long, 5S rRNA 
is the smallest of the ribosomal RNAs and the only one transcribed by RNA 
polymerase III (White, 2001). Following synthesis in the nucleoplasm, 5S rRNA is 
transported to the nucleolus where it is processed and integrated into the large 
ribosomal subunit and has a critical role in translation. Human cells are thought 
to contain 200 to 300 5S genes present in tandem arrays (Lander et al., 2001). In 
addition, 5S gene pseudogenes have been described (Doran et al., 1987). 
 
tRNAs 
tRNAs play an essential role in mRNA translation. These molecules serve as 
adaptors, allowing the genetic information carried in a particular nucleotide 
sequence to be translated by the ribosome into the appropriate amino acid 
sequence. The three residue anticodon sequence of a given tRNA is specific for a 
particular amino acid.  Consequently, base-pairing of the tRNA anticodon with 
the complementary codon of the mRNA ensures the accurate synthesis of the 
polypeptide chain encoded by the mRNA nucleotide sequence.  Following their 
initial synthesis, tRNA transcripts are processed, and in some cases covalently 
modified, resulting in mature tRNAs which range in length from 70 to 90 
nucleotides, and adopt a conformation with complex secondary structure 
(Creighton, 1997; Hopper and Phizicky, 2003). The human haploid genome 
contains 821 tRNA-related loci, 497 of which are tRNA genes, the other 324 are 
tRNA-derived putative pseudogenes (Lander et al., 2001). The considerable 
redundancy displayed among tRNA genes results in an average copy number of 
around 10 genes for each amino acid tRNA adaptor. 
 
U6 snRNA Jana Vavrova, 2008    Chapter 1, 17 
U6 is the smallest of five snRNA species contained in a spliceosome. Four other 
snRNAs are produced by RNA polymerase II (Hastings and Krainer, 2001); 
however, the smallest (106 nucleotides), most highly conserved snRNA U6 is 
manufactured by RNA polymerase III (Reddy et al., 1987). Spliceosomes function 
in post-transcriptional processing of pre-mRNA (Maniatis and Reed, 1987). 
Following their initial synthesis by RNA polymerase II, pre-mRNAs are extensively 
processed prior to translation. For example, 5’ and 3’ end modifications and 
deadenylation (Yamashita et al., 2005) take place and, in addition, splicing is 
required to remove non-coding intron regions, thus producing a continuous 
coding sequence compatible with the translation machinery. Pre-mRNA splicing 
occurs in the nuclei of all eukaryotic cells and is performed by spliceosomes.  
 
H1 and MRP 
H1 is a 369 nucleotide RNA which forms part of RNase P, an endoribonuclease 
involved in processing the 5’-termini of pre-tRNA and which exhibits several 
blocks of sequence homology to MRP RNA (Bartkiewicz et al., 1989).  MRP is a 
265 nucleotide RNA forming part of RNase MRP, another endoribonuclease, 
which serves an important role in the endonucleolytic processing of pre-rRNA 
(Morrissey and Tollervey, 1995).   
 
7SL RNA  
In the human genome, there are four 7SL genes encoding a highly conserved 300 
nucleotide transcript and a number of pseudogenes (Ullu and Tschudi, 1984; Ullu 
and Weiner, 1984).  The class III gene 7SL encodes the RNA component of the 
signal recognition particle. The signal recognition particle (SRP) also contains six 
polypeptides and is responsible for the appropriate targeting of ribosomes 
engaged in translation to the endoplasmic reticulum, thus delivering nascent 
polypeptide chains to this organelle, where they are modified, correctly folded 
and then further directed to their final destinations (see later (Walter and 
Blobel, 1982a; Walter and Blobel, 1982b).  
 
7SK Jana Vavrova, 2008    Chapter 1, 18 
The 7SK gene encodes a snRNA transcript of 330 nucleotides in length (Murphy et 
al., 1986).  It associates with eight proteins to form a 12S RNP with an unknown 
role. It also acts as a negative regulator of the RNA polymerase II elongation 
factor P-TEFb; a factor responsible for the phosphorylation of RNA polymerase 
II’s carboxyl-terminal domain (Nguyen et al., 2001; Yang et al., 2001). 
 
Viral genes transcribed by RNA polymerase III 
Some viral genomes contain class III genes which are necessary for viral 
replication (White, 2004).  Adenovirus is one such example and encodes two RNA 
polymerase III products, VA1 and VA2 (Soderlund et al., 1976; Weinmann et al., 
1976).  These short ~ 160 bp RNAs are expressed at very high levels late in 
infection (Soderlund et al., 1976) and contribute to manipulation of the host 
cell’s translational apparatus, ensuring the synthesis of viral proteins 
(Thimmappaya et al., 1982). The genome of Epstein-Barr virus (EBV) also 
contains two small adjacent genes; EBER1 and EBER2 that are transcribed by 
RNA polymerase III and share homologous regions. During adenovirus infection 
EBERs can functionally substitute for VA1 (Bhat and Thimmappaya, 1985).  
Although EBER RNA is only ~ 170 bp, it has been shown to be sufficient to induce 
growth in soft agar and tumorigenicity in mice (Ruf et al., 2000; Yamamoto et 
al., 2000). Clones with the highest EBER expression are the most tumorigenic 
(Ruf et al., 2000). EBER RNA has the ability to bind and inhibit PKR (the double-
stranded RNA activated protein kinase), a key mediator of the antiviral 
interferon-α response (Nanbo et al., 2002; Yamamoto et al., 2000). EBER RNA 
provides a first example of an oncogenic RNA and a very important precedent for 
the possibility that a RNA polymerase III product can transform cells.  
 
1.1.2 RNA polymerase III-transcribed pseudogenes - SINEs 
 
Almost all short interspersed elements (SINEs) reported from eukaryotic genomes 
are derived from tRNA, with the exception of Alu and B1 families (Okada, 1991a; 
Okada, 1991b; Ullu and Tschudi, 1984). The tRNA-derived SINEs are not simple 
pseudogenes for tRNAs, but have a composite structure, with a tRNA-like RNA 
polymerase III promoter and a C-terminal region homologous to a tRNA, a middle Jana Vavrova, 2008    Chapter 1, 19 
tRNA-unrelated region, and a terminal AT-rich region (Okada, 1991a; Okada, 
1991b). MIR elements are transcriptionally inactive interspersed repeats of tRNA 
origin and can be found in all mammalian orders (Smit and Riggs, 1995). They 
are about 260 bp long and contain an RNA polymerase III promoter. With 
approximately 120,000 copies still detectable in the human genome (0.2-0.3% 
DNA), MIRs represent a 'fossilized' record of a major genetic event preceding the 
radiation of placental orders (Jurka et al., 1995).  
 
B2 and B1 are the most abundant rodent SINE families (Kramerov et al., 1979). 
The B2 family is a highly conserved rodent tRNA-derived family (Daniels and 
Deininger, 1985). It is usually about 190 bp long composed of a 5’-tRNA related 
region containing an RNA polymerase III promoter, a tRNA –unrelated region, and 
a 3’ AT-rich region (Krayev et al., 1982). It is highly abundant in the mouse 
genome with about 348 000 members (Waterston et al., 2002). It is also found at 
low abundance in humans (Mayorov et al., 2000). The B1 family, with about 564 
000 members (Waterston et al., 2002), originated from 7SL RNA (Maraia, 1991; 
Quentin, 1989). It is usually about 140 bp long with a short A-rich region (Krayev 
et al., 1980; Krayev et al., 1982). It shares ∼78% sequence homology with both 
7SL and Alu over their first ∼75 and last ∼30 bases, while containing a central 
region of ∼30 bases not found in 7SL (Maraia, 1991). As opposed to the majority 
of Alu sequences, B1 is a monomer. B1 elements also contain an RNA polymerase 
III promoter and both B2 and B1 are transcribed by RNA polymerase III (Carey et 
al., 1986; Krayev et al., 1982; Singh et al., 1985). They typically lack RNA 
polymerase III terminator sequences (see later (Maraia, 1991; Singh et al., 1985).  
 
Alu elements are the most abundant and the most studied primate-specific 
family of SINEs. With over a million-copies in the human genome, it makes them 
the most abundant of all mobile elements in the human genome (Batzer and 
Deininger, 2002; Deininger and Batzer, 1999; Deininger and Batzer, 2002; Mighell 
et al., 1997). Alu elements are about 300 nucleotides long and were shown to be 
derived from the 7SL gene (Ullu and Tschudi, 1984) and it is thought that they 
evolved through internal deletion of the S domain, acquisition of a 3’ poly-A tail 
and subsequent tandem duplication (Figure 1.1)(Quentin, 1992; Ullu et al., 
1982). They originated approximately 65 million years ago and their propagation 
resulted in the generation of a series of Alu subfamilies of different evolutionary Jana Vavrova, 2008    Chapter 1, 20 
age (Shen et al., 1991).  A typical Alu element has a dimeric structure, 
consisting of two similar but distinct monomers (Batzer and Deininger, 2002; 
Deininger and Batzer, 2002). The right Alu monomer contains a 31 bp insert 
absent from the left monomer. The left monomer contains a functional A- and B- 
block RNA polymerase III type 2 promoter (see later), which is changed by 
various mutations and is inactive in the right monomer. The elements also 
contain a central A-rich region and are flanked by short intact direct repeats 
that are derived from the site of insertion. The 3’ terminus of the Alu element 
usually consists of a run of As that is only occasionally interspersed with other 
bases and it does not contain an RNA polymerase III terminator. 
 
 
Figure   1-1 Evolutionary pathway for generation of the Alu elements (left) and corresponding 
RNA secondary structures (right). 
The S domain of the 7SL was deleted and Alu acquired a poly-A tail. Two such monomers 
then fused to generate 'modern' dimeric Alu. (adapted from Dewannieux et al., 2003) 
The amplification of B1, B2 and Alus is thought to occur by the reverse 
transcription of their RNA polymerase III-derived transcript in a process called 
retrotransposition, using enzymatic machinery of L1 LINEs (Dewannieux et al., 
2003; Dewannieux and Heidmann, 2005). Although SINEs contain an internal 
promoter, they do not encode a protein.  
The rate of amplification of human Alu elements has not been uniform; most of 
them duplicated more than 40 million years ago (Shen et al., 1991). The Jana Vavrova, 2008    Chapter 1, 21 
amplification rate varied throughout primate evolution, giving rise to variable 
copy numbers of each Alu subfamily. The PS subfamily of Alus comprises of four 
old subfamilies, including Alu J, Sx, Sq and Sp subfamily (Batzer et al., 1996).  
Alu J and Alu S represent about 83% of all Alu elements. The Alu Y subfamily is 
the youngest and the only one shown to still be capable of retrotransposition 
(Shen et al., 1991). Early in primate evolution, there was approximately one new 
Alu element insertion in every primate birth. By contrast, today the rate is 
estimated to be one Alu insertion in every 200 births (Deininger and Batzer, 
1999). The rate of amplification has therefore decreased by at least two orders 
of magnitude throughout the expansion of the family. Several factors have been 
suggested to influence the amplification capability and these include low 
transcriptional rates of each family and the ability of the specific transcript to 
associate with the L1 retrotransposition machinery (Dewannieux et al., 2003; 
Dewannieux and Heidmann, 2005) and activity of L1 elements themselves (Han 
and Boeke, 2004). 
SINEs are located throughout the genome, but they tend to be enriched in gene-
rich regions (Korenberg and Rykowski, 1988). They can also be found in almost 
any location within a gene, except those in which they would totally disrupt the 
function of that gene (Deininger and Batzer, 1999). Therefore, very few SINEs 
are found within 5’ noncoding or coding regions of exons. In contrast, insertions 
into the 3’ untranslated regions (3’UTRs) of genes are found commonly and 
appear to have few negative effects. Nevertheless, the human Genetic Mutation 
Database suggests that Alu elements contribute to approximately 0.1% - 0.3% of 
human genetic diseases. This is due to Alu element insertion into different parts 
of the gene, resulting in altered gene expression, disrupted reading frames or 
disrupted splicing, but especially due to unequal recombination events caused by 
dispersion of Alu elements throughout the genome (Deininger and Batzer, 1999; 
Deininger and Batzer, 2002).  
Because of their dispersed character, all SINEs are common in hnRNA as part of 
RNA polymerase II-derived mRNAs (Jelinek et al., 1978; Ryskov et al., 1983). As a 
result, an Alu sequence was identified in 5% of 1616 human full-length cDNAs, 
with 82% and 14% of these located in 3’-UTR and 5’-UTR, respectively (Yulug et 
al., 1995). On the other hand, RNA polymerase III-derived transcripts are very 
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(Carey et al., 1986; Maraia, 1991; Paulson and Schmid, 1986) can be detected 
under physiological conditions in cultured cells or mouse tissues, indicating that 
expression of these repetitive elements is tightly down-regulated. Being 
regarded as parasitic sequences, it is not surprising, as their transcriptional 
activity would be the first step towards multiplication, undesired for the host 
genome, but also for SINEs themselves. So far, there is no evidence that 
increased transcription leads to increased retrotransposition; as the colonisation 
of the genome by these elements can only occur in the germ-line lineage, 
somatic transposition would leave no heritable trace (Bird, 1997).  
SINE transcription, however, increases in a number of situations, which suggests 
that they may have a function. The observation that Alu elements and similar 
elements in other animals behave like classic cell-stress genes suggests a role in 
the stress response (Li et al., 1999; Liu et al., 1995). Cell stresses other than 
heat shock, such as viral infection and transformation and translational 
inhibition, increase the abundance of human Alu RNA, suggesting that the level 
of these transcripts is sensitive to the translational state of the cell (see later).  
Both B1 and Alu transcripts get 3’ processed and accumulate as small 
cytoplasmic RNAs called scB1 and scAlu (Maraia, 1991; Matera et al., 1990). Both 
were shown to associate with SRP9/14 subunits of SRP, although B1 with lower 
affinity than Alu (Hsu et al., 1995; Sarrowa et al., 1997). SRP is a particle 
composed of 7SL RNA (see above) and 6 protein subunits. It interacts with 
translating ribosomes and samples the nascent polypeptide chains for the 
presence of an ER-targeting signal sequence. It tightly binds to the ribosome-
nascent chain complex and transiently blocks chain elongation until the complex 
reaches the ER membrane. There it releases the ribosome and protein synthesis 
is resumed across the ER membrane (Keenan et al., 2001). The signal recognition 
and targeting activities were assigned to the S domain of 7SL and SRP54. The 
arrest and delay in nascent chain elongation requires SRP9/14 subunits and the 
Alu-like part of 7SL (Siegel and Walter, 1988). It was proposed that Alu in 
complex with specific proteins might have the 7SL’s Alu-like part inhibitory 
function. It was shown in vitro that, indeed, AluRNA/ SRP9/14 had an inhibitory 
effect on protein translation. However, unlike the Alu-like part of 7SL, it was 
acting at the level of initiation, resulting in lower polysome levels (Hasler and 
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Alu RNA can also regulate protein levels by interaction with the double-stranded 
RNA (dsRNA)-regulated protein kinase (PKR), an inhibitor of protein translational 
initiation. At low concentration, flAlu RNA can activate PKR (Williams, 1999), 
suggesting that under normal physiological conditions it can contribute to 
inhibition of protein synthesis. However, overexpressed full length Alu RNA 
(flAlu) was shown to be capable of increasing protein synthesis by binding to and 
inactivating PKR (Chu et al., 1998). Increased levels of flAlu RNA caused by 
cellular exposure to different stresses could therefore regulate protein synthesis 
by antagonizing PKR activation. Viruses themselves exploit PKR activity by 
inhibiting it with dsRNAs (Williams, 1999). FlAlus, together with scAlus, were 
shown to bind SRP9/14 during adenoviral infection (Chang et al., 1996), 
suggesting that Alus might be exploited by virus to inhibit PKR and allow protein 
synthesis necessary for viral replication. In addition, full length Alu (specifically 
the right monomer), B1 and B2 can also stimulate reporter gene expression in a 
PKR-independent manner (Rubin et al., 2002). 
Both B1 and B2 RNA increase after heat shock in mouse cells (Fornace and 
Mitchell, 1986; Li et al., 1999; Liu et al., 1995). This increase is, however, 
unique to the SINEs; there is no general increase in RNA polymerase III 
transcripts such as 7SL, 7SK or U6 (Liu et al., 1995). While transcription of many 
heat shock protein and chaperone genes increases too, there is a general 
repression of RNA polymerase II-transcribed genes (Sonna et al., 2002). It was 
discovered in vitro and in vivo that this repression can be mediated via B2 RNA 
binding to RNA polymerase II; this inhibits the activity of pre-initiation complex 
and blocks all detectable RNA production (Allen et al., 2004; Espinoza et al., 
2004). Regions in B2 structure were defined that are required for this effect 
(Espinoza et al., 2007). B1 has no such effect (Allen et al., 2004).   
SINEs also had a global effect on evolution of mammalian genomes. They were, 
for example, shown to carry and spread RNA polymerase II promoters (Ferrigno 
et al., 2001), contain alternative splice sites (Sorek et al., 2002; Sorek et al., 
2004), and generally shape mammalian transcriptomes (Sela et al., 2007). 
Recently they were suggested to regulate mRNA as targets for mi-RNAs if present 
in their 3’ UTR (Smalheiser and Torvik, 2006). miRNA and siRNA are part of a 
mechanism collectively referred to as RNA interference (RNAi) (see later). 
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initiation, resulting in reduced levels of mRNA or protein or both (see later; 
reviewed in (Valencia-Sanchez et al., 2006). However, it may also act at the 
level of transcriptional silencing (Kawasaki and Taira, 2004; Morris et al., 2004). 
Altogether, via RNAi, miRNA can regulate mRNA and protein levels. 
Alus have also been shown to be human chromosome binding sites for 
SNF2h/NuRD-mediated binding of hRAD21, suggesting that Alus may play a role 
in sister chromatid cohesion (Hakimi et al., 2002). Alus are however not the only 
identified binding sites. Recent paper mapped other cohesin binding sites in 
human genome (Wendt et al., 2008). 8811 sites for hRAD21 (SCC1) were 
identified, mostly in intergenic regions, introns and within 5 kb upstream or 
downstream of genes. Although repetitive elements were specifically removed 
from the analysis (including Alu elements), it is known that these regions are 
enriched by them (Deininger and Batzer, 1999). 89% of the identified hRAD21 
sites were identical to CTCF binding sites (Wendt et al., 2008). CTCF was found 
to be required for cohesin enrichment at those sites. However, CTCF and cohesin 
could associate with DNA independently. Chromatin-bound cohesin levels were 
not reduced after CTCF depletion, showing that cohesins still associate, but are 
distributed more broadly (Parelho et al., 2008; Wendt et al., 2008).  
Despite the above, the general opinion is that Alu elements may represent 
“selfish DNA”, which may have a negative impact on the host, but can be 
tolerated. Selfish DNA may also occasionally have positive benefits, but only by 
chance (Deininger and Batzer, 1999).  
1.2 RNA polymerase III transcription and its regulation 
1.2.1 Type 2 promoters 
Class III genes have three distinct types of promoter, type 1, type 2 and type 3. 
The type 2 promoter, which is used by SINEs, is also the most common promoter 
type (White, 2001). It consists of two essential, highly conserved sequence 
elements of about 10bp each: an A-block and a B-block (Galli et al., 1981). In 
the type 2 promoters, the A-block is found further upstream, generally within 
20bp of the transcription start site (White, 2001). The spacing between the A- 
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60bp; however, a distance of up to 365bp can still support transcription (Baker 
et al., 1986; Fabrizio et al., 1987). This variation is remarkable, considering that 
a single transcription factor, TFIIIC, binds simultaneously to both the A- and B-
blocks (Schultz et al., 1989). 
The A- and B-blocks have consensus sequences TGGCNNAGTGG and GGTTCGANN-
CC, respectively. Point mutations in the A- and B-blocks have been found to 
confer a substantial effect on transcription efficiency (Liu and Schmid, 1993; 
Newman et al., 1983; Nichols et al., 1989). 
1.2.2 Transcription initiation complex assembly on class III genes 
The route to RNA polymerase III recruitment varies depending on the promoter 
type of the gene to be transcribed. Type 2 promoter is discussed below. 
The A- and B- block sequences are recognised by a multisubunit complex called 
TFIIIC. TFIIIC is one of the largest and most complex transcription factors known, 
having six subunits in yeast, with an aggregate mass of more than 500 kDa 
(Geiduschek and Kassavetis, 2001; Paule and White, 2000; Schramm and 
Hernandez, 2002). Photocrosslinking experiments have revealed that this 
enormous and flexible transcription factor can span the entire length of a tRNA 
gene (Bartholomew et al., 1990). Although both A- and B-blocks are contacted 
by TFIIIC, the latter is the major determinant of its binding affinity (Baker et al., 
1986).  
Human TFIIIC is composed of 5 polypeptides, known as TFIIIC220, 110, 102, 90 
and 63, according to their molecular masses (Kovelman and Roeder, 1992). 
Three of these TFIIIC subunits (220, 110 and 90) have been shown to possess 
histone acetyltransferase (HAT) activity, which may serve to remodel chromatin 
in the vicinity of class III genes  to access the promoter (Hsieh et al., 1999a; 
Kundu et al., 1999). 
The primary function of TFIIIC is to recruit TFIIIB and to position it just upstream 
of the transcription start site. TFIIIB consists of three proteins: TATA box-binding 
protein (TBP) and two TBP-associated factors, known as TFIIB-related factor 1 
(Brf1) and B double prime (Bdp1) (Schramm and Hernandez, 2002). Human TBP, 
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160kDa, respectively. While Brf1 and Bdp1 are specifically involved in the 
transcription of class III genes, TBP is also used by the transcription machineries 
of RNA polymerase I and RNA polymerase II (Cormack and Struhl, 1992). Brf1 
forms a tight association with TBP in solution; however, Bdp1 is only weakly 
associated with this complex, if at all, in the absence of a DNA template 
(Geiduschek and Kassavetis, 2001; Huet et al., 1994; Kassavetis et al., 1991; 
Schramm and Hernandez, 2002; Schramm et al., 2000). 
The recruitment of TFIIIB to class III gene promoters by TFIIIC has been best 
studied in S. cerevisiae. During transcription initiation complex formation, DNA-
bound TFIIIC initially contacts the Brf1 subunit of TFIIIB, and this is thought to 
occur via the S. cerevisiae equivalent of human TFIIIC102 (Kassavetis et al., 
1992b; Schramm and Hernandez, 2002). Several subsequent interactions that 
occur between each of the TFIIIB subunits and various TFIIIC components are 
also likely to participate in the formation of a stable pre-initiation complex 
(Schramm and Hernandez, 2002). The human TFIIIC102, TFIIIC63 and TFIIIC90 
subunits bind to Brf1 (Hsieh et al., 1999a; Hsieh et al., 1999b) and the TFIIIC102 
and TFIIIC63 subunits bind to TBP (Hsieh et al., 1999a). These interactions 
between the TFIIIC102 and TFIIIC63 subunits, taken together with the fact that 
TFIIIC63 interacts with the A-block (Hsieh et al., 1999a), provides a link between 
the TFIIIB-interacting and DNA-interacting subunits of TFIIIC. Since TFIIIB 
contains TBP, it can bind independently of TFIIIC to a TATA box (Joazeiro et al., 
1994). However, most of the type 2 promoters lack a TATA sequence and cannot 
be recognised this way. 
TFIIIC and TFIIIB are essential for the recruitment of RNA polymerase III to the 
transcription start site of type 2 promoter-class III genes (Figure 1.2). RNA 
polymerase III is the largest of the eukaryotic nuclear RNA polymerases. It is 
composed of 17 subunits in yeast and humans, adding up to a 600-700kDa 
complex (Geiduschek and Kassavetis, 2001; Schramm and Hernandez, 2002). 
Several factors, however, contribute to the selection of the transcription start 
site. Additional internal or flanking sequences commonly confer modulatory 
effects.  Indeed, although the site at which initiation can occur is dictated 
primarily in relation to the A-block (Baker et al., 1987; Ciliberto et al., 1983), 
the precise start site within that region is determined by local sequence.  Thus, 
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(Ciliberto et al., 1983; Fabrizio et al., 1987) and the upstream flanking region 
can also be influential.  In most cases, the 5’ flanking sequences have an overall 
stimulatory influence upon transcription, although repressive effects can also 
occur (DeFranco et al., 1981; Dingermann et al., 1982; Hipskind and Clarkson, 
1983). Despite their modulatory effects, flanking regions are generally poorly 
conserved.  Indeed, the 5’ flanking regions of tRNA genes display little or no 
homology, even between different genes encoding the same tRNA isoacceptor 
(Kubli, 1981).  This variation may provide a mechanism for differential 
regulation of tRNA genes in response to differing codon and amino acid demands 
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Figure   1-2 RNA polymerase III transcription complex assembled on type II promoter. 
 
The 5’ flanking sequence has also been shown to be important for 7SL RNA gene 
function (Ullu and Weiner, 1985). Alu elements ancestrally derived from this 
gene acquire a new 5’-flanking sequence after being transposed and this could 
lead to markedly decreased efficiency in transcription. Studies of Alu elements 
transcription showed that indeed the 5’-flanking region is important and 
alterations can result in a significant decrease in transcription in vitro 
(Chesnokov and Schmid, 1996; Roy et al., 2000; Shaikh et al., 1997). This could 
be due to a reasonable TATA box (Shaikh et al., 1997) or an Ap1 (activator 
protein 1 transcription factor) binding site, which was shown to be responsible 
for stimulating transcription (Chesnokov and Schmid, 1996). These assays were 
further done in vivo in HeLa cells (a cervical cancer cell line). Chimeric 
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transcription, while other Alu flanked just by vector sequence was hardly 
detectable (Roy et al., 2000). In other work, expression of Alu elements was 
tested with or without the added 7SL enhancer sequence. Levels of transcripts 
produced from Alu elements without the 7SL enhancer sequence were 3-5 times 
lower, indicating that the marked Alu sequence should be 
transcription/transposition competent regardless of its flanking DNA 
(Dewannieux et al., 2003). 
Still, the principal determinant that dictates the general location where TFIIIB 
and RNA polymerase III is positioned is TFIIIC. The interface between these 
factors is quite flexible and allows TBP to scan the region within 30 bp for an 
optimal site for TFIIIB. Also, RNA polymerase III has certain sequence 
preferences and will look for optimal initiation sites (Joazeiro et al., 1996). For 
RNA polymerase III recruitment, all the three TFIIIB subunits are required; 
however, only Brf1 and TBP have been shown to make direct contacts with RNA 
polymerase III (Schramm and Hernandez, 2002). The majority of direct 
interactions occur between Brf1 and RNA polymerase III subunits RPC32, RPC39 
and RPC62 (Wang and Roeder, 1997), although TBP can also associate with 
RPC39 (Wang and Roeder, 1997). In addition to these interactions, TFIIIC has 
been shown to interact with the RNA polymerase III subunit RPC62 via TFIIIC63 
(Hsieh et al., 1999a). 
1.2.3 Transcription initiation, elongation and termination by RNA 
polymerase III 
Following RNA polymerase III recruitment, the two strands of DNA around the 
transcription start site are separated to form a transcription bubble (Geiduschek 
and Kassavetis, 2001). This melting of the DNA helix allows the polymerase to 
access the template strand, and is required before transcription can proceed. 
DNA melting is performed by the polymerase, although the Brf1 and Bdp1 
components of TFIIIB also play an active role (Geiduschek and Kassavetis, 2001; 
Kassavetis et al., 1998; Kassavetis et al., 2001; Schramm and Hernandez, 2002). 
Thus, TFIIIB serves not only to recruit RNA polymerase III, but also participates in 
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Once the DNA strands have been separated, RNA synthesis can be initiated, and 
the polymerase progresses into the gene and dissociates from promoter-bound 
TFIIIB without significant pausing or arrest (Bhargava and Kassavetis, 1999). As 
RNA polymerase III progresses into the gene, the bubble of melted DNA moves 
with it (Kassavetis et al., 1992a).  Although TFIIIC assembles within the 
transcribed regions of the majority of class III genes, this large factor is not 
dissociated from promoters during elongation (Paule and White, 2000). It is 
surprising that the DNA-bound transcription complex of TFIIIC and TFIIIB effects 
very little the progression of the polymerase during transcription. During 
transcription in the normal direction, the presence of TFIIIC delays RNA 
polymerase III for just 0.2 s (Matsuzaki et al., 1994). However, unlike RNA 
polymerase I and RNA polymerase II, RNA polymerase III does not require any 
accessory factors for efficient chain elongation (Geiduschek and Kassavetis, 
2001; Schramm and Hernandez, 2002). It is believed that the main reason is that 
RNA polymerase III-transcribed genes are extremely short. SINEs, some of them 
being over 300 nt long, constitute the longest RNA polymerase III-derived 
transcripts.  Also, elongation of RNA polymerase III does not proceed at a 
uniform rate (Matsuzaki et al., 1994) and in yeast, RNA polymerase III subunit 
C11 was found to be involved in the pausing (Chedin et al., 1998). It shares 
significant homology with RNA polymerase II-specific elongation factor TFIIS. It 
may be that C11 subunit performs similar function to TFIIS. 
Termination by RNA polymerase III occurs independently of other factors too: 
four or more T residues within the template strand of a class III gene are 
sufficient to signal the accurate and efficient termination of transcription  
(Bogenhagen and Brown, 1981; Cozzarelli et al., 1983). It has been proposed 
that the La antigen is involved in termination (Gottlieb and Steitz, 1989a; 
Gottlieb and Steitz, 1989b; Maraia et al., 1994). Immunodepletion of La from 
cell extracts
 was found to reduce RNA polymerase III output in vitro, which led 
to the
 suggestion that La could act as a transcriptional termination
 factor that 
mediates nascent transcript release (Gottlieb and Steitz, 1989a; Gottlieb and 
Steitz, 1989b). The presence of La on RNA polymerase III templates was also 
shown in vivo, although its function remains to be confirmed (Fairley et al., 
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Following the synthesis of the first transcript, RNA polymerase III is known to be 
recycled on the same DNA template for several further rounds of transcription 
(Dieci and Sentenac, 1996). The process is likely to involve a direct coupling 
between termination and re-initiation as demonstrated by findings that run-off 
termination on truncated class III genes does not allow efficient recycling and 
re-initiation (Dieci and Sentenac, 1996). This enables a stable complex on a 
yeast tRNA gene to direct subsequent cycles 5- to 10-fold more rapidly than the 
first. During multiple round transcription, synthesis of each tRNA molecule takes 
~35 s, whereas initiation of the first transcription takes ~5 min. As a 
consequence, the slow initial step of polymerase recruitment is avoided, making 
the production of subsequent RNAs by RNA polymerase III more efficient (Dieci 
and Sentenac, 1996). Human RNA polymerase III can also be recycled, as was 
shown for VA and tRNA genes (Jahn et al., 1987). Addition of human 
recombinant La to isolated RNA polymerase III transcription
 complexes 
assembled on the VA1 promoter from mammalian cell extracts led to increases
 in 
transcription, apparently due to enhanced RNA polymerase III recycling
 and 
reinitiation (Maraia, 1996; Maraia et al., 1994). Newer findings indicate that 
yeast TFIIIB participates in this RNA polymerase III recycling on shorter 
transcripts and for longer transcripts, TFIIIC is also required (Ferrari et al., 
2004).   
1.2.4 Regulators of RNA polymerase III transcription 
Transcription of RNA polymerase III genes is essential for sustained protein 
synthesis and is therefore a fundamental determinant of the capacity of a cell to 
grow. It gets upregulated in many situations involving cell growth. This process is 
often regulated through overexpression of transcription factors or release from 
repressors that control RNA polymerase III output in healthy cells. These factors 
have been well studied (see below). However, in the case of SINEs, often more 
global factors are involved in the regulation, such as DNA methylation and 
chromatin. In the following paragraphs, aspects and situations which were shown 
to affect the expression of SINEs are mentioned, excluding chromatin-mediated 
regulation which is going to be described in section 1.3. 
The first way in which RNA polymerase III output is increased is by increased 
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variety of viruses have been shown to stimulate RNA polymerase III transcription 
this way, to meet an increase in biosynthetic demand. Adenoviral infection or 
SV40 transformation studies revealed that TFIIIC activity is increased (Hoeffler et 
al., 1988). In adenoviral infection, deregulation is largely due to the adenoviral 
oncoprotein E1A. Mutant virus strains lacking E1A show little or no activation of 
VA (Berger and Folk, 1985; Sollerbrant et al., 1993).  Furthermore, purified 
recombinant E1A can stimulate VA1 transcription by up to 50-fold in HeLa 
extracts (Datta et al., 1991).  However, E1A does not bind to the VA1 gene to 
exert a direct effect (Datta et al., 1991) but influences transcription through the 
general RNA polymerase III factors.  HeLa cells infected with wild-type 
adenovirus display a significant elevation in TFIIIC2 activity (Hoeffler et al., 
1988).  This is a manifestation of a selective increase in the level of the 
TFIIIC110 subunit, seemingly through an induction of TFIIIC110 mRNA by E1A 
(Sinn et al., 1995) that raises the proportion of the transcriptionally active TFIIIC 
form (Hoeffler et al., 1988). All the five subunits of TFIIIC are overexpressed at 
both the mRNA level and protein level in fibroblasts transformed by Simian virus 
SV40 or polyomavirus (Felton-Edkins and White, 2002; Larminie et al., 1999).  
TFIIIB is also activated during adenoviral infection, SV 40 and EBV transformation 
and infection by human papillomaviruses (HPVs). Several of them achieve that 
through binding to RB protein. RB is a retinoblastoma tumour suppressor protein 
which has strong capacity to repress RNA polymerase III transcription (White et 
al., 1996). When bound by RB, TFIIIB is unable to interact with either TFIIIC or 
RNA polymerase III (Sutcliffe et al., 2000). Viruses encode oncoproteins that 
disrupt RB-mediated repression of TFIIIB by binding to the RB pocket. These 
include the E1A product of adenovirus, the E7 product of HPV and the large T 
antigen of SV40, all of which have been shown to release TFIIIB from repression 
and therefore stimulate RNA polymerase III transcription (DeCaprio et al., 1988; 
Dyson et al., 1989; Whyte et al., 1988). During EBV infection the stimulation of 
TFIIIB is achieved via stimulation of expression of Bdp1 subunit, which is enough 
to increase EBER expression in vivo (Felton-Edkins et al., 2006).  
TFIIIB is bound and repressed not only by RB but also by p53 (Cairns and White, 
1998; Chesnokov et al., 1996). When bound by p53, TFIIIB is unable to interact 
with TFIIIC and be recruited to RNA polymerase III templates (Crighton et al., 
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(Panning and Smiley, 1995).  E1B is able to bind and inactivate p53, suggesting 
that adenovirus infection may also overcome the regulatory effects of p53 on 
RNA polymerase III transcription (Ko and Prives, 1996). The HPV oncoprotein E6 
was also shown to target wildtype p53 for degradation (zur Hausen, 2000). 
p53  appears to function as a general repressor of class III gene expression; 
however, these genes display differential sensitivity to the repressive effects of 
p53, with genes such as Alu and U6, possessing weak promoters, appearing most 
susceptible (Cairns and White, 1998; Chesnokov et al., 1996).   
TFIIIB serves as a direct target for repression by p53.  Co-fractionation and co-
immunoprecipitation experiments demonstrated that p53 associates with 
endogenous TFIIIB in a relatively stable complex at physiological ratios (Cairns 
and White, 1998).  In wild-type fibroblasts TFIIIB is limiting, but disruption of the 
p53 gene conferred a specific increase in TFIIIB activity and RNA polymerase III 
transcription.  Furthermore, the inhibition by p53 of in vitro RNA polymerase III 
transcription can be specifically relieved by the addition of excess TFIIIB (Cairns 
and White, 1998).  It has also been shown that the N-terminal region of p53, 
which possesses a TBP-binding site, is sufficient to bind TFIIIB (Chesnokov et al., 
1996).  Point mutations that abolish the binding of free TBP similarly abolish 
TFIIIB binding and, moreover, also abrogate the ability of p53 to repress RNA 
polymerase III transcription (Chesnokov et al., 1996).  These data suggest that 
p53-repression of RNA polymerase III transcription involves a direct interaction 
with TBP within the TFIIIB complex.  Once TFIIIB has been assembled into a 
transcription complex, however, it becomes significantly less susceptible to p53-
repression (Cairns and White, 1998). Conversely, when bound by p53, TFIIIB 
cannot be recruited to promoters, as shown by chromatin immunoprecipitation 
of tRNA genes in living cells (Crighton et al., 2003). P53 was also shown to 
recruit chromatin remodelling and corepressor complexes such as SIN3 (Murphy 
et al., 1999).  
TFIIIB further interacts with the proto-oncogene product c-myc (Gomez-Roman 
et al., 2003). c-myc is deregulated in a wide range of malignancies, including 
Burkitt’s lymphoma, neuroblastomas and colon cancers (Dang, 1999; Nesbit et 
al., 1999). Depletion of c-myc by RNAi showed that it contributes to elevated 
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2003). Moreover, c-myc significantly contributes to the levels of RNA polymerase 
III transcripts in normal mammalian cells (Gomez-Roman et al., 2003). Gene 
occupancy by TFIIIB increases rapidly in response to c-myc that can be found at 
RNA polymerase III promoters, including B2 SINEs (Gomez-Roman et al., 2003). It 
is then followed by recruitment of RNA polymerase III and induction of 
transcription (Kenneth et al., 2007). c-myc has a strong stimulatory effect on 
RNA polymerase III transcription both in human and mouse cells. When c-myc 
knockout and matched wild type fibroblasts are compared, the knockout 
fibroblasts show approximately sevenfold lower expression of B2 RNA. Human 
SINEs were not tested (Gomez-Roman et al., 2003). 
RNA polymerase III transcript levels (including SINEs) are substantially reduced 
when F9 embryonal carcinoma (EC) cells differentiate into parietal endoderm 
upon induction with retinoic acid and cAMP (Murphy et al., 1983; White et al., 
1989).  This reduction in RNA polymerase III transcription rate was shown to be 
mediated again via this key transcription factor TFIIIB through its specific down-
regulation (White et al., 1989).  There is a significant decrease in the Brf1 
subunit of TFIIIB (Alzuherri and White, 1998) and some decrease in the level of 
TBP (Alzuherri and White, 1998; Alzuherri and White, 1999; Perletti et al., 
2001). Despite the fact that TBP is utilised to transcribe all three classes of 
genes, there is no overall change to RNA polymerase II transcriptional activity 
(White et al., 1989).  
There are many more regulators of RNA polymerase III transcription, but these 
have not yet been connected to regulation of SINEs transcription and they are 
therefore not going to be mentioned here. 
1.3 Chromatin and its effect on transcription 
The human genome would extend to about 2m if unravelled. In order to fit into 
the nucleus, the DNA assembles with histone and non-histone proteins into 
chromatin and is further compacted into chromosomes. The chromatin proteins 
that serve to compact DNA in vivo are not merely a packing material, but 
provide a dynamic structure that is utilized by the cell to regulate gene 
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1.3.1 Chromatin structure 
Chromatin is generally comprised of 147 bp of DNA wrapped 1.65 turns around an 
octamer of histone molecules, the linker DNA between adjacent histone 
octamers, and members of a class of linker histones that bind the linker DNA and 
nucleosome core (Kornberg and Lorch, 1999; Zlatanova et al., 1999). The four 
histone subnits, H2A, H2B, H3 and H4 are amongst the best-conserved proteins in 
eukaryotes. Adjacent nucleosomes are connected by linker H1 DNA, which binds 
at the point where DNA enters and exits the subunits (Crane-Robinson, 1997). 
Progressive coiling of nucleosomes leads to compact higher-order chromatin 
structures. Arrays of nucleosomes compact to form 30-nm chromatin fibre and 
two competing classes of models have been suggested in which nucleosomes are 
either arranged linearly in a one-start higher order helix or zigzag back and forth 
in a two-start helix (Dorigo et al., 2004). A variety of evidence suggests that 
electrostatic interactions between nucleosomes are the driving force in 
chromatin fibre compaction. These interactions are favoured by increasing salt 
concentrations, which reduce the repulsive forces between linker DNA (Sun et 
al., 2005) and are likely to be modulated by post-transcriptional modifications 
that alter the charge of the very long histone tails (see below). The structure 
can also be modulated by other proteins, including the linker histone H1 and the 
HMGN non-histones. H1 and HMGN seem to have opposite effects on the 
structure of chromatin. Linker histone H1 influences the degree of chromatin 
compaction and its removal leads to decondensation (Fan et al., 2005). In 
contrast, HMGN (high mobility group N) proteins are nucleosome binding proteins 
that reduce the compaction, probably via their negatively charged C-terminal 
domains (Bustin, 2001). The chromatin fibres are assembled further into large 
domains, usually of 40-100 kb, containing non-histone proteins performing both 
structural and regulatory functions. These domains undergo further folding 
within the chromosome. 
 
1.3.2 Chromatin regulates gene expression 
Historically, chromatin was classified into two forms, heterochromatin and 
euchromatin (Sarma and Reinberg, 2005). Euchromatin is the region of Jana Vavrova, 2008    Chapter 1, 35 
chromatin that is decondensed and is thought to represent loci that are 
transcriptionally active. Heterochromatin is highly compacted chromatin with 
regions of silenced DNA. Heterochromatin is further classified into constitutive 
heterochromatin and facultative heterochromatin. Constitutive heterochromatin 
is the region that is juxtaposed to centromeres of human chromosomes and is 
irreversibly silenced, while facultative heterochromatin referrers to regions 
which are silenced but can become transcriptionally active. Active and silent 
regions of chromatin are often considered to have ‘open’ and ‘closed’ chromatin 
structures, respectively (Felsenfeld and Groudine, 2003). 
Chromatin fibre structures can be studied through nuclease accessibility. DNase I 
and micrococcal nuclease (MNase) are the two most commonly used nucleases 
for these studies (Rando, 2007). Transcriptionally active regions are considered 
to be more sensitive to DNaseI nuclease digestion than inactive regions (Gazit et 
al., 1982), while this is not seen with MNase that cuts linker DNA (Gilbert et al., 
2004). Only recently was the structure of human 30nm chromatin fibre studied in 
detail. It was shown that human heterochromatin is surprisingly heterogeneous 
in structure and that there is no structural division between heterochromatin 
and euchromatin (Gilbert et al., 2004). There does not seem to be a simple 
correlation between gene expression and open chromatin fibres. Conversely, in 
regions of low gene density, active genes could be found with large domains of 
compact fibres. These findings challenge the historical view of the structural 
division of the two forms of chromatin. 
Significant advances have been made in recent years to understand how 
chromatin and its modification and remodelling contribute to gene regulation. 
Both non-histone and histone proteins play a role, together with modifications of 
DNA itself. Chromatin remodelling complexes have been identified, the SWI/SNF 
family being the best characterised in humans (Langst and Becker, 2001; 
Tsukiyama, 2002). Chromatin-remodelling complexes mobilize nucleosomes, 
involving the breaking and reforming of histone-DNA contacts which cause the 
histone octamers to move short distances along the DNA. The precise mechanism 
is still unknown (Becker and Horz, 2002). Interplay exists between chromatin 
remodelling and histone modifications (see below) which results in gene-specific 
transcriptional activation or repression that is generally affected by the binding 
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1.3.3 Histone posttranslational modifications and gene regulation 
During the past decade strong evidence has built up demonstrating that 
posttranslational modifications of the core histones H2A, H2B, H3 and H4 are 
associated with transcriptionally active and inactive DNA sequences. Histones 
are small basic proteins consisting of a globular domain and a more flexible and 
charged NH2-terminus, called the histone tail that protrudes from the 
nucleosome. Multiple modifications decorate each histone tail within the 
nucleosome, including some amino acids that can be modified in several 
different ways. Covalent modifications of histone tails known so far include 
acetylation, phosporylation, methylation, ubiquitylation and SUMOylation on 
various residues.  
Histones contain a high proportion of amino acids with basic side chains, which 
are positively charged in physiological conditions and they are attracted by 
electrostatic interactions to the negatively charged DNA. Histone modifications 
result in a change in the net charge of nucleosomes (with the exception of 
methylation), which could loosen inter- or intranucleosomal DNA-histone 
interactions, thus control access of DNA-binding proteins such as transcription 
factors. This idea is supported by the observation that acetylated histones are 
easier to displace from DNA (Zhao et al., 2005). Attached chemical moieties also 
alter nucleosome surface and promote the association of chromatin-binding 
proteins (Berger, 2007). 
1.3.3.1  Lysine acetylation 
There are at least two different mechanisms by which acetylation and 
deacetylation of histone lysines regulates chromatin-based processes 
(Shahbazian and Grunstein, 2007). In one case, acetylation (or deacetylation) of 
many residues is coordinated, and the combined effect dictates function. In the 
other case, acetylation (or deacetylation) of specific residues has precise 
effects. It is becoming evident that a combination of these two mechanisms 
dictates the functional outcome of histone acetylation and deacetylation. 
There is abundant evidence that acetylation of histone H3 and histone H4 (H3 
and H4) are associated with active transcription (Kurdistani et al., 2004; 
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acetylation include K9, K14, K18 and K56 at histone H3 and lysines K5, K8, 
K12,K16 at histone H4 (Berger, 2007). The combination of a general effect in 
addition to a position-dependent effect of acetylation is apparent in 
transcription. For example, a study showed that the acetylation of many 
different lysine residues correlates with transcription, but individual mutations 
in H4K5, H4K8 and H4K12 have minor effects on transcription (Dion et al., 2005). 
Combined mutations, however, lead to cumulative changes in the expression of 
a group of genes. In contrast, H4K16 has a specialized role in transcription. If 
mutated it leads to changes in gene expression different than those caused by 
individual and combined mutations in the other H4 tail lysines (Dion et al., 
2005).It was shown that the hypoacetylated state of H4K16 correlates with gene 
activity and with the binding of Bdf1 (Kurdistani et al., 2004).  
In general, acetylated lysines may decrease the histone-DNA interaction and 
promote accessibility of the DNA for transcription. Moreover, an acetylated 
lysine no longer has a basic side chain, allowing it to be recognized by 
bromodomains found in many chromatin-associated proteins including 
transcription complexes  (Agalioti et al., 2002; Lee et al., 1993; Vettese-Dadey 
et al., 1996). 
Acetylation of lysines is established via histone acetyltransferases (Brown et al., 
2000) and removed by histone deacetylases (Cress and Seto, 2000). 
Histone acetyltransferases interact with transcriptional coactivators such as 
p300, CBP and PCAF, that physically connect many DNA-binding factors to the 
basal transcription machinery (Ogryzko et al., 1996; Yang et al., 1996).  
Histone deacetylases (HDACs) have been identified as common components of 
diverse transcription regulators, mainly corepressors, indicating that 
deacetylases play a general role in repression of gene expression. In humans, 
eight deacetylases have been identified, HDAC1-HDAC8 (Cress and Seto, 2000). 
Like acetyltransferases, deacetylases are found as part of multiprotein 
complexes. Two corepressor complexes, Sin3 and NuRD, have been well 
characterised (Knoepfler and Eisenman, 1999). In mammalian cells, both 
complexes contain HDAC1 and HDAC2 (Knoepfler and Eisenman, 1999; Zhang et 
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proteins such as MBDs (Zhang et al., 1999) and p53 (Murphy et al., 1999), or via 
interaction with other corepressors such as coREST (You et al., 2001). 
1.3.3.2  Lysine methylation 
A large body of evidence demonstrated that histone lysine methylation is 
involved at many levels in the regulation of gene expression. However, the 
precise mechanisms by which it contributes to transcription stay mostly 
unresolved (Shilatifard, 2006). The most-studied sites of lysine methylation lie in 
the tails of H3 and H4 histones. Historically, it was thought that methylation of 
lysines 4, 36, and 79 of histone H3 (H3K4, H3K36 and H3K79) occurs primarily at 
transcriptionally active genes (Bannister et al., 2005; Bernstein et al., 2005; 
Pokholok et al., 2005), whereas methylation of H3K9, H3K27 and H4K20 have 
been connected to transcriptionally repressed genes and heterochromatic 
regions (Cao et al., 2002; Peters et al., 2001; Rice et al., 2003; Schotta et al., 
2004).  
It is clear today that lysine methylation displays the highest degree of 
complexity among known covalent histone modifications and this complexity is 
further multiplied by the fact that lysine methylation can occur several times 
(mono-, di- or trimethylation). Recent detailed studies showed that the level of 
modification is very important. Active genes were characterized by high levels of 
H3K4me1, H3K4me2, H3K4me3, H3K9me1 around transcription start sites and 
elevated levels of H3K36me3, H3K27me1, and H4K20me1 downstream of 
transcription start sites and throughout the entire transcribed regions (Barski et 
al., 2007; Vakoc et al., 2006). H3K9me3 could also be found at actively 
transcribed promoters (Squazzo et al., 2006; Vakoc et al., 2005). 
In contrast, inactive genes were characterized by high levels of H3K9me2, 
H3K27me3, H3K79me3 and H4K20me3 in promoter and gene-body regions and 
low or negligible levels of H3K4 methylation at promoter regions and low or 
negligible levels of H3K36me3, H3K27me1, H3K9me1, and H4K20me1 in gene-
body regions  (Barski et al., 2007; Schotta et al., 2004). H3K9me3 was found to 
be associated with inactive genes in both of the studies and has long been 
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Lysine methylation is established via histone methyltransferases (Sims et al., 
2003) and can be removed by histone demethylases (see below). 
Histone methyltransferases (HMTs) transfer methyl groups to histone tails. The 
best studied are HMTs containing a SET domain, 130- to 140-amino acid motif 
responsible for transfer of the methyl group to histone lysines (Jenuwein et al., 
1998). SUV39H1 was described as an HMT whose activity is specific for H3K9 
methylation (Rea et al., 2000). Methylation of H3K9 creates
 a motif that is 
specifically recognized and bound by the chromodomain
 of heterochromation 
protein 1 (HP1) (Lachner et al., 2001). In fission yeast (there is no H3K9 HMT in 
budding yeast (Sims et al., 2003)), the disruption of the Clr4 gene (which 
encodes another HMT) resulted in the loss of
 localization of Swi6 (homologue of 
HP1), illustrating that H3
 methylation is required in the recruitment of HP1 and 
heterochromatin
 assembly in vivo (Nakayama et al., 2001). The activity of 
Suv39h1 and Clr4 and both H3K9 methylation and HP1 binding have critical roles 
in heterochromatin
 formation (Nakayama et al., 2001) (44,58,59 in big review) 
str 251. G9a and SETDB1 are two other well characterised HMTs. G9a is able to 
methylate other residues than just H3K9 (Tachibana et al., 2001) and both G9a 
and SETDB1 contribute to H3K9 methylation mainly in euchromatic rather than 
heterochromatic regions (Schultz et al., 2002; Tachibana et al., 2005). The 
connection with HP1 provides a
 molecular explanation for the general 
correlation of K9 methylation
 with transcription silencing or repression. H3K9 
can also inhibit transcription through its interaction with HDACs (Stewart et al., 
2005).  
Post-translational histone modifications, such as acetylation, are reversible. By 
contrast, lysine methylation of histones was long thought to be irreversible. 
Recently,  lysine-specific demethylase enzymes such as the lysine-specific 
demethylase 1 (LSD1) enzyme (Shi et al., 2004),  the jumonji C (JmjC)-domain-
containing histone demethylase 1 (JHDM1) (Tsukada et al., 2006) and JMJD2 
family (Cloos et al., 2006; Whetstine et al., 2006) were identified. LSD1 and 
JHDM1 were shown to mediate demethylation of di- and monomethylated 
histones. JmjC-domain-containing members of the JMJD2 family efficiently 
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1.3.3.3  Lysine ubiquitination and sumoylation 
Through proteosome-dependent degradation, the covalent modification of 
specific histone lysines by ubiquitin or a small ubiquitin-related modifier sumo 
plays a role in regulating transcription. Sumoylation can play a role in 
transcriptional repression (Shiio and Eisenman, 2003), while ubiquitination of 
lysine residue at histones H2A and H2B is regarded as a positive mediator of 
transcription (Zhang, 2003). Ubiquitination was also shown to be linked to lysine 
methylation (Daniel et al., 2004; Henry et al., 2003). The ubiquitin attachment 
involves E1 activation, E2 conjugation and E3 ligase enzymes. Bre1 was 
identified as E3 ligase for H2B ubiquitination (Wood et al., 2003). Ubiquitination 
is a reversible process and H2B was shown to be deubiquitinated by Ubp8 (Henry 
et al., 2003). 
1.3.3.4  Arginine methylation 
The catalytic module that methylates specific arginines is known as the PRMT 
(protein R methyltransferase) domain. It transfers the methyl group from SAM to 
the guanidine group of arginines to produce monomethylarginine and 
dimethylarginine (Zhang and Cheng, 2003). Methylation of specific arginines in 
histone H3 (R17 and R26) and H4R3 correlates with the active state of 
transcription. For example, methylated H4R3 facilitates H4 acetylation and 
enhances activation of transcription by a nuclear hormone receptor (Wang et al., 
2001). 
1.3.3.5  Serine phosphorylation 
Phosphorylation of the histone serines can be established by several kinases such 
as Aurora B or PKA and reversed by the phosphatase 1 (PP1) family (Hsu et al., 
2000). Phosphorylation of the histone H3 serine10 is the best characterized with 
regards to transcription (Clements et al., 2003). It correlates with mitosis and 
chromosome condensation but also with active transcription. It enhances H3K14 
acetylation by additional interactions with HAT which then results in promotion 
of transcription. Phosphorylation may thus play a role in regulation of other 
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1.3.4 Linker histone H1 and gene regulation 
Another important component of chromatin structure is the linker histone H1. 
H1 plays an important structural and functional role in chromatin. The presence 
of bound H1 also has a strong inhibitory effect in vitro on nucleosome mobility 
(Pennings et al., 1994). It interferes with chromatin remodelling complex 
activities when present on the chromatin fibre (Horn et al., 2002). It is often 
depleted on active chromatin and can cause inhibition of transcription in vitro 
(Bresnick et al., 1992; Shimamura et al., 1989; Smith and Hager, 1997). It was 
therefore long considered as a global repressor of gene activity through its 
compaction of chromatin. The concept of H1 as a general repressor of chromatin 
activity was then challenged in vivo. In higher organisms, studies on H1 are 
complicated by the presence of several subtypes, encoded by separate genes. In 
mice, there are six somatic subtypes (H1a-e and H1
0), which differ in primary 
sequence and in relative abundance from tissue to tissue (Fan et al., 2003; Fan 
et al., 2005). In the mouse, deletion of one or two H1 subtypes results in a 
compensatory upregulation of other subtypes, resulting in the normal level of 
H1/nucleosome and no apparent phenotype (Fan et al., 2003; Fan et al., 2001; 
Sirotkin et al., 1995). Cells and tissues can tolerate very low levels of H1 and 
only a small percentage of genes are affected in their activity (Fan et al., 2003; 
Fan et al., 2005).  
1.3.5 HMGN and gene regulation 
Although removal of histone H1 leads to small changes in global transcription 
levels (Fan et al., 2005), there is evidence on the other hand that non-histone 
architectural proteins such as HMGN can modulate transcription (Bustin, 2001; 
West et al., 2004). HMGN (high mobility group N) proteins alter chromatin 
structure by unfolding chromatin and they are considered to be associated with 
actively transcribed genes. There are currently four members of the family, but 
details about their role in transcription remain mostly unknown mainly due to 
the fact that these proteins are only present in higher eukaryotes (West, 2004). 
Hmgn1
-/- mice appear normal but the expression of some of their genes is 
altered (Birger et al., 2003). Recently, overexpression of two splice variants of 
another member of the HMGN family, HMGN3 indicated that HMGN may play a 
role in Glyt1 (glycine transporter 1) expression (West et al., 2004). Jana Vavrova, 2008    Chapter 1, 42 
 
1.3.6 DNA methylation and its mediators 
DNA methylation is a covalent modification of cytosine by the addition of a 
methyl group to the 5 position of the nucleotide ring. It appears that DNA and 
histone methylation have a cyclical and mutually reinforcing relationship,
 and 
both are required for stable and long-term epigenetic silencing (Cheung and Lau, 
2005). Direct functional links between DNA
 and histone methylation have been 
uncovered. For example, in Neurospora
 and Arabidopsis, genetic evidence 
indicates that H3K9 methylation
 is a prerequisite for DNA methylation to occur 
(Tamaru and Selker, 2001). Loss
 of Suv39H1/2 in knockout mouse cells also 
altered the DNA methylation
 pattern of their pericentric heterochromatin 
(Lehnertz et al., 2003). On the other
 hand, examples of ablation of DNA 
methylation affecting H3 methylation
 and other histone modifications have also 
been found in Arabidopsis
 and human cells (Espada et al., 2004; Tariq et al., 
2003). It is also connected to deacetylation by HDACs and binding of chromatin 
remodelling complexes and corepressors.  
It is known that the presence of methylated CpG can interfere with binding of 
some transcription factors to their cognate sites as shown in Figure 1.3a (Tate 
and Bird, 1993).  Exclusion of transcription factors and other proteins by DNA 
methylation of their cognate DNA binding sites can directly affect the 
transcription of the associated genes (Hark et al., 2000; Kim et al., 2003). Also, 
DNA methylation can directly influence the translational positioning of a 
nucleosome at specific DNA sequences in vitro and could lead to masking of 
essential regulatory elements by nucleosomes (Davey et al., 1997). The methyl 
group is thought to make the double helix more rigid, thereby restricting DNA 
affinity for the histone octamer, which results in an overall effect on the 
positioning of the nucleosome in the chromatin structure (Davey et al., 2004). 
DNA methylation also affects binding of linker histone H1. That has an effect on 
nucleosome structure, but not on chromatin compaction (Gilbert et al., 2007). In 
addition to these direct mechanisms of repression, there is now evidence for 
indirect repression mechanisms that are mediated by proteins that bind to 
methylated DNA (Figure 1.3b). 








Figure   1-3 DNA methylation-mediated repression. 
A. DNA methylation directly inhibits binding of some transcription factors. B. MBD proteins 
directly recognize methylated DNA and recruit corepressors and/or chromatin remodeling 
complexes to modify surrounding chromatin. (adapted from Klose and Bird, 2006). 
 
1.3.6.1  MBD proteins 
Following the initial demonstration that extracts of human cells contain proteins 
that bind to methylated DNA (Huang et al., 1984), and the discovery of the 
MeCP1 complex (Meehan et al., 1989), that has been shown to bind methylated 
promoters and repress transcription both in vitro and in vivo (Boyes and Bird, 
1991), a number of proteins have been identified. MeCP2 was discovered in 1992 
(Lewis et al., 1992; Meehan et al., 1992); MBD1 (formerly PCM1) was identified 
in 1997 by a search of DNA sequence databases. It shared similarity with MeCP2 
in its MBD domain. It was shown to bind to methylated DNA and to repress 
transcription from methylated templates (Cross et al., 1997). In addition to 
MeCP2 and MBD1, three other proteins that contain a methyl-CpG binding 
domain were identified – MBD2, MBD3 and MBD4 (Figure 1.4) – and together with 
MBD1 further characterised (Hendrich and Bird, 1998). With the exceptions of 
MBD2 and MBD3, sequence similarity between the proteins is limited to the MBDs 
themselves. MBD2 and MBD3 show high conservation between human and murine 
genes (97.6 and 93.8% amino acid identity, respectively), whereas the human 
and murine homologues of MBD1 and MBD4 are less conserved (70.9 and 65.5%, 
respectively). All these genes produce alternatively spliced variants. MBD2 and 
MBD4 bind specifically to methylated DNA only and it appears to be independent 
of sequence context. Localisation studies of GFP-fused proteins showed that 
MBD1, MBD2, and MBD4 colocalised with major satellite DNA in mouse cells, but Jana Vavrova, 2008    Chapter 1, 44 
localisation of MBD2 and MBD4 was disrupted in cells lacking a functional DNA 
methyltransferase gene. This suggested that MBD2 and MBD4 are capable of 
binding methylated DNA in vivo as well as in vitro. MBD1 was also capable of 
binding methylated DNA in vivo, but bound to the same heterochromatic sites in 




















Figure   1-4 A family of MBD proteins. Six mammalian MBDs have been characterised so far. 
Kaiso is an atypical MBD, because it depends on a zinc-finger domain (ZF) to recognize 
methylated DNA and a POZ/BTB domain to repress transcription. MBD1 uses its methyl-
binding domain (MBD) to bind methylated DNA sequences. In addition, MBD1 contains three 
zinc-binding domains (CxxC), one of which binds specifically to non-methylated CpG 
dinucleotides, and a C-terminal transcriptional repression domain (TRD). MBD2 possesses 
an MBD that overlaps with its TRD domain, and a GR repeat at its N terminus. MBD3 
contains a well-conserved MBD domain that does not recognize methylated DNA owing to 
crucial amino acid changes. MBD4 binds methylated DNA through an MBD domain and has 
a C-terminal glycosylase domain that is important for its function in DNA repair. MeCP2 is 
the founding member of the MBD protein family and contains a conserved MBD domain and 
an adjacent TRD domain. (adapted from Klose and Bird, 2006). 
 
1.3.6.2  MeCP2 
MeCP2 binds preferentially to single symmetrically methylated CpG and was 
found to bind to chromosomes at sites known to contain methylated DNA through 
its methyl-CpG binding domain (MBD) (Nan et al., 1993; Nan et al., 1996). On 
mouse chromosomes, it binds prominently to the highly methylated major 
satellite located near centromeres (Lewis et al., 1992), whereas on human or rat 
chromosomes which do not contain highly methylated satellite DNAs, MeCP2 was 
broadly distributed throughout chromosome arms (Nan et al., 1997). DNA 
methylation is necessary for MeCP2 localisation as mutant cells with low levels 
of genomic DNA methylation show inefficient localisation of MeCP2 protein (Nan Jana Vavrova, 2008    Chapter 1, 45 
et al., 1996). MeCP2 further contains a transcriptional repression domain (TRD) 
(Nan et al., 1997). Because of its broad distribution in the genome, MeCP2 was 
found to be a global transcriptional repressor of methylated DNA and this 
repression was dependent on the function of both MBD and TRD domains (Nan et 
al., 1997). MeCP2 has no difficulties accessing its target sequences in chromatin. 
When preassembled chromatin containing H1 linker histone was challenged with 
MeCP2, a specific loss of H1 detection was observed. This suggested that MeCP2 
could displace histone H1 from chromatin in order to access its binding sites. 
The underlying mechanism of MeCP2 repression was found to be through the 
Sin3A/HDAC corepressor complex (Jones et al., 1998; Nan et al., 1998). The 
region of MeCP2 that localises with the TRD associates with mSin3A, HDAC1 and 
HDAC2, but mSin3A is the preferred binding partner and HDACs have much 
weaker affinity for MeCP2 . Transciptional repression in vivo is relieved by the 
deacetylase inhibitor trichostatin A (TSA), indicating that deacetylation of 
histones is an essential component of this repression mechanism. However, 
repression is not completely alleviated by TSA, indicating that a component of 
repression by the TRD may be deacetylase-independent, consistent with the 
observation that mSin3A retains some ability to repress transcription even in the 
absence of associated HDACs (Laherty et al., 1997). 
However, only a small amount of mammalian MeCP2 interacts with Sin3A and 
this interaction is not stable (Klose and Bird, 2006). This suggests that MeCP2 is 
not an obligate component of the Sin3a corepressor complex and may therefore 
engage a more diverse range of cofactors for repressive function. On one of the 
most well-characterised neuronal-specific genes, NaCh II, MeCP2 forms a 
complex with co-REST (an associated corepressor of repressor element RE-1 
silencing transcription factor) and is also associated with the HMT SUV39H1 
(histone lysine methyltransferase, suppressor of variegation 39H1), further 
recruiting HP1 (Lunyak et al., 2002). HMT SUV39H1 methylates specifically H3K9 
(Rea et al., 2000) and that recruits HP1 (heterochromatin protein 1), which 
mediates gene silencing (Bannister et al., 2001). MeCP2 was shown to direct 
H3K9 methylation in vivo through interaction with an unidentified H3K9-specific 
HMT (Fuks et al., 2003). MeCP2 also associates with Dnmt1, suggesting a 
mechanism for co-ordinated methylation and gene repression during DNA 
replication (Kimura and Shiota, 2003).  As mentioned above, MeCP2 may also 
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was originally identified in in vitro experiments in which naked DNA was 
incubated with MeCP2 and HeLa nuclear extracts (Nan et al., 1997). Since it may 
be anticipated that nucleosomes were not assembled under the assay conditions, 
it was speculated that transcriptional inhibition was achieved through the 
histone deacetylase-independent pathway. This pathway was later shown to be 
active on the SV40 enhancer/promoter and was not relieved by TSA (Yu et al., 
2000). MeCP2 also interacts with the Brahma component of the SWI/SNF complex 
in vivo and is functionally linked to repression. MeCP2 and Brahma assembly 
occurs on genes methylated in cancer and the FMR1 gene in fragile X syndrome. 
This is the first time MeCP2 was shown to recruit a chromatin remodelling 
complex and use it for repression (Harikrishnan et al., 2005). MeCP2 was also 
shown to mediate chromatin compaction by forming complexes with 
nucleosomal arrays. By mutating MeCP2 sequence, it was shown that it is 
independent of its MBD, which led to the conclusion that MeCP2 compacts 
chromatin independently of DNA methylation (Georgel et al., 2003). This would 
be in agreement with data showing that chromatin secondary structure is not 
altered in the absence of DNA methylation, but it leads to altered binding of 
linker histone H1, independent of MeCP2 (Gilbert et al., 2007). Involvement of 
MeCP2 in maintaining compact chromatin secondary structure (Georgel et al., 
2003) seems unlikely, given that MeCP2 binding was shown to be DNA 
methylation-dependent (Nan et al., 1996). 
MeCP2 is required in neurons for normal brain function and mutation in the 
sequence causes Rett syndrome (Amir et al., 1999), a progressive neurological 
disorder that affects almost exclusively girls. Rett syndrome results from mosaic 
expression of mutant and wild-type MeCP2 alleles in the brain caused by the 
random inactivation of one X-linked MeCP2 allele during early female 
development. How MeCP2 inactivation causes Rett syndrome is not clearly 
understood. Most missence mutations in MeCP2 are tightly clustered at the 
methyl-CpG binding domain causing decreased binding to methylated DNA 
(Ballestar et al., 2000; Yusufzai and Wolffe, 2000). It implies that methyl-CpG 
binding by MeCP2 is essential for proper brain function. MeCP2 can also act as a 
transcriptional repressor and mutations in TRD are also very common in Rett 
syndrome (Ballestar et al., 2000; Yusufzai and Wolffe, 2000). Whether this 
function has relevance to Rett syndrome depends on identification of target 
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several MeCP2 mouse models have been produced. MeCP2-null mice were 
prepared using cre/lox recombination (Chen et al., 2001; Guy et al., 2001). 
These mice had no apparent phenotype until 6 weeks old, when rapid regression 
started, leading to eventual death at ~8 weeks. Good parallels in character and 
the time of onset of symptoms have been found between female mouse 
heterozygous for the MeCP2-null allele and Rett syndrome patients (Guy et al., 
2001). Mice with conditional expression of MeCP2 expressing cre under nestin 
(neuronal progenitors-specific) promoter were then produced (Chen et al., 2001; 
Guy et al., 2001). Mice with nestin-cre MeCP2 conditional mutation showed the 
same phenotype. It implied that the MeCP2 mutation in the brain is sufficient to 
produce the same phenotype as the MeCP2-null mice. Recently, MeCP2
lox-Stop,cre 
animals were produced (Guy et al., 2007). They have MeCP2 inactivated by 
insertion of lox-Stop cassette, but it can be conditionally activated under the 
control of its own promoter and regulatory elements by cassette deletion using 
the cre-ER/TM system (Guy et al., 2007). Female MeCP2 
Stop/+,cre mice behaved 
similarly to MeCP2
+/- female mice. Upon treatment with TM (tomofixen) resulting 
in MeCP2 activation, Stop/+,cre females with clear neurological phenotype 
progressively reverted to a phenotype close to a wild type. The fact that viable 
but defective neurons can be repaired is a very important discovery as Rett 
syndrome patients show abnormal neuronal morphology, but not neuronal death 
(Armstrong et al., 1995). 
1.3.6.3  MBD1 
Similar to MeCP2, MBD1 is an abundant chromosomal protein (Ng et al., 2000). 
MBD1 binds to methylated DNA and, possessing a TRD domain, it can actively 
repress gene transcription (Ng et al., 2000). Transcriptional repression is 
dependent on both MBD and TRD domains and on deacetylation, as TSA 
treatment restores transcription to over 75% of control levels. However, it is not 
depleted by antibodies to the histone deacetylase HDAC1 like MeCP2. Thus, the 
deacetylase-dependant pathway by which MBD1 actively silences methylated 
genes is likely to be different from MeCP1 and MeCP2 (Ng et al., 2000). Uniquely 
among MBD proteins, it was shown that a major MBD1 isoform also contains the 
CXXC-3 domain (Figure 1.4) that binds specifically to nonmethylated CpG 
dinucleotides (Jorgensen et al., 2004). The MBD1 protein therefore makes use of 
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CpG and the CXXC-3 domain requiring nonmethylated CpG. Although only some 
MBD1 isoforms carry the CXXC-3 DNA binding domain, this new finding affects 
the previous view of MBD1 as a protein that exclusively interprets the DNA 
methylation signal. The biological significance of the dual DNA binding capacity 
is currently unknown (Jorgensen et al., 2004). MBD1 interacts with two HMTs, 
SUV39h1 and SETDB1 (histone H3 K9 specific methyltransferases) and with p150, 
a component of the chromatin assembly factor-1 (CAF-1) (Fujita et al., 2003a; 
Reese et al., 2003; Sarraf and Stancheva, 2004). MBD1 association with CAF-1 
and SETDB1 at replication foci appears to facilitate H3K9 tri-methylation before 
histones are loaded onto DNA, indicating that the H3K9 methylation is 
maintained simultaneously with DNA methylation via the replication-coupled 
CAF-1/MBD1/SETDB1 complex (Sarraf and Stancheva, 2004). MBD1-containing 
chromatin associated factor (MCAF) and methylpurine-DNA glycolase (MBP) 
interact with the TRD of MBD1 and repress transcription of reporter genes in vivo 
(Fujita et al., 2003a; Watanabe et al., 2003).  
1.3.6.4  MBD2 and MBD3 
Mammalian MBD2 is a methyl-CpG binding protein, but mammalian MBD3 is not 
(Hendrich and Bird, 1998). MBD3 behaves differently than the other MBD 
proteins, failing to specifically bind methylated DNA in vitro or colocalize with 
major satellite in vivo (Hendrich and Bird, 1998).  
MBD3 was identified as one of the seven subunits of the second most prominent 
histone deacetylase multisubunit complex, the Mi-2/NuRD (the nucleosome-
stimulated ATPase Mi-2/nucleosome remodelling histone deacetylase) complex. 
NuRD complex is composed of the SWI2/SNF2 helicase/ATPase domain-
containing Mi2 protein, the two histone deacetylases HDAC1 and HDAC2, the two 
histone-binding proteins RbAp46 and RbAp48 (Zhang et al., 1998), and 
polypeptides of 70 and 32 kD later identified as metastasis-associated proteins 
MTA2 and MBD3, respectively (Zhang et al., 1999). MBD3b is the major splice 
form of MBD3 in the complex and it only contains a portion of the methyl-CpG 
binding domain. It is embedded within the NuRD complex and it does not bind 
methylated DNA. It however mediates the association of MTA2 with the core 
histone deacetylase complex.  Thus, the function of the NuRD complex might not 
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binding proteins. Mammalian MBD2 shows a strong preference for binding to 
methylated DNA in vitro and in vivo (Hendrich and Bird, 1998). It has been 
shown that in HeLa cells MBD2 associates with HDAC and can repress 
transcription in a TSA-dependant manner (Ng et al., 1999). MBD2 is not part of 
the NuRD complex but it was found to interact with it (Zhang et al., 1999). The 
addition of NuRD to an in vitro methylated DNA-binding assay containing MBD2 
resulted in the production of a DNA-protein complex migrating slower than the 
MBD2-DNA protein complex confirming that MBD2 tethers NuRD complex to 
methylated DNA, raising the possibility that MBD2 might recruit the NuRD 
complex to methylated DNA in vivo (Zhang et al., 1999). More recent data, 
however, suggested that MBD2/NuRD and MBD3/NuRD are
 distinct protein 
complexes with different biochemical and functional
 properties (Le Guezennec 
et al., 2006).  
When the MeCP1 complex discovered in 1989 (Meehan et al., 1989) was 
characterised in more detail, MBD2 was found to be part of it (Ng et al., 1999), 
rather then MBD1 as previously reported (Cross et al., 1997). It was probably due 
to cross-reacting of anti-MBD1 antibody with MBD proteins unknown at the time. 
MeCP1 methylation-mediated repressing activity was found to be due to a 
complex containing 10 major polypeptides including MBD2 and all of the known 
NuRD components, including MBD3. MBD2 associates here with the NuRD in 
MeCP1 in vivo and therefore it probably targets the nucleosome remodeling and 
histone deacetylase NuRD complex to methylated DNA (Feng and Zhang, 2001). 
MBD2 was also shown to interact with the Sin3A complex (Boeke et al., 2000).  
MBD2 and MBD3 were also shown to interact with two members of the p66 
protein family, which are novel proteins involved in transcriptional repression 
(Brackertz et al., 2002). Dnmt1 has also been identified in a complex that 
contains both MBD2 and MBD3, binds to hemimethylated DNA and is located at 
the replication focus during late S phase, suggesting that MBD2 and MBD3 may 
act to repress transcription of newly synthesized DNA (Tatematsu et al., 2000). 
The genes for both MBD2 and MBD3 have been deleted in mice (Hendrich et al., 
2001) and Mbd3 knockout mice die during early embryogenesis, whilst Mbd2 
knockout mice appear to be largely normal except for defective maternal 
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1.3.6.5  MBD4 
MBD4 is the only member of the MBD family of proteins that does not appear to 
be involved in transcriptional repression (Hendrich and Bird, 1998). Apart from 
the MBD domain, it has a glycosylase domain and it was shown to have a G/T 
mismatch glycosylase activity, as well as 5-methylcytosine DNA glycosylase 
activity (Hendrich et al., 1999), so it is possibly involved in DNA demethylation 
(see later).  
1.3.6.6  Kaiso 
Kaiso protein is a more recent addition to the family of methyl-CpG binding 
domain proteins. It is unrelated in structure to other MBD proteins (Figure 1.4). 
It belongs to the BTB/POZ family of zinc finger proteins (Prokhorchuk et al., 
2001). In vitro, Kaiso
 recognizes DNA sequences that contain at least two 
methyl-CpGs,
 and represses transcription from reporter templates in a methyl-
CpG-dependent
 manner (Prokhortchouk et al., 2001). In vivo, it is required to 
maintain DNA-methylation dependent transcription
 silencing during early 
Xenopus laevis development. Developmental arrest and apoptosis can be rescued 
by injection of human Kaiso mRNA into the embryos (Ruzov et al., 2004). Kaiso 
was found to reduce the enhancer-blocking activity
 of CTCF (Defossez et al., 
2005). CTC-binding factor (CTCF) is a DNA-binding protein of vertebrates
 that 
plays essential roles in regulating genome activity through
 its capacity to act as 
an enhancer blocker (Ohlsson et al., 2001). Insulators
 are DNA elements that 
maintain partition between transcriptionally active and inactive chromatin, and 
they can
 be subdivided into two functional classes: barrier elements,
 which stop 
the spread of heterochromatin, and enhancer blockers,
 which prevent an 
enhancer from activating transcription in a
 neighbouring repressed region (West 
et al., 2002). These data suggest that the Kaiso-CTCF interaction
 negatively 
regulates CTCF insulator activity (Defossez et al., 2005).  
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1.3.6.7  DNA methyltransferases 
In mammalian genomes, DNA methylation is found predominantly in the context 
of CpG dinucleotides. In fact, 70% of all CpG dinucleotides are methylated in 
mammals (Fraga et al., 2003), with the exception of CpG islands, which are CG-
rich regions mostly coincident with the promoter of protein-coding genes. The 
human genome is predicted to contain around 29,000 CpG islands (Lander et al., 
2001). The mechanism(s) by which CpG islands escape methylation when the 
vast majority of CpGs are targeted for methylation are not yet clear, but one 
possibility is that local chromatin structure may exclude the methylation 
machinery.  
DNA methylation is essential for normal development and to faithfully maintain 
genome function in adult cells. Patterns of DNA methylation are highly dynamic 
during mammalian development, during which the epigenome is reprogrammed 
with the erasure of genome-wide methylation so that cell- or tissue-specific 
methylation patterns can be established de novo (Dean et al., 2003; Okano et 
al., 1999; Santos et al., 2002). 
As a consequence of the dynamic state of DNA methylation, two different 
methylation processes occur: De novo methylation establishes the methylation 
state; maintenance methylation copies it onto daughter DNA strands after DNA 
replication. To date, five mammalian DNMTs have been identified (Hermann et 
al., 2004).  
Dnmt1 is the most abundant methyltransferase in mammalian cells and is 
essential for genomic stability. It is believed to be the primary maintenance DNA 
methyltransferase as it normally restores DNA methylation to symmetrical CpG 
nucleotides in a semi-conservative manner during or shortly after DNA 
replication (Yoder et al., 1997). During mammalian development, DNA 
demethylation of the maternal genome during preimplantation results as a 
consequence of the exclusion of Dnmt1 from the nucleus (Carlson et al., 1992).  
The role of Dnmt2 in establishing or maintaining the epigenome is not yet clear; 
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Dnmt3a and Dnmt3b function as de novo methyltransferases and play distinct 
roles in establishing methylation patterns during embryonic development. 
Deletion of Dnmt3b results in multiple developmental defects in the mouse, 
including substantial hypomethylation of centromeric minor repeats, and 
Dnmt3a null mice are viable but die at about four weeks of age (Okano et al., 
1999). Deletion of both Dnmt3a and Dnmt3b in the mouse yields a more severe 
phenotype than either single mutant with a reduction in global methylation 
(Okano et al., 1999). Studies of deletions of DNA methyltransferases showed that 
only Dnmt1 mutants manifest marked loss of genomic cytosine methylation (Li et 
al., 1992; Okano et al., 1999; Okano et al., 1998). Although Dnmt3
- ES cells 
showed only partial loss of DNA methylation at the time (Okano et al., 1999), 
during prolonged culturing  virtually no DNA methylation remained (0.6%), 
possibly due to Dnmt1 failure to maintain the DNA methylation levels (Gilbert et 
al., 2007). 
Dnmt3L is a DNA methyltransferase 3-like protein, which lacks the catalytic 
motifs that characterize the DNA cytosine-5-methyltransferases but is related to 
the active methyltransferases Dnmt3a and Dnmt3b in framework regions (Aapola 
et al., 2000). Deletion of Dnmt3L does not prevent oogenesis, but the 
heterozygous offspring of homozygous mutant females die before mid-gestation 
as a result of biallelic expression of imprinted genes normally methylated and 
silenced on the allele of maternal origin. Dnmt3L was shown to collaborate with 
Dnmt3a to generate genomic methylation patterns on maternal imprinted genes 
in oocytes. However, male mice that lack Dnmt3L are viable but sterile, with a 
complete absence of germ cells in adult males (Bourc'his et al., 2001). It was 
shown using Dnmt3L-deficient male germ cells that Dnmt3L is involved in de 
novo methylation of dispersed and tandem repeated sequences, and not 
imprinted genes. It is specifically required for de novo methylation and heritable 
silencing of interspersed repeated sequences in a brief perinatal period in the 
non-dividing precursors of spermatogonial stem cells. In Dnmt3L-deficient 
spermatocytes they remain unmethylated and transcribed at high levels. Loss of 
Dnmt3L from early germ cells also causes meiotic failure in spermatocytes, 
which do not express Dnmt3L. This result indicates that the Dnmt3L protein 
might have a function in the de novo methylation of dispersed repeated 
sequences in a premeiotic genome scanning process that occurs in male germ 
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supporting role in stimulating methylation activities of Dnmt3a and Dnmt3b in 
vitro and these directly interact with the N-terminus of Dnmt1 and all three 
latter enzymes co-operate to establish and maintain methylation patterns 
throughout the genome (Kim et al., 2002; Liang et al., 2002).  
1.3.6.8  DNA demethylation 
DNA demethylation is associated with the erasure and subsequent resetting of 
imprinted marks in the development of gametes, the paternal pronucleus during 
fertilisation and the preimplantation period. Asynchronous demethylation of the 
paternal genomes occurs rapidly after fertilisation and it is believed to be an 
active process as it occurs in the absence of DNA replication.  
Several attempts have been made to identify and characterise the mechanisms 
of demethylation and two distinct ways of demethylation have been described. 
First is a passive demethylation as a result of the absence of DNA 
methyltransferases maintaining DNA methylation during DNA replication (Matsuo 
et al., 1998); the second is an active demethylation (Reik et al., 2001). 
MBD2b was identified as an active demethylase by some (Bhattacharya et al., 
1999; Detich et al., 2002), but this was not seen by other researchers (Boeke et 
al., 2000; Ng et al., 1999). Against MBD2b activity as a demethylase is also the 
fact that mutant mice that have MBD2 with an inactive MBD domain showed the 
same demethylation profile as wild type mice (Santos et al., 2002). In 
Arabidopsis, ROS1 protein has been shown to have glycosylase activity in vivo 
and mutations in its sequence resulted in hypermethylation and transcriptional 
silencing of specific genes (Kapoor et al., 2005). The recombinant protein had 
glycosylase activity only on methylated templates, bringing evidence that a base 
excision mechanism is involved in active demethylation (Kapoor et al., 2005).  
DNA break and repair involvement in demethylation has since been reported in 
mammalian cells (Kress et al., 2006). In vitro, thymine excision activities of two 
glycosylases, TDG (thymine DNA glycosylase) and MBD4, have been proposed to 
be compatible with the cleavage products detected (Zhu et al., 2000).   
Recently, DNA methyltransferases Dnmt3a and Dnmt3b were shown to be able to 
demethylate as well as methylate CpGs via deamination (Metivier et al., 2008). 
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cytosine in vitro. It was proposed that T:G mismatches generated by 
deamination of methylated cytosine could then be removed through base 
excision repair of MBD4 and TDG. General abasic sites could then be repaired by 
activities of endonucleases, polymerases and DNA ligases (Waters et al., 1999). 
MBD4
-/- mice, however, do not show any developmental defects suggestive of 
perturbed DNA demethylation, but rather show an increase in frequency of C:T 
transitions, consistent with a role of MBD4 in DNA repair mainly (Millar et al., 
2002). Dnmt3a and TDG were shown to associate and influence each other in 
vitro (Li et al., 2007) and the involvement of TDG in DNA repair after 
deamination is currently favoured (Metivier et al., 2008). As DNA strand breaks 
would bear the risk of damaging genome integrity, these mechanisms of active 
demethylation must be tightly regulated and understanding of these processes is 
necessary for understanding DNA methylation not only as a stable epigenetic 
mark but also as an integral component of transcription. 
1.3.7 RNAi 
RNA interference (RNAi) or RNA silencing is a regulatory mechanism mediated by 
short RNAs called miRNA and siRNA. miRNAs and siRNAs are  21-26-nucleotide 
(nt) RNA molecules. Although both types of molecules can be functionally 
equivalent and interchangeable, they are distinguished by their mode of 
biogenesis (Carmell and Hannon, 2004). miRNAs are produced from transcripts 
that form
 stem-loop structures. These are processed in the nucleus by
 a complex 
comprised of at least two components: the RNase III
 enzyme Drosha, and a 
protein called Pasha in Drosophila or DGCR8
 in mammals (Landthaler et al., 
2004). Initial cleavage
 is followed by transport to the cytoplasm
 of about 70-nt 
pre-miRNA, which is further processed by the cytoplasmic
 RNase III endonuclease 
Dicer complex (Provost et al., 2002). Final processing by Dicer appears coupled 
to assembly
 of the miRNA into the RNA-induced silencing complex (RISC),
 which 
is the effector of RNAi (Gregory et al., 2005). In contrast,
 siRNAs are produced 
from long double-stranded RNA (dsRNA) precursors,
 which can be either 
endogenously produced or exogenously provided.
 Processing of siRNAs is also 
Dicer-dependent (Provost et al., 2002). Because both miRNA and siRNA are found 
in the same complex (RISC), they are thought to be interchangeable and this 
complex can mediate both cleavage and translational inhibition of target mRNA 
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complex is an Argonaute protein.
 Argonaute proteins
 directly interact with the 
miRNA/siRNA through a PAZ domain (Ma et al., 2004; Song et al., 2003). The 
Argonaute
 protein family of mammalian argonaute proteins is diverse, with only 
Argonaute 2 (Ago2) being capable of mRNA cleavage (Liu et al., 2004). 
1.3.7.1  RNA induced posttranscriptional gene silencing  
The first manner in which miRNAs and siRNAs control gene expression is post-
transcriptional, by directing endonuclease cleavage of the target mRNA by RISC 
complex. Studies indicate that the minimal composition of the RISC complex is 
the miRNA/siRNA and Ago2 (Liu et al., 2004). The products of the cleavage 
appear to be degraded by the same mechanisms as bulk mRNA involving 
decapping and deadenylation (Yamashita et al., 2005). miRNA can also target 
mRNAs for decapping directly without involvement of the RISC complex. Several 
activators of decapping are concentrated in cytoplasmic processing bodies (P-
bodies) and mammalian argonaute proteins were shown to concentrate there 
too. Reporter mRNAs that are targeted for translational repression by 
endogenous or exogenous miRNAs become concentrated in P-bodies in a miRNA-
dependent manner (Liu et al., 2005). A third way that miRNAs silences mRNAs 
posttranscriptionally is by interfering with their translation. It was revealed by 
multiple examples, where silencing by miRNAs resulted in no change or change 
smaller than was observed at the protein level (Pillai et al., 2005; Zeng et al., 
2003). Argonaute proteins were again shown to be involved (Pillai et al., 2005). 
However, other Argonaute proteins than argonaute2 must be involved, as 
translational repression in response to miRNAs remains intact in Ago2-null cells 
(Liu et al., 2004).  
Post-transcriptional gene silencing achieves specificity through RNA-RNA 
sequence recognition and base pairing. However, RNA can also form base pairs 
with DNA and through RNA interference affect gene expression at the level of 
genomic DNA (see below). 
1.3.7.2  RNA-derived DNA and/or histone methylation and transcriptional 
gene silencing 
RNA-directed DNA methylation was originally discovered with a viroid system in 
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shown that the process requires a dsRNA processed into small RNAs, that, when 
homologous to promoter regions, trigger promoter methylation and 
transcriptional gene silencing (Mette et al., 2000). RNA directed DNA 
methylation in Arabidopsis starts by dsRNA trigger and site specific de novo 
methylation of cytosine that can occur in all cytosines, not just in CG 
dinucleotides (Aufsatz et al., 2002a). Unlike RNAi-based heterochromatin which 
can spread over several kilobases from the RNA-targeted DNA sequence (Hall et 
al., 2002), RNA-directed de novo DNA methylation is largely confined to the 
target region with only the homologous DNA sequence becoming methylated 
(Aufsatz et al., 2002a). The maintenance of DNA methylation and transcriptional 
gene silencing requires MET1 DNA methyltransferase (Aufsatz et al., 2004) which 
cooperates with SNF2-like chromatin remodelling protein, DDM1 (Lippman et al., 
2004) and histone deacetylase HDA6 (Aufsatz et al., 2002b). Other DNA 
methyltransferases such as DRM2 have been implicated in maintaining DNA 
methylation (Cao et al., 2003). RNA-directed histone H3K9 methylation was 
shown to require SUVH4 HMT (Jackson et al., 2002).  By experimental mutations, 
other components were found necessary for RNA-directed histone and DNA 
methylation in plants, such as Argonaute 4 (Zilberman et al., 2003), Dicer-like 3 
(DCL3), RNA-dependent RNA polymerase 2 (RDR2) and silencing-defective 4 
(sde4) (Chan et al., 2004), linking it further to RNAi. Whereas Argonaute 4 seems 
to have a role specifically in transcriptional gene silencing where its mutation 
correlates with the loss of H3K9me2 and transcriptional gene silencing (Xie et 
al., 2004; Zilberman et al., 2003; Zilberman et al., 2004), Argonaute1 can 
contribute to both posttranscriptional and transcriptional silencing (Kim et al., 
2006; Vaucheret et al., 2004).  
However, RNAi-mediated transcriptional gene silencing does not necessarily 
involve DNA methylation. RNAi was also described to be connected with 
assembly of heterochromatin in fission yeast (Volpe et al., 2002), where there is 
no endogenous DNA methylation (Antequera et al., 1984).  In contrast to 
Arabidopsis, it shows that transcriptional silencing can be achieved without DNA 
methylation. Here, transcription of the two strands of the centromeric repeats 
generates dsRNAs. Dicer protein then cleaves dsRNAs to small RNAs that guide 
the HMT Clr4 to the respective site on the chromosome resulting in H3K9 
methylation and recruitment of HP1 homologue Swi6 resulting in silencing 
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pathway such as Argonaute1, Dicer or RNA-dependent RNA polymerase disrupts 
heterochromatin-mediated silencing which correlates with loss of H3K9 
methylation and Swi6 association (Hall et al., 2002; Volpe et al., 2002). An RNAi 
effector complex called RITS complex (RNA-induced initiation of transcriptional 
gene silencing) is then tether to silenced loci by H3K9 methylation. This 
tethering results in generating more siRNAs from the locus and promotes the 
RNAi-derived heterochromatin maintenance in a self-enforcing loop mechanism 
(Noma et al., 2004).  
1.3.7.3  RNA-directed DNA and histone methylation in mammals 
Whether transcriptional gene silencing in mammals involves RNA-directed DNA 
methylation like in plants, or is established without it remains to be determined. 
Recent observations revealed that target genes might be silenced by RNA-
associated silencing in mammalian cells at the level of the chromatin (Kim et 
al., 2006; Morris et al., 2004; Ting et al., 2008). siRNA were shown to mediated 
transcriptional repression that includes DNA methylation of the silenced gene 
(Kawasaki and Taira, 2004; Morris et al., 2004). The silencing is abolished by the 
addition of 5-azacytidine and TSA (Morris et al., 2004) or by suppression of 
Dnmt1 and Dnmt3b expression (Kawasaki and Taira, 2004). There is also an 
induction of H3K9 methylation (Kawasaki and Taira, 2004) The precise 
mechanism is not known (Kawasaki and Taira, 2004; Morris et al., 2004). 
However, high controversy surrounds RNA-directed DNA methylation. Kawasaki’s 
paper (Kawasaki and Taira, 2004) has been retracted together with other papers 
from the lab, and there has not been much work published in following years. 
Moreover, other papers ruled out involvement of DNA methylation in RNAi-
directed silencing (Park et al., 2004; Ting et al., 2005); silencing of dsRNA-
targeted promoter was achieved even in HCT DKO cells, which have less than 5% 
genomic methylation and lack the capacity to methylate DNA (Ting et al., 2005). 
This was consistent with data from S. pombe, in which silencing effects and 
heterochromatin formation induced by dsRNAs were achieved in the absence of 
DNA methylation (Volpe et al., 2003; Volpe et al., 2002). 
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So is there at least a potential for RNA-directed DNA and histone methylation 
transcriptional gene silencing in mammals? There are two issues. Firstly, do 
mammals have the necessary components for this pathway? Some components 
have mammalian homologues or closely related counterparts. DNA 
methyltransferases Dnmt1 and Dnmt3a/3b are mammalian homologues of Met1 
and DRM2, respectively (Goll and Bestor, 2005). DDM1 which cooperates with 
Met1 (Lippman et al., 2004) has a mammalian homologue, the lymphoid specific 
helicase (LSH)(Dennis et al., 2001). Another SNF2 like protein DRD1 is related to 
mammalian ATRX SNF2 subfamily (Gibbons et al., 2000). DICER and Argonaute1 
are also present in mammalian cells (Kim et al., 2006; Ting et al., 2008). So, it 
seems like mammals have much of the machinery necessary for RNA directed 
DNA methylation. Secondly, do trigger RNAs exist in the nucleus? RNA-directed 
DNA methylation in plants clearly takes place in nucleus. dsRNAs corresponding 
to repetitive elements have been detected in the hnRNA fraction in the nucleus 
of mammalian cells (Kumar and Carmichael, 1998). However, while plant’s DCL3 
(Dicer-like 3) localises to nucleus, human DICER is cytoplasmic (Billy et al., 
2001). Whether there is a mechanism to produce small RNAs from dsRNAs in the 
nucleus or whether small RNAs could translocate to nucleus is currently not 
known. Certainly mature miRNAs were shown to be present both in nuclear and 
cytoplasmic cellular fractions (Meister et al., 2004).  
RNAi-dependent DNA methylation therefore remains a vital and controversial 
issue. Further work from Morris’ group brought more evidence that histone 
methylation is connected with RNAi-derived transcriptional silencing. siRNA-
targeted promoters were shown to establish H3K9me2 and H3K27me3 (Weinberg 
et al., 2006), and follow-up study showed that both histone methylation 
modifications are mediated via Argonaute1 and its recruitment of HMT activity 
(Kim et al., 2006). It was also shown there that only negligible amounts of DNA 
methylation were detected at the siRNA-targeted promoters (Kim et al., 2006). 
Recently, however, DICER was identified to be important for maintaining 
aberrant hypermethylation of selected genes in HCT116 cells (Ting et al., 2008). 
Because DICER null cells are not viable (Bernstein et al., 2003), Dicer helicase 
domain knock out HCT116 cells were used for the study. These Dicer
ex5 cells 
were previously shown to have defects in miRNA processing (Cummins et al., 
2006), but observed selective demethylation of some genes was surprising. 
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hypermethylation and transcriptional silencing require DICER to maintain the 
hypermethylated status in these cells. The only well-defined role for DICER is to 
process dsRNAs therefore it suggests that RNA molecules may be involved in this 
hypermethylating and silencing pathway.  
The evidence available so far suggests following putative mechanisms for RNA-
mediated transcriptional gene silencing suggested from the initial work (Figure 
1.5). Firstly, the nuclear delivered siRNAs might bind to an argonaute such as 
Argonaute1 or 2, possibly involving HDACs as siRNA-mediated transcriptional 
silencing was shown to be TSA sensitive (Morris et al., 2004). The siRNA/Ago 
complex then searches until a match is made between the antisense strand of 
siRNA and the target promoter region. Then it recruits HDACs. The HDACs 
activity then leads to nucleosomal compaction which may or may not be marked 
with DNA methylation and/or histone methylation (Figure 1.5a). Alternatively, 
the siRNAs may complex with HP1 and SUV39H1. HP1 contains a hinge region 
that has been found to exhibit RNA binding activity (Muchardt et al., 2002). Also 
Dnmt3a was shown to bind siRNA (Jeffery and Nakielny, 2004). The siRNAs may 
then function to direct the chromatin remodelling complexes which are known 
to interact with HDACs, such as NuRD, to the target gene resulting in histone 
deacetylation, DNA methylation, and silencing (Figure 1.5b). A third scenario 
could be that siRNAs somehow affiliate with a chromatin remodelling complex 
like Sin3, subsequently facilitating DNA methylation of the target gene and 
recruitment of the Sin3, possibly via MBD proteins. Both MeCP2 and MBD2 were 
shown to interact with RNA through their RG repeats region with high affinity 
(Jeffery and Nakielny, 2004)(Figure1.5c). Alternatively, chromatin remodelling 
complexes could be recruited via argonaute/siRNA complex rather than siRNA on 
its own (Figure 1.5d). Or, a putative transcriptional silencing complex can be 
guided to the targeted promoter by promoter associated RNA. That may be 
recognised by the antisense strand of the siRNA or possibly endogenous antisense 
RNAs as it was recently described by Morris et al. (Han et al., 2007). Jana Vavrova, 2008    Chapter 1, 60 
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Figure   1-5 Putative mechanisms for siRNA mediated transcriptional silencing. 
Four scenarios are presented here. (A) Silencing via siRNA/argonaute complex. (B) siRNA 
might bind through HP1 and direct the HP1 and its cognate complex to a target gene. (C) 
siRNA somehow affiliates with chromatin remodeling complexes interacting with MBD 
proteins. (D) Involvement of multiple complexes including siRNA/argonaute and chromatin 
remodeling and corepressor complexes such as NuRD. (adapted from (Kawasaki et al., 
2005) Jana Vavrova, 2008    Chapter 1, 61 
 
 
1.3.8 The effect of chromatin and DNA methylation on RNA 
polymerase III transcription 
DNA methylation appears to affect only specific categories of class III genes. 
Apart from Alus, template methylation can repress RNA polymerase III 
transcription of tRNA and VA in vitro and in the case of VA1 also in transfected 
cells (Juttermann et al., 1991; Kochanek et al., 1993; Liu and Schmid, 1993). It 
can also inhibit tRNA genes if injected into Xenopus oocytes, but a 5S rRNA gene 
are unaffected (Besser et al., 1990). 
DNA methylation-mediated silencing has long been investigated as a possible 
cause of SINE’s transcriptional repression. Alu sequences are CpG rich and these 
are highly methylated in the mammalian genome (Fraga et al., 2003). In fact, 
more than 90% of methylated CpG dinucleotides in the human genome occur in 
retrotransposons (Bird, 2002). Association of H3K9 methylation, which is a 
marker of heterochromatin and is specifically associated with inactivation of 
gene expression (Lachner and Jenuwein, 2002; Lachner et al., 2001), was 
demonstrated with Alu elements (Kondo and Issa, 2003), suggesting that H3K9 
methylation may be related to the suppression of Alu elements through DNA 
methylation. 
DNA methylation was shown to be connected with Alu transcriptional silencing 
both in vitro and in vivo (Li et al., 2000; Liu et al., 1994; Liu and Schmid, 1993). 
HeLa cells were treated with 5-azacytidine to demethylate DNA and the DNA 
demethylation verified using enzymatic methyl-sensitive restriction digests. Alu 
transcripts were then detected using primer extension and northern blot. 
Treatment with 5-azacytidine resulted in a 5- to 8-fold increase in full length Alu 
transcript expression, while the effect on scAlu RNA (left monomer only Alu) was 
much less pronounced. Also, methylated and unmethylated Alu constructs were 
transfected into human cells (Li et al., 2000). Depending on the amount of 
transfected methylated template, methylated constructs were 9- to 20-fold less 
active.  
However, some silenced Alus when demethylated with 5-azacytidine remained 
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elements were shown to be the main target sequences for MeCP2 binding in vivo 
(Koch and Stratling, 2004). However, MeCP2-mediated repression of Alu 
elements was not so far demonstrated. In transient transfection assays, MeCP2 
had no inhibiting effect on the AluSx reporter construct, although it was shown 
to repress an L1 reporter construct in the same assay (Yu et al., 2001). The 
mechanisms of DNA methylation-mediated SINE repression remain unknown.  
The effect of DNA methylation and chromatin on SINE expression was mainly 
studied in cell stress conditions where SINE expression was shown to be 
upregulated (see below).  
There is an increase in SINE RNA levels in viral infections such as adenovirus 
infection (Li et al., 2000; Panning and Smiley, 1995; Russanova et al., 1995). 
Viral infections and transformation can increase RNA polymerase III transcription 
through deregulation of transcription factors and their regulators as it was 
described in section 1.2.4. However, studies suggested that this upregulation 
can be global, not specific to RNA polymerase III activity (Li et al., 2000; 
Russanova et al., 1995). Treatments with other agents which lead to cell stress 
response were shown to increase SINE expression. Heat shock, ethanol and 
cycloheximide treatment greatly induces levels of B1,B2 and Alu RNA (Fornace et 
al., 1989; Fornace and Mitchell, 1986; Liu et al., 1995). While the basal and 
induced levels of B2 elements are higher than B1, the kinetics of their response 
is essentially coincident (Liu et al., 1995). SINE function in these situations was 
described in section 1.1.2. Because many SINE members are transcribed, it was 
believed to be achieved via a global repressive mechanism; DNA methylation was 
considered. 
DNA methylation-mediated repression of SINEs was studied during cell stress 
conditions in three cell lines, K562, HeLa and 293. K562 cells have naturally low 
levels of endogenous DNA methylation (Li et al., 2000). There is a 5-fold increase 
in Alu RNA levels in K562 cells compared to HeLa or 293 cells. However, when 
K562 and HeLa cells were infected with adenovirus 2, treated with 
cycloheximide or heat-shocked, there was very little effect on Alu RNA levels in 
K562 cells compared to HeLa cells. That these differences were not caused by 
different levels of methylation was shown by studying activities of methylated 
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containing the constructs to heat shock or cycloheximide increase expression 
from both templates only ~ 2- to 3-fold. Taken together, this demonstrated that 
cell stress does not relieve the methylation-mediated repression in K562 cells. 
Alus activity therefore can be increased via cell stress leaving DNA methylation 
levels constant.   
In vitro transcription assays performed using nuclei from infected and uninfected 
HeLa cells incubated with uninfected extracts revealed that increase Alu activity 
in infected cells is due to increased accessibility of Alu templates to RNA 
polymerase III complexes (Russanova et al., 1995). K562 cells were shown to 
have more open chromatin than HeLa cells, as measured by the nucleosomal 
repeat unit length (Li et al., 2000). After adenoviral infection, there is an 
increase in nucleosomal spacing in HeLas but very little effect on nucleosomal 
spacing in K562 cells. Similar results were obtained after treatment of HeLa and 
293 cells with heat shock or cycloheximide. Accessibility of α-satellite DNA was 
measured and it was shown that both in control K562 cells and in adenovirus-
infected HeLa cells the chromatin accessibility, including α-satellite, is greater 
than in control HeLa cells. This suggested that the opening is not Alu-specific or 
RNA polymerase III specific.  
A variety of studies have established that RNA polymerase III transcription can be 
inhibited by the presence of histones (Almouzni et al., 1990; Gottesfeld and 
Bloomer, 1982; Morse, 1989). In yeast, some data suggest that TFIIIC competes 
for DNA access with histones (Marsolier et al., 1995).  Another report showed 
that yeast RNA polymerase III can transcribe through nucleosomal DNA by 
mobilizing histones along the templates (Studitsky et al., 1997). The 
susceptibility of class III genes to nucleosomal repression is template-dependent. 
tRNA genes are highly resistant to repression by histones as, removal of H1 from 
murine fibroblasts makes little or no difference in accessibility of tRNA genes to 
transcription factors. On the other hand, B2 SINEs seem highly susceptible (Carey 
and Singh, 1988; Russanova et al., 1995). In HeLa chromatin preparations, Alu 
genes seem to be silenced by chromatin, while tRNA and 5S rRNA genes seem 
accessible to transcription factors in the same extracts (Russanova et al., 1995). 
However, H1 was shown to have little effect on Alus in human cells (Russanova 
et al., 1995). Acetylation can facilitate the access of transcription factors to 
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human TFIIIC possesses histone acetyltransferase (HAT) activity (Hsieh et al., 
1999a; Kundu et al., 1999) suggests that TFIIIC performs a role, in addition to its 
function as an assembly factor, to weaken the interaction of nucleosomes with 
the transcribed region of at least some class III genes.   
Nucleosome positioning was shown before to have an effect on Alu activity 
(Englander and Howard, 1995; Englander et al., 1993). It was shown that Alu 
elements possess the capacity to fix the rotational and translational positions of 
tetramer or octamer particles reconstituted in vitro (Englander et al., 1993). 
The reconstitution of an Alu element with octamers of core histones was shown 
to result in the complete abrogation of in vitro RNA polymerase III-dependent 
template activity. It was further shown that transcription could be fully 
abolished when a CpG methylated Alu template was reconstituted with (H3/H4)2 
tetramers. The nucleosome positioning capacity of Alu elements was further 
examined within native chromatin (Englander and Howard, 1995) and it was 
shown that a significant fraction of human Alu elements is associated with 
rotationally positioned nucleosomes.  
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1.4 Project aims and general strategy 
The general aim of this PhD project is to further examine if and how DNA 
methylation and chromatin are involved in transcriptional regulation of SINEs.  
The first aim was to assess the involvement of methyl-CpG-binding domain 
proteins in silencing SINEs. The presence of MeCP2 will be re-examined to 
include B1 and B2 families and association of other MBD proteins will be tested. 
The presence of methyl-CpG-binding proteins at chromosomal SINEs would 
provide more evidence about the mechanism of DNA methylation regulation. If 
ChIP confirms the presence of methyl-CpG-binding proteins at Alu, B1 and B2 
genes, the presence of chromatin-associated complexes which would contribute 
to SINE regulation will be investigated.  
The second aim was to seek further support for above mechanisms by testing if a 
DNA methylation-free in vivo environment leads to dissociation of methyl-CpG-
binding domain proteins from SINE promoters and whether this will have an 
effect on SINEs activity. Human and rodent cells with reduced levels of DNA 
methylation will be used. Also, cDNA extracted from wild-type and MeCP2-
knockout mice tissue will be used to look for changes in expression of B1 and B2.  




2  Chapter 2- Materials and methods 
2.1 Cell culture 
2.1.1 Bacterial culture 
All strains of Escherichia coli were grown in Luria Broth (LB; 10 g Bacto tryptone, 
5 g Bacto yeast extract and 10 g NaCl per litre pH 7.5). LB plates were made by 
adding 7.5 g bacto agar to 500 ml LB. All media were autoclaved before use and 
supplemented with ampicillin (50μg/ml). The plasmids used in this study 
contained the ampicillin resistance gene encoding β-lactamase and so were 
selected for by the presence of ampicillin. 
2.1.2 Budding yeast culture 
Saccharomyces cerevisiae (S. cerevisiae) strain GG BY 62 (his4-912Δ lys2-128Δ 
ura3-52) was streaked to plates containing YPD complete media (50 g/l) and 2% 
(w/v) yeast agar and incubated at 30°C. Single colony was picked and streaked 
into new YPD/agar plate or 5 ml YPD pre-culture was inoculated and shaken by 
orbital shaker at 30°C overnight. This was then added into fresh YPD media and 
grown to exponential phase (1 x 10
7 cells/ml) in volume needed for further 
application. Following transformation, cells were also grown on Formedium 
minimal media lacking uracil (Formedium Ltd).  
2.1.3 Mammalian cells culture 
Mammalian cell culture was performed in a class II hood, using aseptic technique 
and sterile equipment and reagents. All cell types were grown in humidified 
atmosphere containing 5% CO2 at 37°C.  HeLa cells, CCL 39 cells (Chinese 
hamster lung fibroblasts) and BALB/c 3T3 (A31) cells were maintained in DMEM 
supplemented with 10% FBS, 1% penicillin and 1% streptomycin (all Sigma). 
HCT116 and HCT116 Dnmt1 
-/- Dnmt3b 
-/- (HCT DKO) cells were grown in RPMI 
1640 (+ L glutamine) supplemented with 10% FBS, 1% penicillin and 1% 





-/- mouse fibroblasts were grown in 
DMEM supplemented with 15% FBS, 1% penicillin and 1% streptomycin, 1% non-Jana Vavrova, 2008    Chapter 2, 67 
essential AMK (GIBCO Invitrogen), 1% sodium pyruvate and 0.1% β 
mercaptoethanol. 
Cells were passaged when subconfluent (approximately every 2 to 3 days) using 
buffered trypsin (0.05% trypsin, 0.02% EDTA; Sigma). Cells were also stored by 
cryo-freezing. For cryo-freezing, trypsinised cells were resuspended in 70% DMEM 
(plus penicillin and streptomycin), 20% FBS and 10% DMSO or in 90% FBS and 10% 
DMSO. 1 ml aliquots were transferred to cryo-tubes, and frozen overnight at -
80˚C, before transferring to liquid nitrogen for permanent storage. 
2.2 Plasmid DNA 
2.2.1 Plasmids 
The following table lists all the plasmids used in this study. 
Gene  Description of plasmid 
7SL   pUC19  vector containing the HindIII-
EcoRI fragment of human 7SL gene 
Alu Jo  pGEM®-5Zf(+) (Promega) vector 
containing the SpeI-SacI fragment of 
Alu Jo chromosome 19 
pYES2int   pYES2int is integrating version of 
pYES2 Invitrogen plasmid with 
removed 2 μl ORI (origin of 
replication). It contains ura3 gene 
7SL  pYES2int containing the HindIII-EcoRI 
fragment of human 7SL gene 
Alu Jo  pYES2int containing the XbaI-SpeI 
fragment of human Alu Jo  
Table   2-1 Plasmids 
 
Alu Jo and 7SL were digested out of pGEM®-5Zf(+) and pUC19  vector, 
respectively, and subcloned into pYES2int vector (Invitrogen, modified) using 
restriction digest, gel purification, ligation and control restriction digest (below) 
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2.2.2 Restriction digest 
Plasmids were digested as follows: 2-5 μl DNA was digested using 1 μl restriction 
enzyme for a single digest or 1 μl of each enzyme for a double digest, together 
with 2 μl of appropriate enzyme buffer in a 20 μl final volume. The reaction was 
incubated for 1 h at the optimal temperature for the enzymes’ activity. 
2.2.3 Ligations 
A standard ligation reaction was carried out as follows: 1 μl plasmid was mixed 
with 5 μl insert, 2 μl of 10 × T4 DNA ligase buffer (1 × final concentration) and 1 
μl T4  DNA ligase. The reaction mix was incubated at 10°C overnight and the 
following day transformed into DH5α competent cells using the standard 
protocol (Section 2.2.6, 2.2.7). The resulting colonies were screened by 
restriction analysis (Section 2.2.2) to confirm the presence of inserted DNA. 
2.2.4 Agarose gel electrophoresis 
For the required percentage gel, routinely 1%, the appropriate amount (1 g/100 
ml) of agarose was dissolved in 1 × TBE (45 mM tris-borate, 1 mM EDTA) then 2-3 
μl ethidium bromide was added to give a slab of agarose gel. Samples for 
analysis were diluted by the addition of 6 × loading buffer (0.25% (w/v) 
bromophenol blue, 0.25% (w/v) xylene cyanol FF, 0.15% (w/v) Ficoll) before 
being loaded on the agarose gel. Gels were run at 100 V in 1 × TBE buffer for 
about an hour. Gels were viewed using a UV transluminator and photographed 
using E.A.S.Y. imaging software. 
2.2.5 DNA extraction from agarose gel 
The QIAquick Gel Extraction Kit (QIAGEN) was used to purify DNA from agarose 
gels according to manufacturer’s instructions. Briefly, DNA was excised from the 
gel using a sterile scalpel. 3 × gel volumes of Buffer QG (supplied) was added to 
the gel and dissolved at 50°C. The melted agarose-DNA mix was applied to a 
QIAquick spin column and centrifuged for 1 min. The supernatant was discarded 
and the DNA was now bound to the column. The column was then washed with 
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min to remove buffer and then spun for a further minute to remove excess 
ethanol. Finally DNA was eluted by adding 30 or 50 μl of nuclease-free water and 
stored at -20°C.  
2.2.6 Transformation of competent cells using heat shock 
For plasmid storage and propagation, E.coli XL-1 blue supercompetent cells 
(Stratagene) were transformed. These cells were stored at –80˚C and thawed on 
ice prior to use, to prevent loss of transformation efficiency. 10-20 ng of plasmid 
DNA was added to 50 μl of thawed cells and mixed gently. The mixture was 
incubated on ice for 30 min, with occasional gentle agitation. Following this 
time, cells were heat-shocked for exactly 45 sec at 42˚C, then transferred to ice 
for a further 2 minutes. 450 μl of SOC medium (LB, 0.04% glucose, 10 mM MgSO4, 
10 mM MgCl2), which had been pre-heated to 42˚C, was then added and cells 
were incubated at 37˚C for 1 h on an orbital shaker (225-250 rpm). 
Subsequently, 150 μl of the transformation mixture was plated on LB-agar (2% 
LB, 2% agar) containing 50 μg/ml of the selective antibiotic ampicillin, and then 
incubated at 37˚C overnight to allow colony formation. An isolated bacterial 
colony was selected from a streaked LB-agar plate, and used to inoculate 5 -10 
ml of LB medium containing 50 μg/ml ampicillin. This mini-culture was 
incubated at 37˚C overnight on an orbital shaker (300rpm). 1 ml was frozen in 
20% sterile glycerol for stock, the rest used for Miniprep or the QIAGEN Plasmid 
Maxi Kit, according to the manufacturer’s instructions. 
2.2.7 Transformation of competent bacterial cells using 
electroporation 
The BIORAD E.coli pulser was used in electro-transformation using the method 
adapted from the BIORAD manual. To 50μl of competent DH5α E.coli cells, 1-2 μl 
of the required plasmid DNA was added and left on ice for 1 min. The DNA/cell 
mix was transferred to an ice cold cuvette, and the cuvette inserted into the 
cuvette holder of an electroporator, which was set at 2.4 V. Both pads were 
kept pressed until the electroporator beeped. 1 ml of SOC media was added 
immediately and this mix then transferred to a 1.5 ml screw top microfuge tube 
and incubated in a 37°C shaker for 45-60 min. Transformed cells were plated Jana Vavrova, 2008    Chapter 2, 70 
onto LB plates containing appropriate antibiotics and incubated at 37°C 
overnight. 
2.2.8 Plasmid preparation using QIAprep
® Spin Miniprep 
Kit (QIAGEN) 
Plasmid DNA was purified from overnight E.coli culture using the QIAprep
® Spin 
Miniprep Kit (QIAGEN) using the protocol in the manufacturer’s manual. After 16 
h incubation at 37°C, cells were collected at 13,000 rpm for 1 min and then 
resuspended in 250 μl buffer P1 (50mM Tris/HCl pH 8.0, 10 mM EDTA, RNase A 
100 μg/ml). Cells were then lysed by addition of 250 μl buffer P2 (0.2 M NaOH, 
1% SDS) and incubated for 5 min. 350 μl of buffer N3 (2.55 M KOAc pH 4.8) was 
added and the mixture was then centrifuged at 13,000 rpm for 10 min to pellet 
cell debris. Supernatant was put through a QIAprep column to allow DNA to bind 
to column. The column was washed with 750μl buffer PE and spun twice to 
remove all trace of buffer. Finally to elute the DNA, 50μl of nuclease-free water 
was added. DNA was stored at -20°C. 
2.2.9 Plasmid preparation using the QIAGEN Plasmid Maxi 
Kit 
For large scale plasmid DNA preparation, the QIAGEN Plasmid Maxi Kit was used. 
250 ml of bacterial cell culture was harvested by centrifugation (Sigma 
Laboratory Centrifuge 4K15) at 6000g for 15 min at 4˚C, then resuspended in 10 
ml of Buffer P1 (500 mM Tris pH 8.0, 10 mM EDTA, 100 μg/ml RNase A). Cell lysis 
was performed by adding 10 ml of Buffer P2 (200 mM NaOH, 0.1% SDS) to initiate 
an alkaline lysis reaction. This reaction was allowed to proceed at room 
temperature for 5 min before lysates were neutralised by adding 10 ml of chilled 
Buffer P3 (3 M potassium acetate, pH 5.5). Addition of Buffer P3 caused the 
precipitation of potassium dodecyl sulphate, SDS-denatured proteins, 
chromosomal DNA and cell debris. Precipitation was enhanced by 20 min 
incubation on ice. The SDS-denatured proteins and chromosomal DNA were co-
precipitated with the detergent, whilst the plasmid DNA remained in solution 
due to a lack of close protein associations. Centrifugation at 20000g for 30 min 
was performed (at 4˚C) to separate precipitated debris from soluble material. 
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promptly removed and applied to a QIAGEN-tip 500, pre-equilibrated with 10 ml 
of Buffer QBT (750 mM NaCl, 50 mM MOPS pH 7.0, 15% isopropanol, 0.15% Triton 
X-100). Gravity flow allowed the supernatant to pass through the anion-exchange 
resin to which plasmid DNA is able to bind tightly.  The resin was then washed 
twice with 30 ml of buffer QC (1 M NaCl, 50 mM MOPS pH 7.0, 15% isopropanol), 
before eluting the purified plasmid DNA into a Falcon tube with 15 ml of buffer 
QF (1.25 M NaCl, 50 mM Tris pH 8.5, 15% isopropanol). DNA was precipitated 
with 10.5 ml of isopropanol. The sample was then centrifuged at 15000g for 30 
min at 4˚C. Following this, the supernatant was carefully decanted out leaving 
the pelleted plasmid DNA, which was then washed with 70% ethanol and 
recentrifuged. The pellet was air-dried for approximately 10 min, and then 
resuspended in an appropriate volume of sterile distilled H2O. All plasmid DNA 
stocks were stored at -20˚C.  
2.3 Competent yeast stable transformation 
To make competent S. cerevisiae cells GGBY62 strain was used. It is a his4-912Δ 
lys2-128Δ ura3-52 strain (collection of Dr McInerny). It was streaked to YPD 
complete media (50 g/l) 20 g/l yeast agar and a few days later, 5 ml YPD 
preculture was inoculated and shaken by orbital shaker at 30°C. This was then 
added into fresh 100 ml of YD media and grown to exponential phase (1 x 10
7 
cells/ml). Cells were spun at 2000 rpm and washed with sterile H2O, spun and 
resuspended in 1 ml sterile 1 x TE/LiAc. Cells were spun again at 2000 rpm and 
resuspended in 0.25 ml 1 x TE/LiAc. 50 μl yeast cell suspension was mixed with 5 
μl transforming linearised DNA (Alu Jo or 7SL in pYES2int linearised with StuI) 
and 5 μl of salmon sperm DNA (10 mg/ml, Sigma). 300 μl sterile PEG (40% 
PEG4000, 1 x TE, 1 x LiAc made fresh from sterile 50% PEG4000, 1 x TE, 1 x LiAc) 
and mixed thoroughly. This was incubated for 30 min in roller drum for 30 min. 
40 μl dimethyl sulphoxide (DMSO) was added and cells were heat shocked at 
42°C for 15 sec. Cells were then spun briefly (6 sec) at 4000 rpm, pellet 
resuspended in 1 ml 1 x TE and spread onto plates containing minimal media 
without uracil (1.9 g/l, Formedium). They were left to grow at 30°C for several 
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2.4 Transient transfection of Alu Jo and VAI  
CCL39 cells were transfected using the Lipofectamine™ reagent (Invitrogen™ Life 
Technologies Inc.) The transient transfection with Lipofectamine™ required cells 
to be at a confluency of ~75% at the time of transfection. 7 μg of plasmid DNA 
extracted using the QIAGEN Plasmid Maxi Kit was used per 10 cm dish. Alu Jo in 
pGEM-5zf(+) plasmid was transfected either alone (7 μg) or co-transfected with 
VAI (in pUC19, 3.5 μg of each) or VAI alone was transfected as a negative 
control. Per each dish, plasmid DNA and 0.5 ml of OptiMEM were mixed, which 
was then mixed with 0.5 ml OptiMEM and 30 μl Lipofectamine™. The 
Lipofectamine™-DNA-OptiMEM solution was incubated for 45 min in the dark at 
room temperature. During this time, 10 cm plates were washed with 1 ml of 
OptiMEM and 4 ml of OptiMEM was then added and left until the end of the 45 
min incubation time. At this point, solution of the Lipofectamine™-DNA-OptiMEM 
mix was added to each plate and incubated at 37°C for 3 h.  Media on plates 
containing transfected cells was replaced with DMEM after 3 hours, and cells 
grown for 24 hours or until confluent. RNA was extracted using TRI reagent 
(Section 2.6.1) and used for cDNA synthesis or primer extension. 
2.5 Genomic DNA isolation 
2.5.1 Isolation of yeast genomic DNA  
10 ml of S.cerevisiae cells were grown for 2-3 days at the permissive 
temperature until saturation point (absorbance of 0.5 – 0.6 at 600 nm). Cells 
were harvested by centrifugation at 2000 rpm for 5 min. The cell pellets were 
then resuspended in 0.5 ml dH2O and transferred to a 1.5 ml screw cap 
microfuge tube where they were pelleted by a short 5 sec spin. Supernatant was 
discarded and the cells were resuspended in the residual liquid before adding 
0.2 ml of solution A (2% Triton, 1% SDS, 100 mM NaCl, 10 mM Tris-HCl pH 8.0, 1 
mM EDTA), 0.2ml phenol:chloroform (1:1) and 0.3 g acid washed glass beads. 
Cells were lysed using the HYBAID Ribolyser at 3×40 sec bursts at setting 4. 400μl 
of TE (10 mM Tris-HCl pH 8, 1 mM EDTA) was added followed by centrifugation at 
14000 rpm for 5 min. The aqueous layer only, containing both DNA and RNA, was 
transferred to a fresh 1.5 ml microfuge tube. 1 ml of 100% ethanol was added to 
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fragments and put at -80°C for 10 min. This was then pelleted by centrifugation 
at 13000 rpm for 2 min and supernatant discarded. The pellet was resuspended 
in 400 μl of TE and 3 µl Ribonuclease A (10 mg/ml) and incubated at 37°C for 5 
min to digest unwanted RNA. 1 ml of 100% ethanol and 8 μl of 5 M ammonium 
acetate was then added, gently mixed by inversion and left at -70°C for 25-30 
min. The DNA was pelleted by centrifugation at 13000 rpm for 2 min and the 
supernatant discarded. The pellet was air-dried and resuspended in 100 μl TE 
and the DNA stored at -20°C.  
2.5.2 Isolation of mammalian genomic DNA  
Mammalian cells were grown on tissue culture dishes until subconfluent. Cells 
were detached from dishes using buffered trypsin (0.05% trypsin, 0.02% EDTA; 
Sigma), collected to 15 ml falcon tubes, spun at 500g and supernatant was 
discarded. Cells were resuspended in 10 ml ice cold PBS, spun at 500g and 
supernatant discarded. This step was repeated. Cell pellet was resuspended in 
0.5 ml of digestion buffer (100 mM NaCl, 10 mM Tris-Cl pH 8, 25 mM EDTA pH 8, 
0.5% SDS) per dish (1 x 10
7 cells). 5 μl of proteinase K (10 mg/ml) was added and 
cells were incubated with shaking at 55°C for 12-18 h. Nucleic acids were 
extracted with equal volume of phenol/chloroform (1:1). Samples were spun for 
10 min at 1700g in a swinging bucket rotor. The aqueous layer was transferred 
into a new tube and 1/10 volume of 7.5 M ammonium acetate and 2 volumes of 
100% ethanol were added. The DNA immediately formed a stringy precipitate. It 
was picked with a glass pipette and transferred to fresh 1.5 ml microfuge tubes 
containing 70% ethanol. Samples were spun at 13000g for 2 min, ethanol 
removed and samples air-dried for 10 min. DNA was resuspended in 1 ml sterile 
H2O and incubated for 1 h at 65°C to facilitate solubilisation.  
2.5.3 Quantification of DNA  
DNA concentration was determined by measuring absorbance at 260 nm, and 
using the following calculation: DNA concentration (μg/ml) = absorbance at 260 
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2.6 Isolation of total RNA  
2.6.1 RNA extraction from mammalian cells 
Total cellular RNA was extracted from all mammalian cells grown on 10 cm 
tissue culture dishes using TRI reagent (Sigma), according to the manufacturer’s 
instructions. Media was aspirated from the cells, then cells were scraped into 
TRI reagent and transferred to sterile 1.5 ml microfuge tubes. 1 ml of TRI 
reagent was used per plate. Samples were incubated for 5 min at room 
temperature, to allow the complete dissociation of nucleoprotein complexes, 
then 0.2 ml of chloroform was added to each. Thorough mixing of chloroform 
and TRI reagent was ensured by vortexing each sample for 15 sec. Samples were 
incubated at room temperature for a further 5 min, then centrifuged at 12000g 
for 15 min at 4˚C. This centrifugation separated the samples into 3 phases: a 
lower organic phase containing proteins, a middle interphase containing DNA, 
and an upper aqueous phase containing RNA. The RNA-containing phase was 
carefully removed, and transferred to a fresh microfuge tube. To precipitate 
RNA, 0.5 ml of isopropanol was added, samples were mixed by vortexing for 10 
seconds, then incubated for 10 min at room temperature. Subsequently, samples 
were centrifuged at 12000g for 10 min at 4˚C. Following centrifugation, the 
supernatant was discarded, and the remaining RNA pellet was washed using 1 ml 
of 75% ethanol, made using diethylpyrocarbonate (DEPC)-treated H2O (0.1% 
DEPC). Samples were centrifuged for a further 5 min at 12000 g (4˚C), then the 
supernatant was aspirated off, and RNA pellets left to air dry for approximately 
10 min. Once dry, RNA was resuspended in 30-50 μl of DEPC-treated H2O. To aid 
resuspension, samples were incubated at 50˚C for 15 min. All RNA samples were 
stored at -80˚C.  
2.6.2 RNA harvested from mouse kidneys 
MeCP2 wild type, female heterozygous and male knock-out mouse kidneys were 
obtained from Dr Mark Bailey (Guy et al., 2001). Table 2 below lists all animals 
used. 
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Mouse  Date of birth  MeCP2 genotype  Strain 
Ko671 20/08/02  +/+  C57 
Ko672 20/08/02  +/-  C57 
Kob13 28/02/03  -/y  C57/Balb/6 
Kob14 28/02/03  +/y  C57/Balb/6 
Ko771 28/03/03  +/y  C57 
Table   2-2 MeCP2 mice 
 
Following removal, kidneys were immediately snap-frozen in liquid nitrogen and 
stored in a -80°C freezer. Prior to handling, tissue was put onto dry ice. Tissue 
was crushed using a pestle and mortar in liquid nitrogen, then transferred to 
sterile microfuge tubes. 1 ml of TRI reagent was added per kidney. 
Subsequently, the homogenate was centrifuged at 12000g for 5 min to remove 
any insoluble material. The supernatant containing RNA was transferred to a 
fresh tube and RNA extracted as described above. 
2.6.3 RNA extraction from yeast  
RNA extraction from budding yeast required the growth of a 200 ml culture of 
cells to exponential phase and harvesting at 3000 rpm for 5 min. Supernatant 
was discarded and the cell pellet was resuspended in 1 ml STE (0.32 M sucrose, 
20 mM Tris-HCl pH 7.5, 10 mM EDTA pH 8.0) and transferred to a screw cap 
microfuge tube and centrifuged at 13000 rpm for 5 sec. Cells could be stored at 
-80°C or used further. The cell pellet was resuspended in 200 μl STE and 600 μl 
NTES (100 mM NaCl, 5mM EDTA, 50 mM Tris-HCl pH 7.5, 1% (w/v) SDS) was added 
together with 500 μl of water saturated hot phenol at 65°C and 0.3 g acid-
washed glass beads. Cells were lysed using a Hybaid Ribolyser for 3 × 40 sec 
bursts at setting 4. After centrifugation at 13000 rpm for 5 min, the upper 
aqueous phase and protein interface was transferred into a fresh microfuge tube 
containing 500 μl hot phenol. The mixture was again ribolysed for a 1 × 40 sec 
burst and again spun for 5 min. This step was repeated with room temperature 
phenol. The aqueous phase was then transferred to 400 μl of phenol/chloroform 
(1:1) at room temperature, ribolysed and spun. The aqueous phase was then 
transferred to a second 400 μl aliquot of phenol/chloroform, ribolysed and spun. 
The aqueous phase was then transferred to a 300 μl aliquot of chloroform and 
ribolysed. Finally after spinning for 5 min the aqueous phase was transferred to 
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volume of 3M sodium acetate pH 5.2 were added. The RNA was precipitated 
overnight at -20°C or for a couple of hours at -70°C. RNA was then pelleted by 
centrifugation at 13000 rpm for 10 min and supernatant was discarded. The 
pellet was washed in 70% ethanol in RNAse-free dH2O and centrifuged for 1 min. 
Ethanol was removed and the pellet was left to air dry. Pellet was then 
resuspended in 50 μl of RNAse-free dH2O and dissolved by incubating at 65°C 
with frequent pipetting.  
2.6.4 Quantification of RNA 
Spectrophotometer was employed to measure the absorbance of each sample at 
260 nm, and the following formula was used to calculate the RNA concentration: 
RNA concentration (μg/ml) = absorbance at 260 nm x 40 x dilution factor.  
2.7 Protein extraction 
2.7.1 Preparation of extracts 
Extracts for polyacrylamide gel electrophoresis were prepared from all 
mammalian cells grown on 10 cm dishes. Dishes with cells were placed on ice 
and washed twice in ice cold PBS (phosphate-buffered saline). Cells were then 
scraped directly into cell lysis buffer (20 mM HEPES pH 7.8, 150 mM NaCl, 25% 
glycerol, 50 mM NaF, 0.2 mM EDTA, 0.5% Triton X-100, 0.5% NP-40, 10 mM β-
glycerolphosphate, 1 mM sodium orthovanadate, 1 mM PMSF 
(phenylmethylsulfonyl fluoride), 1 mM DTT, 0.5 μg/ml leupeptin, 1 μg/ml trypsin 
inhibitor, 0.5 μg/ml aprotinin and 40 μg/ml bestatin) and transferred to sterile 
microfuge tubes. 250 μl of buffer was used per plate. The cell lysates were 
incubated on ice for 15 min, and then passed through a 26-guage needle three 
times. Cell debris was collected by centrifugation at 12000g for 10 min and 
supernatant collected, snap-frozen on dry ice and stored at -80°C. 
2.7.2 Determination of protein concentrations  
The protein concentrations of whole cell extracts were determined using 
Bradford’s reagent (BioRad) diluted 1 in 5 with distilled H2O. The colour change 
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absorbance at 595 nm, and is directly proportional to the concentration of 
protein in the sample. For each experiment, a standard curve was constructed 
by measuring the absorbance (using a spectrophotometer) of 0, 2, 4, 6, 8, 10 and 
12 μg of BSA in 1ml of Bradford’s reagent. 1 or 2 μl (depending on the colour 
change) of the whole cell extracts were added to 1 ml of reagent. Absorbance 
readings at 595 nm were performed in duplicates, and the protein concentration 
of each sample determined from the standard curve. 
2.8 Western blot analysis 
2.8.1 Separation of proteins by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE)  
Whole cell lysates (prepared as described above) containing 30-50 μg of protein 
were resolved by denaturing SDS-PAGE on 10% or 12% (unless otherwise 
indicated) polyacrylamide minigels (resolving buffer contained 375 mM Tris pH 
8.8, 0.1% SDS), 4% polyacrylamide stacking gels contained 125 mM Tris pH 6.8, 
0.1% SDS. Prior to loading, samples were boiled for 4 min in 1 x protein sample 
buffer (62.5 mM Tris pH 6.8, 0.5% SDS, 5% β-mercaptoethanol, 10% glycerol, 
0.125% bromophenol blue). Electrophoresis was performed in 1 X SDS running 
buffer (0.1% SDS, 76.8 mM glycine, 10 mM Tris pH 8.3) at 200 V for 1 h. 
2.8.2 Western blot analysis 
Following resolution by SDS-PAGE, proteins were transferred to a Hybond™-P 
membrane (Amersham) using the BioRad Mini Trans-Blot Electrophoretic Transfer 
Cell system. Transfer was carried out in 1 x transfer buffer (76.8 mM glycine, 10 
mM Tris pH 8.3, 16.5% methanol) at 70 V for 1 h at room temperature or 50 V at 
4°C overnight. Membrane was then stained using 1 x Ponceau S solution to 
ensure efficient transfer of the protein to the membrane, and subsequently 
washed with 1 x TBS (2.5 mM Tris pH 7.6, 15 mM NaCl). Membrane was then cut 
into pieces of membrane containing proteins of interest and these were 
separated into dishes and blocked in milk buffer ((1 x TBS, 0.5% Tween-20, 5% 
skimmed milk powder (Marvel)) for 1 hour at room temperature. After 1 h, 
membranes were transferred into fresh milk buffer and primary antibody was 
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utilised are listed in Table 4 (Section 2.16). After incubation, membranes were 
washed 3 times for 5 minutes in 1 x Western buffer (32.5 mM Tris, 150 mM NaCl, 
0.5% Tween-20) to remove excess primary antibody. Subsequently, membranes 
were incubated with the appropriate horseradish peroxidase-conjugated 
secondary antibody (Dako), diluted 1 in 1000 in milk buffer, for 1 h at room 
temperature. Excess secondary antibody was then removed by three 5 min 
washes and two 15 min washes in 1 x Western buffer. Following a final 5 min 
wash in 1 x TBS (2.5 mM Tris pH 7.6, 15 mM NaCl), the HRP-conjugated 
(horseradish peroxidase) secondary antibodies were detected using the enhanced 
chemiluminescence (ECL) method (Amersham). Chemiluminescence detection, 
using the ECL™ Western Blotting analysis system (Amersham Pharmacia), was 
performed by adding equal volumes of reagent 1 and reagent 2 to the 
membrane, incubating at room temperature for 1 min, and then exposing the 
membrane, covered in Saran Wrap, to ECL film (Amersham Pharmacia) for 
different lengths of time before developing using the X-OMAT film processor.  
2.9 Northern blot  
2.9.1 Total RNA separation by electrophoresis and 
membrane transfer 
1 g of agarose was dissolved by boiling in 63 ml of dH2O and 20 ml of 5 x MNE 
(120 mM MOPS, 25 mM NaOAc, 5 mM EDTA pH 7) and then cooled to 
approximately 60°C. 17 ml of formaldehyde was added and gently mixed. The 
mixture was poured into a horizontal gel mould and left to set for 30 min. 10-20 
μg RNA was mixed with 20 μl of RNA buffer (600 μl formaldehyde, 200 μl 
formamide, 240 μl 5 x MNE, 160 μl dH2O) and 1 μl of 0.5 mg/ml ethidium 
bromide. Samples were incubated at 60°C for 5 min to denature RNA secondary 
structure and then loaded onto the formaldehyde gel. RNA was then separated 
by electrophoresis at 60 V for 2.5 h in 1 x MNE. The gel was visualised under a 
UV transilluminator to ensure effective RNA separation and equal loading. 
The gel was then washed in 0.1 M sodium phosphate buffer pH 6.5 (61 ml 1 M 
Na2HPO4, 39 ml 1 M NaH2PO4 made to 1 litre with dH2O) with gentle shaking for 
10 to 15 min. For capillary transfer of the RNA, the gel was inverted and placed 
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in and was fed from a reservoir of 0.1 M sodium phosphate buffer pH 6.5. A gel-
sized piece of pre-soaked Hybond N nylon membrane (Amersham Pharmacia), 
followed by 2 pieces of pre-soaked Whatmann paper, were placed on the gel 
ensuring no air bubbles between layers. A stack of folded paper towels was then 
added followed by a 0.5 kg weight, to ensure efficient transfer of RNA to the 
membrane by capillary action. Pieces of autoradiography film were placed at the 
edges of the gel to prevent the paper towels from contacting the wick. The 
transfer was allowed to proceed for 16 to 18 hours, and then RNA was fixed to 
the membrane by UV exposure and baking in a 70°C oven for 1 h.  
2.9.2 Probe preparation, radiolabelling and purification 
To specifically detect the RNA of interest, radiolabelled complementary DNA 
probes were used: the Alu Jo probe was prepared from a 349bp SacI-SpeI 
fragment of Alu Jo in pGEM-5zf(+) plasmid (Promega), and the probe for Gal1 
transcript was prepared from the 523bp SpeI-SacI fragment of pYES2int plasmid 
(Invitrogen, modified). A Megaprime DNA Labelling Kit (Amersham Pharmacia) 
was used to label the probes by random oligonucleotide priming, according to 
the manufacturer’s instructions. 5 μl of random hexamer oligonucleotides were 
mixed with 2 μl (25 ng) of the DNA fragment to be probed, and 26 μl with DEPC-
treated H2O. This was heated at 95˚C for 5 min to denature the DNA. Slow 
cooling of the mixture to room temperature allowed the random hexamer 
oligonucleotides to anneal to the DNA. 10 μl of reaction buffer (dATP, dGTP, 
dTTP in Tris pH 7.5, β-mercaptoethanol and MgCl2), 2 μl (2U) of DNA polymerase 
I Klenow fragment, and 50 μCi of [α-
32P] dCTP (Amersham Pharmacia) were 
added, and labelling was allowed to proceed at 37˚C for 1 h. The labelled DNA 
was then denatured by heating at 100˚C for 5 min, and then chilled and stored 
on ice until used.  
To achieve higher specifity of the probe and decrease background radioactivity, 
the probe was purified from unincorporated [α-P
32] dCTP using a size-exclusion 
column. Sephadex G-50 was prepared by adding two volumes of TE and 
autoclaving. The plunger of a 1 ml syringe (Plastipak) was removed and a small 
amount of glass wool (silane treated, Supelco) was used to plug the end of the 
syringe before a microfuge tube was placed on the end of the syringe. Both 
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Sephadex G-50 was added to the syringe and centrifuged for 5 min at 3000 rpm. 
TE was removed and the process repeated until 0.7 ml of Sephadex G-50 
remained in the syringe. A fresh microfuge tube was then placed on the bottom 
of the syringe and the radiolabelled probe (made up to 100 μl with dH2O to 
increase volume added to column) was added to the Sephadex G-50 column and 
centrifuged for 5 min at 3000 rpm. The probe was collected and the labelled 
DNA was denatured by heating at 100˚C for 5 min, and then chilled and stored 
on ice until used. 
2.9.3 Hybridisation and analysis 
Prior to hybridising the membrane with an appropriate radiolabelled probe, it 
was pre-hybridised in a Techne hybridisation oven for 2-4 h at 42°C in 18 ml of 
hybridisation buffer (10 ml formamide, 4 ml P buffer (1% BSA, 1% polyvinyl- 
pyrrolidone, 1% ficoll, 250 mM Tris-HCl pH 7.5, 0.5% sodium pyrophosphate, 5% 
SDS), 4 ml 50% dextran sulphate (Pharmacia), 1.16 g NaCl). The hybridisation 
buffer was heated to dissolve salt at 42°C and then 200 μl salmon sperm DNA 
(Sigma, denatured at 95°C for 5 min and chilled on ice) was added. Denatured 
radiolabelled probe was added to the hybridisation buffer and hybridisation 
carried out at 42°C overnight. The following day the hybridisation buffer was 
poured away and the membrane was first washed twice for 5 min each time in 2 
x SSPE (20 x SSPE stock is 3 M NaCl, 20 mM NaH2PO4, 200 mM EDTA pH 7.4) at 
42°C.  The membrane was then washed in 2 x SSPE + 0.5% SDS at 65°C for 15 min 
to remove unspecific binding. The signal to background ratio was monitored 
using a Geiger counter and if background was still high, the 65°C wash was 
repeated. Finally, the membrane was rinsed in 0.1 x SSPE. The membrane was 
then exposed to autoradiography film for an appropriate length of time. To 
reprobe the membrane, it was boiled in DEPC-treated H2O for 5 minutes and 
exposed to autoradiography film overnight to check there is no detectable 
radioactivity. Then it was pre-hybridised and probed as before. 
2.10 In vitro transcription assay 
In vitro transcription of class III genes was reconstituted using 20 μg of HeLa 
nuclear extracts (Computer Cell Culture Center, Mons, Belgium) to provide the 
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2 μl (250 ng/ml) of plasmid DNA containing the templates Alu Jo in pGEM-5zf(+) 
plasmid (Promega) and 7SL in pUC19 was mixed with 2μl of dH2O. The following 
25 μl mix was added to the template: 2 μl of HeLa nuclear extract, 2 μl of dH2O, 
13 μl LDB (12 mM HEPES pH 7.9, 60 mM KCl, 7.2 mM MgCl2, 0.28 mM EDTA, 1.2 
mM DTT, 10% glycerol), 2 μl TC(NE) (0.5 mM of each rATP, rCTP and rGTP in 
DEPC EDTA), 1 mM CP/ED (creatine phosphate) and 10 μCi of [α-32P]UTP 
(Amersham Pharmacia). In vitro transcription without [α-32P]UTP was 
sometimes performed if the RNA product was subsequently used for primer 
extension. If unlabelled IVT was performed, 0.5 mM rUTP were added instead of 
of [α-32P]UTP. Transcription was carried out at 30°C for 1 hour. Transcription 
was stopped by the addition of 250 μl of 1 M ammonium acetate/0.1% SDS 
containing 20 μg of yeast tRNA (which stabilises the newly synthesised RNA in 
the samples). Phenol/chloroform extraction was then performed, to remove 
protein and DNA, by adding 250 μl of phenol/chloroform (1:1) to each sample. 
Samples were mixed thoroughly by vortexing, and then centrifuged at 13000g for 
5 min. 200 μl of the resulting upper aqueous layer was then transferred to a 
fresh microfuge tube containing 750 μl of 100% ethanol. The samples were mixed 
by repeated inversion, and left at -20°C overnight to precipitate RNA. The 
following day, samples were centrifuged at 13000g for 30 min to pellet the 
precipitated RNA. The supernatant was carefully removed and discarded, then 
pellets were washed using 750 μl of 70% ethanol (prepared using DEPC-treated 
H2O) and re-centrifuged at 13000g for 5 min. Again, the supernatant was 
discarded. RNA pellets were dried at 50°C for 5 min. Once dry, cold RNA was 
mixed with 4 μl of DEPC-treated H2O and kept at -80°C. 4 μl of formamide 
loading buffer was added to radioactive RNA. Samples were then vortexed for 30 
min to ensure complete resuspension of the RNA, and heated at 95°C for 2 min. 
Electrophoresis and autoradiography of radiolabelled transcripts was performed, 
as described in section 2.17 for PCR products. 
2.11 Primer Extension  
RNA from CCL cells transfected with Alu Jo (0.25 μg) and RNA polymerase III 
template VA1 (0.25 μg), was analysed by primer extension. RNA from in vitro 
transcribed Alu Jo was used as a positive control. VA1 (5’-
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CTC TGC TAC C -3’ or PxuniqR primer 5’- GTA ATT CTT TTG TAG AGA CAG ACT 
CAC -3’) primers were [γ-
32P]ATP end-labelled using T4 polynucleotide kinase 
(Promega). 50 ng of each primer was mixed with 2 μl T4 kinase buffer, 40 μCi of 
[γ-
32P]ATP, 2 μl of T4 kinase and 11 μl DEPC-treated H2O.  The mix was incubated 
at 37°C for 1 h and then stopped by addition of 1 μl 0.5 M EDTA and heated to 
65°C for 10 min. This was stored overnight at -20°C if necessary.  
For each primer extension reaction, 10 μg of RNA (made up to 10 μl with DEPC- 
dH2O) were mixed with 10 μl of the relevant labelled probe diluted 1:10 in First 
Strand Buffer (Invitrogen) and incubated at 80ºC for 10 min. Samples were then 
immediately transferred to a heat block at 50°C, then briefly spun and 
incubated further for 2 h. This allowed the labelled probe (primer) to hybridise 
to the target sequence. Tubes were then pulse-microfuged and moved to a heat 
block at 42 °C. 30 μl of an elongation mix (23 μl DEPC-dH2O, 0.5 μl 0.1 M DTT, 5 
μl 5 mM dNTP mix (5 mM in DEPC- dH2O), 0.5 μl 5 mg/ml actinomycin D, 0.5 μl 
RNASin (Promega) and 0.5 μl (100 U) of Superscript II Reverse Transcriptase 
(Invitrogen) was then added to the samples to initiate reverse transcription and 
the reaction was allowed to proceed for 1 h at 42ºC. Reaction products were 
ethanol precipitated overnight as described above. Pellets were resuspended in 
4 μl of formamide loading buffer (98% (v/v) formamide, 10 mM EDTA pH 8.0, 
0.025% (w/v) bromophenol blue, 0.025% (w/v) xylene cyanol FF) was added to 
each sample, which was then vortexed for 1 h to ensure the RNA was fully 
dissolved.  1.5 μl of each sample was loaded on a pre-run 7% (v/v) 
polyacrylamide sequencing gel and analysis continued as described in section 
2.17.   
2.12 Nuclear run 
2.12.1  Extraction of nuclei 
HeLa cells were grown in 10 cm tissue culture dishes as described above until 
80% confluent. Cells were trypsinised with buffered trypsin (0.05% trypsin, 0.02% 
EDTA; Sigma) and collected into 50 ml falcon tubes. Cells were spun at 500g for 
5 min and washed with cold PBS and then spun and kept on ice. Cells were then 
counted using a haemocytometer. Typically, 5 dishes of cells were used, which 
gave about 3 x 10
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again, spun and resuspended in 3 ml of extraction solution A (0.5% NP-40, 10 mM 
Tris pH 7.4, 10 mM NaCl, 3 mM MgCl2) with added 20 μl/ml of solution A of 
protease inhibitor mix ((PIM, consisting of 1.6 ml of bestatin (2.5 mg/ml), 50 μl 
of leupeptin (1 mg/ml), 100 μl of trypsin inhibitor (1 mg/ml), 24 μl of aprotinin 
(2.2 mg/ml), 70 μl of pepstatin (1 mg/ml) and 150 μl of E-64 (2 mg/ml)), 1 mM 
PMSF (phenylmethylsulfonyl fluoride) and 1 mM DTT on the day of use. The 3 ml 
of suspension were transferred into an ice cold loose homogeniser and 
homogenised by 10 strokes up and down. The suspension was kept on ice. Two 
disposable Beckman tubes were filled with 4 ml of extraction solution B (1.8 M 
sucrose, 5 mM Mg acetate, 0.1 mM EDTA, 10 mM Tris pH 8 with freshly added PIM 
(10 μl/ml of solution B), 1 mM DTT and 1 mM PMSF). 6 ml of extraction solution 
was also added to the suspension in homogeniser and gently mixed with a 
pipette. This mix was then layered carefully on top of the extraction solution B 
in the disposable Beckman tubes. Tubes were carefully transferred to the chilled 
Floor Beckman L8-55R Ultracentrifuge, SW 40 Ti rotor and spun at 30000g for 45 
min at 4°C. In the meantime, 1 ml of extraction solution C was prepared (25% 
glycerol, 5 mM Mg acetate, 0.1 mM EDTA, 50 mM Tris pH 8 with freshly added 20 
μl of PIM, 5 mM DTT and 1 mM PMSF). After the spin, the supernatant was 
discarded and any remaining liquid carefully dried. The pellet of nuclei was 
resuspended in extraction solution C (100 μl/1 x 10
7 nuclei) and aliquoted to 
cryotubes, snap-frozen in liquid nitrogen and kept in liquid nitrogen until used. 
2.12.2  Probe and membrane preparation 
10 μg of linearised plasmid (Alu Jo and 7SL in pYES2int plasmid) or 2 μg of DNA 
fragment (Alu Jo and 7SL) was used as a probe.  2 μl of the probes were also 
loaded on an agarose gel to check equal loading of all probes onto the 
membrane. Probes were dissolved in 0.5 M NaOH and boiled at 85°C for 15 min 
to denature DNA strands, then chilled on ice. In the meantime, Hybond™-N 
membrane (Amersham) was soaked in 10 x SSC (1.5 M NaCl and 0.15 M sodium 
citrate) for 10 min and put into a slot blot manifold (Amersham Biosciences) 
attached to a vacuum pump.  Every slot of membrane was washed with some 10 
x SSC and liquid run through the membrane using vacuum.  Probe was diluted to 
200 μl with 10 x SSC and applied onto the membrane using vacuum. Each slot of 
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Membrane was then air-dried and probes were UV and heat cross linked to the 
membrane. Membrane was kept until needed. 
2.12.3  Nuclear run-on assay 
50 μl of run-on solution A (2 mM of each ATP,GTP, CTP and UTP, 0.1 M S-
adenosyl methionine in DEPC-treated H2O) was mixed with 10 μl DEPC-treated 
H2O and run-on solution B (0.6 M KCl and 12.5 mM Mg acetate). 1 x 10
7 nuclei per 
reaction was carefully defrosted in a 30°C waterbath and the above mix 
together with 5 μl of RNasin and 100 μCi of very fresh [α-
32P] UTP (Amersham 
Pharmacia) was added. Samples were incubated at 30°C for 30 min. After 
incubation, 3 μl of DNase (Invitrogen) was added and samples incubated for 
another 10 min. RNA was then diluted with 10 μl 10% SDS and 100 μl TES (TE and 
0.5% SDS) and mixed with 340 μl of phenol/chloroform, vortexed and spun at 
13000g for 10 min. The top layer containing the RNA was transferred into a fresh 
1.5 ml microfuge tube and mixed with 125 μl 3M NaOAc and 1 ml 100% ethanol. 
Tubes were vortexed briefly and spun at 13000g for 5 min. Supernatant was 
removed and pellet resuspended in 375 μl of TES. 125 μl of 3 M NaOAc and 1 ml 
of 100% ethanol were added and samples left to precipitate overnight at -20° 
Next day, samples were spun at 13000g for 20 min. In the meantime membrane 
with probes was prehybridised in pre-warmed rapid hybridisation buffer (Rapid-
hyb buffer, Amersham Biosciences) at 70°C for 1 h. Supernatant was removed 
from the samples and pellet was resuspended in 1 ml of pre- warmed 
hybridisation buffer and the mix added to the membrane and hybridised at 70°C 
overnight in a hybridisation oven. The following day, membrane was washed in 2 
x SSC/0.1% SDS for 20 min in room temperature, twice in 0.5 x SSC/0.1% SDS at 
65°C for 15 min and then covered in Saran Wrap and exposed to ECL film 
(Amersham Pharmacia) for different lengths of time before developing using the 
X-OMAT film processor. 
2.13 Polymerase chain reaction 
Polymerase chain reactions (PCRs) were performed using a Techgene thermal 
controller (TECHNE). Each reaction had a total volume of 20 μl and contained 2 
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U of Taq DNA polymerase (Promega), 1 x Taq DNA polymerase buffer (Promega), 
1.5 mM MgCl2, 0.2 mM of each non-radioactive dNTP, and 2 μCi of [α-
32P] dCTP 
(Amersham). Table 2.3 lists the primers used for PCR, their sequences, Tm and 
cycle numbers. Those used for reverse transcription PCR are labeled R, those 
used for chromatin immunoprecipitation assays are labeled C, primer extension 
P. It is also stated whether they were used for human or mouse DNA or cDNA (H 
or M respectively). Star indicates primers designed using UCSC Genome Browser 
(www.genome.ucsc.edu) and Primer3 software. The cycling parameters 
employed typically were 95°C for 3 minutes, number of cycles of [95°C for 30 
seconds, annealing temperature for 30 seconds, 72°C for 30 seconds], 72°C for 5 
minutes. Annealing temperature was typically 54-59°C or for primers with Tm 
over 70°C (whichever was lower from the primer pair) annealing temperature 
was selected 5°C below the Tm. Number of cycles was lower for cDNA and 
higher for DNA. PCR reaction products were diluted 1:1 with formamide loading 
buffer and resolved on 7% polyacrylamide sequencing gels as described in section 
2.17. 




R  H/M  F: 5’-GCA CTG GAA GTC CAA CTA CTT C-3’ 






R/C  H/M  F: 5’-GTC AGG ATG GCC GAG TGG TCT AAG 
GCG CC-3’ 
R: 5’-CCA CGC CTC CAT ACG GAG ACC AGA 






R/C  H/M  F: 5’-CCT TCG ATA GCT CAG CTG GTA GAG 
CGG AGG-3’ 







R/C  H/M  F: 5’-GTG TCC GCA CTA AGT TCG GCA TCA ATA 
TGG-3’ 







R  H/M  F: 5’-GGC ATA CCA CCC TGA ACG C-3’  






R/C  M  F: 5’-TGG TGG TGC ATG CCT TTA AT-3’ 






R/C  M  F: 5’-GGG GCT GGA GAG ATG GCT-3’ 






R  M  F: 5’-TCC ACC ACC CTG TTG CTG TA-3’ 






R  H  F: 5’-GAA GGT GAA GGT CGG AGT C-3’ 






R  M  F: 5’-GTT TCG GAA GGA GCT GAC TG-3’ 






C  M  F: 5’-TTC GGA AGG AGC TGG TAA GAC-3’ 






R  S.C.  F: 5’-CGT TCC AAT TTA CGC TGG TT-3’ 






C  H  F: 5’-CAG CGG AGG TGA AGG ACG TC-3’ 
R: 5’-CTC CTC  CTC TCC CCA AG-3’ 
69.4 
59.8 
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p53BP2* 
(189bp) 
R  M  F: 5’-GTT GGT TTC GGC GAG AAG G-3’ 








C  H  F: 5’-CTC ACG ATC ATG GCT AAC TGC-3’ 








C  M  F: 5’-GCA TGC ATA CCA CTC CAC AC-3’ 








C  M  F: 5’-CTG CCT TCA GAC ACA CCA GAA G-3’ 






R/C  M/H  F: 5’-GGA TGA TCC TCA GTG GTC-3’ 




ALU Jo   
genomic* 
(419bp) 
C  H  F: 5’-CTA CTC AAA ATA TTA AAC ATA GGC-3’ 





PxUNIQR* R/P  H  R:  5’-GTA  ATT CTT TTG TAG AGA CAG ACT 
CAC-3’ 
59.4  25 
H19* 
(161bp) 
R/C  M  F: 5’-AGA GCT GGA GGA GAG TCG TG-3’ 







R  H  F: 5’-CTT ACA CGT GTC ATC CCA GC-3’ 






C  H  F: 5’-CCC TGC CAG GTA AGT ATG-3’ 








R  H  F: 5’-ACC ATC CCG GCT AAA ACG GTG A-3’ 








R H F:  5’- CTT ACA CGT GTC ATC CCA GC -3’ 





Alu chr 6 
(396bp) 
C  H  F: 5’-CCA GAA AAT TAC CAA TTA GTT C-3’ 







C  H  F: 5’-GAT TCT CAA CAG CAG AAT TCC ATG CC-
3’ 









C  H  F: 5’-GTT CTG ACA CAC TTG GAG AAA GTG-3’ 




Table   2-3 Primer information 




2.14 Reverse transcription PCR (RT-PCR) 
RNA harvested from cells or mouse kidneys was DNase I-treated prior to cDNA 
synthesis using a DNA-free kit (Ambion), according to the manufacturer’s 
instructions. 10 μg of RNA was diluted with DEPC-treated H2O to give a final Jana Vavrova, 2008    Chapter 2, 87 
volume of 25 μl. To this, 2.5 μl of 10 x DNase I Buffer (Ambion) and 1 μl (2 U) of 
DNase I (Ambion) were added. Samples were incubated at 37˚C for 30 min. To 
inactivate the DNase I, 5 μl of DNase Inactivation Reagent slurry (Ambion) was 
added, and samples incubated for 2 min at room temperature. Subsequently, 
samples were centrifuged (in an Eppendorf Centrifuge 5415R) at 10000g for 1 
min to pellet the Inactivation Reagent. The supernatant containing DNA-free 
RNA was transferred to a fresh sterile microfuge tube, and stored at –80˚C. 1.2 
μg of this RNA was used for cDNA synthesis. 
1.2 μg (3 μl) of RNA and 200 ng (2 μl of 1:10 dilution) of random hexanucleotide 
primers (Roche) were diluted in DEPC-treated H2O to give a final volume of 24 
μl. Primer annealing was carried out for 10 min at 80˚C. Following this, samples 
were transferred to ice and 1 μl (200 U) of Superscript II reverse transcriptase 
(Invitrogen Life Technologies), 8 μl of 5 x First Stand Buffer (Invitrogen Life 
Technologies), 4 μl of 0.1 M dithiolthreitol (DTT) (Invitrogen Life Technologies) 
and 2 μl of 10 mM dNTPs (Promega) were added to each. One sample was also 
treated with the same mix but no reverse transcriptase was added. Reverse 
transcription was then allowed to proceed for 1 h at 42˚C. The reaction was 
stopped by heating to 70˚C for 15 min. cDNAs were stored at –20˚C.  Polymerase 
chain reaction using cDNA as a template was then performed as described 
above. No superscript samples served in the PCR analysis as a control that no 
DNA contamination is present. PCR was also performed with 1:2 diluted cDNA to 
check whether it gave a weaker product and therefore confirm that the amount 
of cycles used was quantitative. Radiolabelled PCR products were loaded on 7% 
polyacrylamide sequencing gels and visualised by autoradiography as described 
in section 2.17.  
2.15 Chromatin immunoprecipitation (ChIP) assay 
Mammalian cells were grown on 10 cm tissue culture dishes. One dish (1 x 10
7 
cells) was used per condition. To crosslink cellular DNA and proteins, cells were 
treated with 1% formaldehyde. Crosslinking was allowed to proceed for 10 min at 
37˚C, then glycine was added at a final concentration of 0.125 M to stop the 
crosslinking, and plates were transferred to ice. 2 ml of ice cold PBS was added 
to each dish and cells were scraped and transferred to Falcon tubes. Tubes were 
centrifuged (in a Sorvall RT 6000 D) at 500g for 5 min at 4˚C, then cells were Jana Vavrova, 2008    Chapter 2, 88 
washed twice by resuspension in ice-cold PBS, followed by centrifugation at 500g 
for 5 min. Following removal of supernatant after the final wash, cell pellet was 
snap-frozen on dry ice and tubes kept at -80°C until used or used immediately 
for chromatin immunoprecipitation. Cell pellets were resuspended in 50 ml of 
PBS/0.5% NP-40, spun 5 min at 500g in a swing rotor and supernatant removed. 
Cells were resuspended in high salt buffer (0.5% NP-40/PBS, 1 M NaCl) and 
incubated on ice for 30 min. Cells were then centrifuged at 500g for 5 min, and 
washed once in 0.5% NP-40/PBS. Subsequently, hypotonic disruption was 
performed by resuspending cells in 50 ml of low salt buffer (0.1% NP-40, 10 mM 
Tris pH 8.0, 1 mM EDTA, 0.1 M NaCl) and incubating on ice for 30 min. Following 
this, samples were centrifuged at 500g for 5 min at 4˚C, and the resulting 
pellets resuspended in 1 ml of low salt buffer. To obtain nuclei, samples were 
then passed through a 26-guage needle 3 times. 1.7 ml of low salt buffer was 
added and remaining cell membranes lysed with 300 μl of 20% sarkosyl (N-lauroyl 
sarcosine). Subsequently, lysed nuclei were transferred to a sucrose cushion (40 
ml low salt buffer/100 mM sucrose) and centrifuged at 4000g for 10 min at 4˚C. 
The supernatant was discarded, and the pellet was resuspended in 3 ml of TE (10 
mM Tris pH 8.0, 1 mM EDTA). This 3 ml was then applied to a second sucrose 
cushion and the centrifugation process repeated. The final pellet containing 
genomic DNA was resuspended in 2 ml of TE, and then the DNA was sheared into 
smaller fragments (500 bp-1 kb on average) by ChIP sonicator (Bioruptor, 
Diagenode) with 30sec on/off cycles for 10 min set according to the 
manufacturer’s instructions. 0.2 ml of 11 x NET buffer (1.65 M NaCl, 5.5 mM 
EDTA, 5.5% NP-40, 550 mM Tris pH 7.4) was added to 2 ml of sonicated material, 
then this was transferred to microfuge tubes for centrifugation at 13000g for 5 
min. The supernatants were then aliquoted evenly into microfuge tubes. Each 
aliquot was incubated in the presence of 5 μg (25 μl) of an appropriate antibody 
overnight at 4˚C on a rotating wheel. Antibodies used for ChIP analysis are listed 
in Table 4. As a negative control, one aliquot was incubated in the absence of 
antibody (beads only). Also, 10% of the aliquot volume was retained for use as an 
input control. 
The following day, 100 μl containing a 1:1 mix of appropriate protein-A-
Sepharose or protein-G-Sepharose beads (Sigma) and 1 x NET buffer were added 
for further 2 h incubation at 4°C, and then recovered on disposable Polyprep 
columns (Pierce). Columns were washed 4 times in 5 ml of RIPA buffer (50 mM Jana Vavrova, 2008    Chapter 2, 89 
Tris pH 8.0, 150 mM NaCl, 0.1% SDS, 0.5% deoxycholate, 1% NP-40), 4 times in 5 
ml of LiCl buffer (10 mM Tris pH 8.0, 250 mM LiCl, 0.5% NP-40, 0.5% 
deoxycholate, 1 mM EDTA pH 8.0) and 4 times in 5 ml of TE. Any unbound 
material was washed off. Columns were then closed with caps and beads were 
incubated in 200 μl of 1% SDS/TE for 10 min to detach immunoprecipitated 
material off the beads. This was then eluted to 1.5 ml microfuge tubes and 
incubation and eluting step repeated with another 200 μl of 1% SDS/TE. The 
pooled samples (and input DNA made up to a total volume of 400 μl with 1% 
SDS/TE) were incubated overnight at 42˚C with 0.125 mg/ml Proteinase K to 
degrade the antibodies and any other proteins present. Subsequently, genomic 
DNA was extracted using phenol/chloroform, as described above. Ethanol 
precipitation was performed overnight at -20˚C. The immunoprecipitated DNA 
was then resuspended in 40 μl TE. 2 μl of immunoprecipitated or input DNA was 
used per PCR reaction following the protocol outlined in PCR section. Primers 
and number of cycles of PCR are listed in Table 2.3 and they are indicated with 
letter C. 
2.16 Sequential ChIP analysis  
A31 and HeLa cells were grown on forty 10 cm tissue culture dishes until 
subconfluent and harvested as in section 2.15. Formaldehyde crosslinking, PBS 
washes and cell lysis were followed up to the sonication step, as described in the 
ChIP analysis protocol (section 2.15). 11 x NET buffer was added as before, 
samples spun briefly and the supernatants then aliquoted evenly into two 
microfuge tubes only. 5 μg (25 μl) of TFIIIC (Ab7) or RNA polymerase III (1900) 
antibodies and a negative control antibody were used and samples incubated 
overnight at 4˚C on a rotating wheel. 10% of the aliquot volume was retained for 
use as an input control.  The following day, appropriate beads were added. 
Incubation, transfer to the disposable Polyprep columns (Pierce) and the washes 
were performed as described above up to the elution step.  Columns were closed 
with caps and beads were incubated only once in 200 μl of 1% SDS/TE for 20 min. 
Samples were eluted to 1.5 ml microfuge tubes and diluted 1:10 in 1 x NET to 2 
ml final volume. TFIIIC (Ab7) or RNA polymerase III (1900) precipitated samples 
were then aliquoted evenly into fresh microfuge tubes and incubated in the 
presence of 5 μg (25 μl) of appropriate antibody overnight at 4˚C on a rotating 
wheel. 10% of the aliquot volume was retained for use as an input control. Next, Jana Vavrova, 2008    Chapter 2, 90 
appropriate beads were added and the rest of the protocol (columns, washes, 
elution and genomic DNA extraction) was performed as described for ChIP 
analysis above. The immunoprecipitated DNA was then resuspended in 40 μl TE. 
Inputs from the first chromatin immunoprecipitation step were diluted 1:10 (to 
match the dilution of the antibody-precipitated samples). 2 μl of 
immunoprecipitated or input DNA was used per PCR reaction following the 
protocol outlined in section 2.13. 
Antibody Protein  Source  Host  Type  Quantity μl  Beads 
Ab7  TFIIIC 220  In house   Rabbit  serum  25 a 
128  Brf1 (TFIIIB)  In house  Rabbit  serum  25 a 
330  Brf1 (TFIIIB)  In house  Rabbit  serum  25 a 
1900  RNA pol III 
(RPC 155) 
In house  Rabbit  serum  25 a 
06-866 Acetyl 
Histone H4 
Upstate   Rabbit  serum  5 a 
06-599 Acetyl 
Histone H3 




Upstate  Rabbit  serum  5 a 
FL 109  TFIIA Santa  Cruz  Rabbit  serum  25 a 
C-18 TFIIB  Santa  Cruz  Rabbit  serum  25 a 
M 9317  MeCP2*  Sigma  Rabbit   monocl  6 a 
 MBD2*  Stancheva  Rabbit  serum  25 a 
IMG-306A MBD1*  IMGENEX  Mouse  monocl  10 g 
Sc-28710 Brm*  Santa  Cruz  Rabbit   serum  25 a 
Sc-7899 HDAC2*  Santa  Cruz  Rabbit   serum  25 a 
Sc-7872 HDAC1  Santa  Cruz  Rabbit   serum  25 a 
Sc-11378 Mi2  Santa  Cruz  Rabbit   serum  25 a 
Sc-994 mSin3A Santa  Cruz  Rabbit   serum  25 a 
8WG16  RNA pol II  Covance  Mouse   monocl  3 g 
554293 p53  BD 
Pharmingen™ 
Mouse  monocl  Western blot  - 
Sc-1615  Actin (C-11)  Santa Cruz  Goat  serum  Western blot  - 
Table   2-4 List of antibodies  
* indicates antibodies also used for Western blot analysis 
 
2.17 Polyacrylamide sequencing gels electrophoresis 
Radiolabelled products of any analysis resulting in PCR, primer extension and in 
vitro transcription were diluted 1:1 with formamide loading buffer (98% 
formamide, 0.01% bromophenol blue, 0.01% xylene cyanol, 5 mM EDTA), and 
resolved on 7% polyacrylamide sequencing gels containing 7 M urea and 0.5 X 
TBE (45 mM Tris, 45 mM boric acid, 0.625 mM EDTA pH 8.0), 200 μl 20% APS and 
20 μl TEMED. Gels were pre-run at 40W for 30 min in 0.5 X TBE prior to loading 
samples (1.5 μl of each). Before loading, samples were heated at 95˚C for 2 min, Jana Vavrova, 2008    Chapter 2, 91 
and then quenched on ice. Electrophoresis was carried out for 1 h at 40W in 0.5 
x TBE, then gels were vacuum-dried for 1 h at 80˚C. Radiolabelled PCR products 
were visualised by autoradiography. 
2.18 Quantification and statistical analysis of data 
Data were quantified by densitometry using ImageJ software 
(http://rsb.info.nih.gov/ij/docs/menus/analyze.html#gels). ImageJ is a public 
domain Java image processing program. It quantifies gray values and the number 
of pixels found for each gray value for each band. It uses a simple graphical 
method that involves generating lane profile plots, drawing lines to enclose 
peaks of interest, and then measuring peak areas. Statistical analysis was 
performed using a Student’s t-Test (www.physics.csbsju.edu; unpaired, unequal 
variance) or a t- test (Microsoft Excel; two-tailed distribution, unequal 
variance). A probability (p) value of less than 0.01 or 0.05 was taken as a 
statistically significant difference between two groups. Box and whisker plots 
were used as a graphic representation. 
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3  Chapter 3 – Transcriptional activity of human 
Alu elements 
3.1 Introduction 
Despite the abundance of Alu sequences in RNA polymerase II-generated 
heterogeneous nuclear RNA (Jelinek et al., 1978), it was reported that Alu 
elements are not generally transcribed by RNA polymerase III and these 
transcripts are rare in vivo (Liu et al., 1994; Paulson and Schmid, 1986). Some of 
them got copied into heterochromatic regions and are probably silenced as a 
consequence. However Alus are interspersed throughout the whole genome 
(Schmid and Deininger, 1975) and the majority of them is concentrated in 
euchromatic gene-rich regions therefore their incidence in heterochromatin is 
unusual (Gilbert and Allan, 2001; Korenberg and Rykowski, 1988). Some 
proportion of Alus accumulated mutations in their RNA polymerase III promoter 
resulting in its inactivation. Such a promoter can no longer drive transcription. 
Those with preserved promoters are not usually transcribed by RNA polymerase 
III in vivo (Liu et al., 1994; Paulson and Schmid, 1986) despite of being 
transcribed in vitro (Duncan et al., 1979; Fuhrman et al., 1981). Alu elements 
are highly methylated (Schmid, 1991). There is growing evidence that 
methylation may be the main silencing mechanism, but it will be addressed in 
the next chapters.  
In this chapter, a member of the Alu family was selected that would have typical 
properties of the old Alu families. Members of the young families can still be 
transcriptionally active and therefore they are not the subject of this thesis 
(Batzer et al., 1996; Matera et al., 1990). All these aspects were considered 
when selecting the representative Alu. There are restrictions in this approach, as 
one selected Alu can be in its unique environment or have unique properties 
resulting in difficulties with transcriptional activity and therefore not be 
representative of the whole large family. Characterising one Alu element 
however allows one to examine specific aspects which can then be translated 
into understanding of other Alu elements. This approach was used in numerous 
studies before and helped elucidate properties of the Alu family. For example, 
studies of Alus in the α-globin locus led to the recognition that the family is RNA Jana Vavrova, 2008    Chapter 3, 93 
polymerase III-transcribed (Duncan et al., 1979; Duncan et al., 1981). Alus from 
the ε-globin locus and their in vitro transcription were also studied (Di Segni et 
al., 1981) and led to characterisation of the Alu tRNA-like bipartite promoter 
(Paolella et al., 1983). 
3.2 Results 
3.2.1 Characterisation of an individual Alu  and its activity in vitro 
An Alu Jo element was obtained cloned into pGEM®-5Zf(+) (Promega) vector 
(Hever, kind gift). It was one amongst many human genomic fragments that 
bound strongly to a methyl-binding domain (MBD) column, suggesting that its 
DNA is methylated, as it is recognised by the MBD domain of MeCP2 protein. It is 
a full length 300 bp Alu element, consisting of left and right monomers. It 
belongs to the oldest family of Alus, family J (Batzer et al., 1996; Jurka and 
Smith, 1988), a large family which appeared very early in the ancestral human 
lineage and any silencing mechanisms would be therefore well established here. 
Its sequence with diagnostic mutations (Shen et al., 1991) is depicted in Figure 
3.1a. It is located on human chromosome 19 in an intergenic location in a small 
cluster of other SINEs and LINEs (Figure 3.1b). 
The first necessity for Alu elements’ in vitro activity is a preserved RNA 
polymerase III promoter. One of the causes for low transcriptional activity of old 
Alus is that they often accumulated mutations in the promoter and the promoter 
is no longer active. The Alu promoter is a bipartite structure, as found in tRNA 
genes, with two highly conserved sequences, an A and B block, located 
approximately 60 nucleotides apart (Paolella et al., 1983). Previous in vitro 
transcription assays showed, that the fidelity of both A box sequence (Liu and 
Schmid, 1993) and B box sequence (Murphy and Baralle, 1983) of the RNA 
polymerase III promoter is a critical determinant of activity. Comparison of the 
Alu Jo’s promoters with the consensus A and B block sequences revealed that 
the A block of Alu Jo exactly matches the consensus sequence, while there is a 
purine to pyrimidine mutation in the fifth position of the B block (Figure 3.1c). 
This position has not been reported as critical for promoter activity (Murphy and 
Baralle, 1983), but there is a possibility that Alu Jo’s transcription might be 

















Figure   3-1 Details of Alu Jo used in this study 
(A) The Alu Jo’s sequence. Diagnostic mutations determining its origin are highlighted in 
bold. (B) Alu Jo’s location in the genome is shown using the UCSC Genome Browser 
(www.genome.ucsc.edu).(C) Alu Jo’s promoter sequence. A and B box consensus 
sequences are aligned with Alu Jo’s A and B box to determine mutations. Mutation in the B 
box is highlighted in red. Jana Vavrova, 2008    Chapter 3, 95 
To determine whether, despite the mutation, the promoter can drive 
transcription in vitro, an in vitro transcription assay (IVT) was performed using 
the Alu Jo cloned into pGEM®-5Zf(+). The 7SL pUC19 construct was used here as 
a positive control. Briefly, plasmid DNA was mixed in a low salt buffer with HeLa 
nuclear extract containing basic RNA polymerase III transcription machinery 
components. rATP, rCTP and rGTP were added to the reaction together with [α-
32P] UTP and transcription was allowed to proceed for 1 hour. Labelled 
transcript was then recovered and detected on a polyacrylamide sequencing gel.  
In vitro, Alu Jo was transcribed, although at a lower level than 7SL (Figure 3.2a). 
It gave a product significantly longer than expected (around 550 bp). Alu Jo, like 
other Alus, lacks a RNA polymerase III terminator sequence, poly(T) (Schmid and 
Maraia, 1992), present in other RNA polymerase III templates (Bogenhagen and 
Brown, 1981). After the transcription of Alu sequence, RNA polymerase 
continues into the adjacent 3’ sequence before it eventually dissociates 
(Fuhrman et al., 1981). This explains the length of the Alu Jo in vitro transcript. 
To confirm that it is indeed a transcript derived from the Alu Jo promoter, 
another in vitro transcription assay was performed without [α-32P]UTP. The 
unlabelled IVT product was then used as a template for a primer extension 
(Figure 3.2b). The primer extension method is used to determine the 5’ end of 
the transcript and it was performed here using the Alu JoINR primer. A product 
of the expected size of approximately 270 bp was detected, along with other 
prematurely terminated cDNA. Alu transcripts have complex secondary structure 
(Labuda and Striker, 1989) which can be an obstacle for the reverse 
transcriptase (Sambrook and Russell, 2001b). This may explain the multiple 






















































Figure   3-2 Alu Jo's promoter is active in vitro. 
(A) Radiolabelled IVT using the Alu Jo cloned into the pGEM vector shows a transcript of 
around 550 bp long. It is presumably derived from the Alu Jo promoter as there is no other 
RNA polymerase III promoter in the pGEM vector. 7SL cloned into pUC19 served as a 
control. Reaction showed in duplicate. Marker sizes are indicated. Autoradiograph. (B) 
Primer extension using unlabelled Alu Jo IVT product as a template confirmed that the 
transcript obtained in the IVT reaction is indeed driven from the Alu Jo promoter. Product of 
expected 270 bp was obtained when radiolabelled JoinR primer was used for the extension. 
Yeast RNA was used as a negative control. Half of the unlabelled Alu Jo IVT product was 
used in the second lane. Marker sizes are indicated. Autoradiograph. 
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3.2.2 Transcriptional activity of Alu Jo in vivo 
To test the activity of this promoter in vivo, Alu Jo was transiently transfected 
into CCL cells, a rodent line where there are no other similar sequences present. 
This tested whether it is capable of assembling the RNA polymerase III machinery 
on its promoter and being transcribed in a non-chromosomal context. Total RNA 
was extracted and assayed using the primer extension method (Figure 3.3a). Co-
transfected VAI was used as a positive control for transfection efficiency (VAI 
panel). Briefly, primers were labelled with [γ-32P]ATP and allowed to hybridise 
with target RNA sequence extracted from cells. Reverse transcription was then 
used to extend the primers. Labelled products were recovered and detected on 
a polyacrylamide sequencing gel. cDNA complementary to the RNA transcript 
would match in length the distance between the primer and the 5’ terminus of 
the RNA. Unlabelled RNA from in vitro transcribed Alu Jo was used as a positive 
control for the primer extension and RNA from CCL cells transfected with VAI 
only was used as a negative control.  No transcript was detected for Alu Jo using 
JoINR primer design to detect full length transcript (data not shown). PxuniqR 
primer was then used to look at the left monomer only transcript as many 
dimeric Alus are processed to the left monomer only (Maraia et al., 1993; Matera 
et al., 1990). However, still no transcript was detected. Primer extension may 
not be sensitive enough for rare transcripts, because it does not contain a signal 
amplification process. cDNA was therefore made and RT-PCR  performed (Figure 
3.3b). Sample where no reverse transcriptase (Superscript) was added during 
cDNA synthesis was used as a control for genomic contamination. cDNA made 
from CCL cells transfected with VAI only was used as a negative control. RT-PCR 
using JoINF /JoINR primers detected full length transcript, presumably driven 
from Alu Jo’s promoter because there is no RNA polymerase II promoter on the 
pGEM®-5Zf(+) plasmid. CCL cells are rodent Chinese hamster cells which do not 
have any human Alu sequences. They however have B1 sequences which are 
monomeric homologues of Alus. To make sure B1 sequences are not detected 
this primer pair is designed to detect dimeric Alu transcript. cDNA from CCL cells 
transfected with VAI template alone was used to check that, indeed, there was 
no endogenous transcript detected. RT-PCR also showed that the quantity of the 
Alu Jo transcript increased with the amount of available template. Alu Jo  Jana Vavrova, 2008    Chapter 3, 98 
 
transfected on its own (7 μg of DNA) gave stronger signal then when co-
transfected with VAI (3.5 μg each). Endogenous 7SL shows equal levels of cDNA.  
This is evidence that Alu Jo can be transcribed in vivo from its own promoter by 


















































































































Figure   3-3 Alu Jo's activity in CCL cells 
Alu Jo and VAI were transiently co-transfected into CCL cells and total RNA extracted from 
the cells was then analyzed for Alu Jo’s transcriptional activity. (A) The primer extension 
using radiolabelled PxuniqR primer detected no transcript. Unlabelled Alu Jo IVT product 
and co-transfected VAI primer extensions were used as controls. The blue bars indicate the 
position of primers. Marker sizes are indicated. Autoradiograph. (B) Alu Jo transcript was 
detected by RT-PCR using the JoinF and JoinR primers. Endogenous 7SL served as control 
for cDNA loading. NS= sample with no Superscript added during cDNA synthesis served as 
a negative control for DNA contamination. Marker sizes are indicated. Autoradiograph. Jana Vavrova, 2008    Chapter 3, 100 
 
To overcome the problem with secondary structure and to find out more about 
the rates of transcription, nuclear run-on analysis was employed to look at level 
of Alu Jo’s transcription. It was performed using HeLa nuclei which were snap-
frozen immediately after extraction. They were carefully defrosted and 
incubated in a reaction containing [α-
32P]UTP for 30 min (see Material and 
methods). Only the transcripts that were initiated before freezing proceed and 
these transcripts incorporate the [α-
32P]UTP and can therefore be detected. Any 
mature transcripts present in the nuclei would not be detected. This technique 
is therefore suitable to compare rates of transcription between two genes or a 
gene under different conditions (Sambrook and Russell, 2001b). 7SL and Alu Jo 
transcript levels were examined using either 7SL and Alu Jo gel-purified 
fragments (Figure 3.4a) or using linearised pYES2int plasmid containing 7SL or 
Alu Jo inserts (Figure 3.4b). Equal loading of the two probes on the membrane is 
shown on an agarose gel on the right hand side of the figure.  In the Figure 3.4b 
uncut pYES2int was also loaded on the agarose gel only as a control for the 
linearization. A clear transcript signal for 7SL is detected using both probes. 
However, for Alu Jo there is only trace signal detected in the nuclei when the 
fragment probe is used (Figure 3.4a) and no transcript detected when using the 
whole plasmid (Figure 3.4b). It is impossible to tell whether this weak signal is 
due to Alu Jo’s transcription initiated by RNA polymerase III or RNA polymerase 
II. It may also be a background hybridisation signal that is non-specific. Run-on 
analysis with added α-amanitin was tried and led to complete loss of the Alu Jo 
signal, but it also resulted in reduced signal for 7SL making it impossible to draw 
any conclusion about the nature of the transcript (data not shown). In any case, 










































































Figure   3-4 Nuclear run-on shows negligible levels of Alu Jo activity compared to 7SL in 
HeLa cells.  
HeLa nuclei were defrosted and incubated in a reaction containing [α-
32P]UTP for 30 mins. 
Only the transcripts initiated before freezing can proceed and incorporate the radioactive 
UTP. This technique is therefore suitable for comparison of rates of transcription. (A) Slot 
blot showing nuclear run-on where the Alu Jo and the 7SL fragment were used as probes. 
(B) Slot blots showing nuclear run-on where linearised pYES2int vector containing Alu Jo or 
7SL inserts were used as probes. Agarose gels on the right hand side show that equal 
amounts of probes were used. Marker sizes are indicated. 
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3.2.3 Despite the low transcript abundance, transcription 
machinery is present on Alus 
 
Following analysis of Alu Jo’s activity in transfected CCL cells, RT-PCR was 
performed to find whether there is indeed Alu Jo RNA present in HeLa cells. 
JoINF and PxuniqR primers were designed to ensure specific detection of the 
transcript. PxuniqR primer anneals to the tail of the left monomer of Alu Jo, 
which has a unique sequence. Two HeLa cDNAs were used and genomic DNA was 
used as a positive control for the PCR. Sample where no Superscript was added 
during cDNA synthesis was used as a control for genomic contamination. Figure 
3.5 shows that very low Alu Jo transcript level was detected. Levels of the 7SL 
cDNA were approximately 1400 times higher than that of Alu Jo. Differences in 
the product levels can be partially explained by the fact that 7SL primers detect 
all 4 active genes. Also, annealing efficiency of the primer pair to each 
transcript could be different. However, the product from the genomic DNA 
templates suggests that JoINF/ PxuniqR primers anneal well and that a real 


























Figure   3-5 RT-PCR shows low level of Alu Jo RNA in HeLa cells. 
JoinF and PxuniqR primers were used to detect Alu Jo transcript (lanes 1 and 2). Genomic 
DNA (gDNA) was used as a positive control. NS is a sample with no Superscript added 
uring cDNA synthesis, used as a negative control for DNA contamination. 7SL was used as 
ol gene. Marker sizes are indicated. Autoradiograph. 
 
d
a contrJana Vavrova, 2008    Chapter 3, 104 
 
JoINF/PxuniqR primers detected the left monomer of the transcript only, which 
could represent cytoplasmic processed Alu RNA - scAlu (Maraia et al., 1993; 
Matera et al., 1990). Further primer pairs were designed to detect the full 
length transcript and to determine whether the observed transcript is part of a 
longer transcript produced from a different promoter of another nearby Alu or a 
read-through transcript of RNA polymerase II (Figure 3.6). Localisation of each 
primer pair within or outside the Alu Jo sequence is shown on a diagram next to 
each PCR panel. HeLa cDNA and HeLa genomic DNA were used. Sample where no 
Superscript was added during cDNA synthesis was used as a control for genomic 
contamination. Top panel is RT-PCR using the JoINF/PxuniqR primers again as a 
control. The following panel shows the RT-PCR result using a forward primer 
designed for the adjacent 5’ flanking sequence (Alu Jo genomicF) and PxuniqR 
primer. Next panel below shows the RT-PCR result using both primers placed 
outside of Alu Jo in the adjacent flanking sequence (Alu Jo genomicF/R). Last 
panel shows GAPDH product as additional positive control. Figure 3.6 shows that 
indeed full length transcript was detected in HeLa cells. However, RT-PCR using 
AluJo genomicF/R primers detected transcript containing the 5’ and the 3’ 
adjacent sequence (21 bp of the 5’ end and 106 bp of the 3’ end). This raises the 
possibility that Alu Jo is not transcribed from its own promoter, but the Alu Jo 






















Figure   3-6 RT-PCR detects flanking sequence in the Alu Jo transcript. 
Different sets of primers were used for RT-PCR of HeLa cDNA. Samples with no Superscript 
added during cDNA synthesis were used as a negative control for DNA contamination (data 
not shown). HeLa gDNA was used as a positive control for the PCR reaction. The diagrams 
next to the PCR panels show the localization and product sizes of each primer pair 
designed to detect transcript containing Alu Jo and its flanking sequence. GAPDH was used 
as a positive control. Autoradiograph.Jana Vavrova, 2008    Chapter 3, 106 
 
It was further examined whether the observed Alu Jo transcript is RNA 
polymerase II- or RNA polymerase III-derived. HCT116 cells were subjected to 
ChIP analysis using antibodies against RNA polymerase III machinery components 
together with antibody for RNA polymerase II (Figure 3.7). Analysis included 
other Alus to check that the presence of RNA polymerase III machinery is not 
only a unique property of this Alu Jo. Primers were designed to look at individual 
Alus located on different human chromosomes (6, 10, 22). Alu19 is a primer set 
aimed at the middle part of a long stretch of tandem Alu repeats on another 
locus at chromosome 19. Input DNA was diluted to 10%, 2% and 0.4% to ensure 
quantitative PCR reactions. The U1 snRNA gene is a RNA polymerase II-
transcribed gene and its promoter region was used as a positive control for RNA 
polymerase II antibody and a negative control for RNA polymerase III antibody. 
The 7SL gene was the reverse control, positive for the RNA polymerase III 
antibody and negative for the RNA polymerase II antibody.  
RNA polymerase III machinery - transcription factor TFIIIB, transcription factor 
TFIIIC and RNA polymerase III - was detected at all studied Alus with very low 
levels at Alu19. On the other hand, RNA polymerase II and transcription factor 
TFIIB were only detected on the U1 snRNA gene promoter.  The selective 
absence of RNA polymerase II suggested that the Alu Jo was not associated with 
RNA polymerase II and therefore the transcript is derived from either its own 
promoter or it may also be driven from a nearby RNA polymerase III-transcribed 






















































Figure   3-7 ChIP analysis shows the presence of the RNA polymerase III machinery but not 
the RNA polymerase II machinery on Alu genes in HCT116 cells. 
ChIP analysis included Alu Jo together with Alus on other chromosomes and Alu19 (located 
in a cluster of SINEs on another location on chromosome 19). 7SL and U1 snRNA were used 
as reciprocal controls for RNA polymerase III and RNA polymerase II, respectively. Input 
DNA was diluted to 10%, 2% and 0.4% to ensure quantitative PCR reactions. Antibodies 
used in the ChIP analysis are listed at the top of the panel. Samples with beads-only were 
used as a general negative control for ChIP analysis. Primers used in each PCR reaction are 
listed in Table 2-3 and indicated with letter C (ChIP) in the second column and H (human) in 
the third column of the table. Alu Jo was amplified using AluJogenomicF/R primers. PCR 
reactions contained [α-
32P] dCTP. Autoradiograph. Marker sizes are indicated. Jana Vavrova, 2008    Chapter 3, 108 
 
It was surprising that all components of the RNA polymerase III transcription 
complex were found on Alu Jo given its low transcription rate. ChIP analysis was 
performed again using antibodies against TFIIIB, TFIIIC and RNA polymerase III, 
together with antibodies for acetylated histone H3 (directed against acetylated 
lysine 9 and 14) and H4 (directed against acetylated lysine 5, 8, 12, 16), both 
often associated with transcriptionally active genes (Kuo et al., 1996) (Figure 
3.8). TFIIA was used as a negative control antibody. 7SL and tRNA 
Sec were used 
as positive control genes. As 7SL primers used here detect all 4 active genes and 
three pseudogenes, tRNA 
Sec was used because it is a single copy gene and 
therefore signal could be compared with the signal on a single Alu Jo. RNA 
polymerase III transcriptional machinery and both acetylated H3 and H4 were 
detected on both active genes and on the Alu Jo. TFIIIB on tRNA 
Sec was not 
detected (background signal only). This is expected because the tRNA 
Sec gene 
actually binds Brf2 (TFIIB-related factor 2) rather than Brf1 (TFIIB-related factor 
1)  present on other type 2 promoters (Fairley, unpublished data); TFIIIB 
antibody used here is directed against Brf1, hence the lack of signal. It was also 
noticed, that in both ChIP experiments, the occupancy of RNA polymerase III on 
Alus seems to be lower than on the active genes (7SL and tRNA 
Sec) relative to 
TFIIIC.  
It has been shown so far that Alu Jo has a promoter that is active both in vitro 
and in vivo. Also, RNA polymerase III machinery was detected on the Alu Jo’s 
promoter by ChIP analysis. Despite that, nuclear run-on analysis and RT-PCR 
analysis suggested that the rate of transcription of Alu Jo is very low when 
compared to 7SL. If the occupancy of the RNA polymerase III is indeed lower, 
this could mean that despite TFIIIB and TFIIIC being present, there may be a 
difficulty in the last step of the transcription complex assembly, recruitment of  



























































Figure   3-8 RNA polymerase III machinery and acetylated histones are present on Alu Jo in 
HeLa cells. 
ChIP analysis of the RNA polymerase III machinery and acetylated H3 and acetylated H4 on 
Alu Jo. 7SL and tRNA
Sec genes were used as positive controls. Input DNA was diluted to 
10%, 2% and 0.4% to ensure quantitative PCR reactions. Antibodies used in the ChIP 
analysis are listed at the top of the panel. TFIIA antibody was used as a negative control 
antibody. Samples with beads-only were used as a general negative control for ChIP 
analysis. Primers used in each PCR reaction are listed in Table 2-3 and indicated with letter 
C in the second column of the table. Alu Jo was amplified using AluJogenomicF/R primers. 
PCR reactions contained [α-
32P] dCTP. Autoradiograph. Marker sizes are indicated. 
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HeLa and HCT116 cells were therefore subjected to more ChIP analyses and 
statistical analysis of the occupancy signals of the RNA polymerase III 
transcription complex (TFIIIC-TFIIIB- RNA polymerase III) was performed. The 
occupancy signals of TFIIIB, TFIIIC and RNA polymerase III at 7SL and different 
Alus (Alu Jo, Alu6, Alu22, Alu19) were quantified and the ratios of TFIIIB/TFIIIC, 
RNA polymerase III/TFIIIB and RNA polymerase III/TFIIIC were calculated. Images 
were quantified using ImageJ software according to ImageJ’s instructions 
(http://rsb.info.nih.gov/ij/docs/menus/analyze.html#gels). ImageJ is a public 
domain Java image processing program. It quantifies gray values and the number 
of pixels found for each gray value for each band. It uses a simple graphical 
method that involves generating lane profile plots, drawing lines to enclose 
peaks of interest, and then measuring peak areas. Nine different ChIP analyses 
were used and 9 7SL gene analyses and 12 Alus were included. Both two-tailed t-
test analysis and student t-test analysis were performed and showed that there 
is a significant (p<0.05) difference in the occupancy ratios between the two sets 
of samples (Table 3.1). 
 
 Mean  St  dev  T test P  Student t test P 
7SL IIIB/IIIC  0.6623  0.3309  0.013  0.020 
Alus IIIB/IIIC  1.1701  0.5245 
7SL RIII/IIIB  2.6134  1.7472  0.013  0.002 
Alus RIII/IIIB  0.7518  0.3025 
7SL RIII/IIIC  1.3843  0.4341  0.008  0.007 
Alus RIII/IIIC  0.8098  0.4364 
  
Table   3-1 Statistics of 7SL and Alu genes’ occupancy by RNA polymerase III (RIII), TFIIIB 
(IIIB) and TFIIIC (IIIC).  
 
 
Box and whisker plots show graphic representation of each sample sets’ 
descriptive statistical values (Figure 3.9). As observed, there is a significantly 
higher level of RNA polymerase III to TFIIIB and RNA polymerase III to TFIIIC 
cross-linked on the 7SL gene than on Alus, showing that indeed, there is lower 
amount of cross-linked RNA polymerase III on Alus. It may mean that there is a 
problem with RNA polymerase III recruitment or its access to the Alu promoter. 
Alternatively, RNA polymerase III epitopes may be masked by other molecules 
present only on Alus, possibly also impeding its proper function. There is  Jana Vavrova, 2008    Chapter 3, 111 
 
surprisingly a significantly higher level of TFIIIB to TFIIIC detected on Alus. 
Possible explanation for this could be an epitope masking on TFIIIB (Brf1) when 
RNA polymerase III is present. That would lead to decreased signal on the 7SL 


































Figure   3-9 Ratios of RNA polymerase III machinery components on 7SL and Alus. 
Box and whisker plots chart shows graphic representations of descriptive statistical values 
found for each sample set. 9 ChIP analyses were included and 9 7SL gene and 12 Alus were 
analyzed. Ratios of TFIIIB/TFIIIC, RNA polymerase III/TFIIIB and RNA polymerase III/TFIIIC 
occupancies were measured by ImageJ. 




The PS subfamily of Alus comprises four old families called the Alu J, Sx, Sq and 
Sp families (Batzer et al., 1996). It was active 65 to 40 million years ago and 
accounts for approximately 85%  of the total Alu elements in the human genome 
(Shen et al., 1991), but only 36% of the cDNAs representing full-length Alu 
transcripts belong to the PS subfamily (Shaikh et al., 1997).  
In this chapter, Alu Jo was selected as a representative of this old Alu family in 
order to learn more about its transcriptional activity. It was characterised and 
studied in vitro and in vivo. It was active in vitro, but it gave a product longer 
than expected. Alu Jo, like other Alu elements, does not have a RNA polymerase 
III terminator sequence and RNA polymerase III therefore continues until it 
reaches a poly(T) signal in the adjacent sequence (Schmid and Maraia, 1992). 
Primer extension detected a product of Alu Jo-driven transcription. It was, 
however, difficult to detect Alu Jo’s transcription in its genomic environment by 
primer extension. Its promoter is capable of driving transcription in vivo, as was 
shown by transient transfection, but even such activity needed to be amplified. 
These problems were encountered in similar studies before. Paulson and Schmid 
(1986) could only detect transcripts approximately corresponding to the 
expected Alu size at very high exposures. However, this band showed length 
heterogeneity, which was unexpected since Alus share a precise 5’ end. Using 
more oligos derived from the Alu sequence, they found other products where at 
least one of them resulted from a strong stop for reverse transcription due to 
RNA secondary structure. After using more stringent conditions, which 
eliminated background bands, they saw a barely detectable product of expected 
size. In this chapter, RT-PCR proved to be more suitable than primer extension 
to study endogenous Alu transcripts. It is probable that due to the complicated 
secondary structure of CG-rich Alus, reverse transcriptase may have difficulty in 
traversing the stable secondary structure such that only very few molecules of 
cDNA were produced (Sambrook and Russell, 2001a). One solution would be to 
carry out the first strand synthesis at higher temperature using heat-resistant 
reverse transcriptase. However, random hexanucleotide primers could not be Jana Vavrova, 2008    Chapter 3, 113 
used then, because some of the hybrids (RNA-DNA) will be unstable at 
temperatures at which the thermostable reverse transcriptase is active 
(Sambrook and Russell, 2001a). 
There was clearly a scAlu transcript detected by RT-PCR. The level of this 
transcript was very low when compared to the 7SL. Paulson and Schmid also 
estimated the relative abundance of the Alu RNA compared with the 7SL RNA, as 
detected by primer extension, with 7SL RNA being at least 500-fold more 
abundant (Paulson and Schmid, 1986). This is less than the estimate in this 
study. 7SL RNA detected here was around 1400-fold more abundant. If 4 active 
7SL genes (Ullu and Weiner, 1984) are detected by the primers and only one Alu 
Jo, each 7SL gene is expressed approximately 350-fold more than the Alu Jo. 
The ratio is not regarded as a precise number, but the inescapable conclusion is 
that there are very few copies of Alu Jo RNA in HeLa cells.  
RT-PCR also detected the presence of the 5’ upstream sequence in the Alu Jo’s 
transcript as well as the 3’ adjacent sequence. The 5’ upstream sequence may 
be due to activity of a promoter somewhere upstream such as that the Alu RNA 
is then part of this read-through transcript. Jelinek et al. also detected 5’ 
upstream sequences in Alu RNA (Jelinek et al., 1978). They reason that as there 
is Alu sequence present in hnRNA, Alu RNA may result from degradation products 
of hnRNA. Alu RNA forms duplex structures that are RNAse resistant. In this 
event, hnRNA degradation could result in Alu RNAs which are cleaved at sites 
near their duplex ends. Alu Jo could be transcribed as a part of the large NR1H2 
RNA putatively derived from this genomic region (Figure 3.1). NR1H2 is a 
ubiquitously expressed nuclear receptor subfamily 1 group H member 2 
(RefSeq NM_007121) encoding liver X receptor beta (LXR-β) transcription factor 
(Song et al., 1995). However, three other predictions for the NR1H2 start are 
almost 1.5 kb in the 3’ end of Alu Jo and in general, NR1H2 is described in
UCSC browser to have genomic position 
 the 
gain  chr19:55571497-55578079, a
corresponding to the other three sequences. The putative NR1H2 sequence 
would need to be 50 kb compared to 7 kb of the other three NR1H2 sequences. It 
is therefore more likely to be a sequencing artefact. Due to the presence of RNA 
polymerase III on the Alu Jo promoter and little or no RNA polymerase II it is 
suggested here that the Alu Jo transcript may also be RNA polymerase III-
derived. It can be derived from Alu Jo or from other nearby SINE. Alu Jo is Jana Vavrova, 2008    Chapter 3, 114 
flanked in 5’ sequence with AluSx, which would be transcribed in the Alu Jo 
direction. As it does not contain any T-run, RNA polymerase III could continue 
through to the adjacent sequence into Alu Jo. In the 3’ end, however, Alu Jo is 
flanked by 3’ end of LINE L1, which is RNA polymerase II-transcribed. The 
explanation for the presence of the 3’ end sequence would be that Alu Jo, like 
other Alu elements, does not have a RNA polymerase III terminator sequence and 
RNA polymerase III therefore continues until it reaches a poly(T) signal in the 
adjacent sequence (Schmid and Maraia, 1992).  
Several possible explanations for the low transcripts detected are discussed 
below. The presence of the 3’ end in the Alu Jo’s transcript could be a problem 
for the facilitated recycling pathway used for RNA polymerase III transcription 
(Dieci and Sentenac, 1996). It was shown that runoff transcription (without RNA 
polymerase III terminator) does not allow efficient recycling typical for active 
RNA polymerase III genes. Lack of this mechanism resulted in a much lower 
transcriptional rate. Future experiment would test this hypothesis by addition of 
a T-run into the Alu Jo’s A-rich tail. In vitro transcription assay would compare 
levels of transcripts obtained using Alu Jo and Alu Jo/polyT in pGEM vector as 
templates.  
Long tails of Alus also contribute to their instability (Li and Schmid, 2004) and 
this could be the case of Alu Jo too. The transcripts which are produced are 
unstable and quickly degraded and this could be the reason why only scAlu can 
be detected, as the left monomer is more stable (Li and Schmid, 2004). 
However, the nuclear run-on method is designed to detect newly initiated 
transcripts avoiding issues with RNA stability in vivo. Since transcripts are 
generated in vitro from RNA polymerase molecules that had initiated 
transcription when the nuclei were harvested, issues of transcript stability 
should be circumvented. 
5’ flanking sequence matching the first 37 nucleotides of the 7SL upstream 
sequence has been implicated as highly enhancing for in vitro transcription (Ullu 
and Weiner, 1985), but is not completely necessary (Dewannieux et al., 2003). It 
was not necessary in our hands, as Alu Jo inserted into the pGEM®-5Zf(+) 
plasmid does not contain flanking sequence and was still transcribed in vivo from 
this plasmid. Jana Vavrova, 2008    Chapter 3, 115 
The presence of RNA polymerase III on Alu Jo and other studied Alus was 
surprising given the low level of its transcript. It was suggested previously that 
because Alus lack the appropriate upstream flanking sequences they cannot 
compete for RNA polymerase III transcription factors (Ullu and Weiner, 1985). 
However, this study showed that it is not the case for TFIIIB and TFIIIC. It is 
possible that having lower affinity for RNA polymerase III, Alus are out-competed 
by active RNA polymerase III transcribed genes. It was shown previously that 
transcription of a RNA polymerase III template can be lower if two templates 
were used in an in vitro assay and one of the two templates was added after the 
other (Bogenhagen et al., 1982). Detecting RNA polymerase on a promoter of a 
gene is regarded as a sign of transcriptional activity by some researchers 
(Alexiadis et al., 2007); however, given the low levels of transcripts detected 
normally in somatic cells, it suggests that the RNA polymerase III complex 
detected on Alus is very inefficient or poised. The conclusion from this work is 
that the problem may be in low occupancy of RNA polymerase III on Alu 
promoters. Lower amounts of cross-linked RNA polymerase III were detected on 
Alus by ChIP analysis, which could mean that RNA polymerase III has limited 
access to the promoter. It may also be that its epitopes are masked by some 
other proteins only present on Alus. In any case, RNA polymerase III is important 
for Alu’s transcription. If RNA polymerase III is present in equal amount as on the 
7SL genes, but its epitopes are masked, then its activity seems to be impaired 
compared to its activity on 7SL. What can be masking its epitopes or what can 
be impeding its proper access to the promoter or its function is unclear. 
However, DNA methylation could be the main candidate. It has been implicated 
in Alus’ transcriptional repression before (Schmid, 1991). It is known in other 
genes to prevent access of the transcription machinery to the promoter. It also 
acts through transcriptional repression domains of the methyl-DNA-binding 
proteins or through the recruitment of repressor complexes. It will now be 




4  Chapter 4 – DNA methylation and Alu elements 
4.1 Introduction 
DNA methylation-mediated silencing and chromatin-derived silencing have long 
been investigated as possible causes of SINE’s transcriptional repression. Alu 
sequences are CpG-rich and highly methylated (Schmid, 1991). In fact, more 
than 90% of methylated CpG dinucleotides in the human genome occur in 
retrotransposons (Bird, 2002). Association of H3K9 methylation, which is a 
marker of heterochromatin and is specifically associated with inactivation of 
gene expression (Lachner and Jenuwein, 2002), was demonstrated with Alu 
elements (Kondo and Issa, 2003), suggesting that H3K9 methylation may be 
related to suppression of Alu transciption through DNA methylation. There is 
evidence that methylation is connected with Alu transcriptional silencing both in 
vitro and in vivo (Li et al., 2000; Liu et al., 1994; Liu and Schmid, 1993).  
DNA methylation was shown to inhibit Alu transcription in vitro, but only at low 
template concentrations (Liu and Schmid, 1993). At low template concentrations 
(10 to 50 ng template DNA used for the in vitro transcription assay), there was a 
2.7- fold inhibition of APO Alu transcript expression due to methylation, but at 
high concentrations, inhibition was undetectable. This is probably because the 
methyl-DNA binding proteins are present in limiting concentration in the nuclear 
extracts. Flanking sequences did not alter the effect of methylation. The same 
research group then studied the effect of methylation on Alu transcription in 
vivo (Liu et al., 1994). HeLa cells were treated with 5-azacytidine to 
demethylate DNA and the DNA demethylation verified using enzymatic methyl-
sensitive restriction digests. Alu transcripts were then detected using primer 
extension and northern blot. Treatment with 5-azacytidine resulted in a 5- to 8- 
fold increase in full length Alu transcript expression, although the effect on 
scAlu (left monomer only Alu) was much less pronounced.  
Hela cells, 293 cells (human embryonic kidney cells) and K562 cells (an 
erythroleukemic line) were used for other in vivo studies of methylation-
repressed transcription (Li et al., 2000). It was shown that naturally 
hypomethylated K562 cells have an unusually low level of Alu methylation 
compared to other somatic cells. Expression of Alu elements in all three cell Jana Vavrova, 2008    Chapter 4, 117 
lines was investigated and it was found that K562 has extremely high levels of 
Alu RNAs compared to the other two. They contain Alu transcripts from different 
loci, indicating that many Alu loci were transcribed. Using actinomycin to block 
transcription, it was shown that these high levels are indeed due to transcription 
and not due to unusually stable transcripts. The three cell lines were further 
transfected with methylated and unmethylated Alu constructs. It turned out that 
in all the three cell lines, methylation inhibited expression of templates; in K562 
cells, expression from unmethylated templates was 9- to 20-fold greater than 
from methylated templates.  
The mechanism of methylation-induced repression could be either through direct 
repression of transcription due to exclusion of transcription factors which can 
not recognise a methylated version of their cognate DNA binding sites. Or 
transcription may be inhibited by the presence of the methyl-CpG binding 
domain proteins (MBD proteins), either directly, or through recruitment of 
transcription repressor complexes (see later). Alu elements were shown to bind 
to MBD columns when human genomic DNA fragments were examined (Brock et 
al., 1999; Shiraishi et al., 1999). Specifically, Alus were shown to be the main 
target sequences for MeCP2 binding in vivo (Koch and Stratling, 2004). However, 
MeCP2-mediated repression of Alu elements has not so far been demonstrated 
(Yu et al., 2001).  
The role and the mechanism of DNA methylation in Alu silencing still needs to be 
clarified. Although DNA methylation is well documented to be connected with 
transcriptionally silenced genes and it was shown to be connected with Alu 
sequences and their repression, it is still not clear whether it is the primary 
silencing event or whether methylation occurs as a default mechanism, whereby 
a drop in the transcriptional potential of a gene leads to the spreading of DNA 
methylation to the promoter region to lock down gene transcription. For 
example, a stably transfected PV Alu repeat was transcriptionally silent in mouse 
cells, although unmethylated (Leeflang et al., 1992; Liu and Schmid, 1993). Alus 
demethylated by 5-azacytidine and transiently transfected into HeLa cells were 
inactive, whereas the identical templates were abundantly expressed in 293 
cells (Liu et al., 1995). These studies show, that methylation is not necessary for 
repressing Alu transcription. In this chapter, the presence of methyl-DNA binding 
proteins on Alus was further investigated and DNA methylation-free systems Jana Vavrova, 2008    Chapter 4, 118 




4.2.1 Analysis of the Alu methylation status 
As mentioned in the introduction Alu sequences are CpG-rich and have been 
repeatedly found to be highly methylated (Schmid, 1991). Moreover, majority of 
methylated CpG dinucleotides in the human genome occur in retrotransposons 
(Bird, 2002). To determine whether Alus used in this study are methylated, 
methylation sensitive restriction digest was performed with HeLa gDNA (Figure 
4.1). HeLa cells were also treated with 8 μM 5-azacytidine (Sigma) for 8 days in 
an attempt to demethylate their DNA (Liu 1994). Three enzymes cut in Alu 
sequence, including the BstUI (only cuts when sequence is unmethylated), 
Tth111I and TaqI (Liu, 1994). Double digest with BstUI and Tth111I would give 
251 bp product if BstUI site was unmethylated and no product if the site was 
methylated.  TaqI is not methylation sensitive and double digest using TaqI and 
Tth111I releases 189 bp fragment that serves as a positive control. [α-
32P] dCTP-
labelled Alu Jo or [γ-
32P]ATP end-labelled PV51 primer (data not shown) were 
used as probes for Southern blot. Alu Jo in pYES vector and Alu Jo fragment were 
loaded on the gel as controls for hybridization. Undigested HeLa gDNA served as 
additional control for the restriction digest. 
Unfortunately, problems were encountered during the experiment, most likely in 
the restriction digest step (Figure 4.1). No product was detected in 
BstUI/Tth111I double digest in untreated HeLa. It could suggest that all Alus are 
methylated in HeLa cells. However, 5-azacytidine treatments did not result in 
any increase in the susceptibility of the Alu BstUI site to cleavage (lanes 4 and 
6). Moreover, control TaqI/Tth111I double digest also did not result in any 
product (lanes 5 and 7). The difficulty was not likely to be at the hybridization 
step as the [α-
32P] dCTP-labelled Alu Jo probe hybridized to the control DNA 
samples (lanes 1, 2, and 3). The restriction digest was also repeated with MspI 
and HpaII (only cuts when sequence is unmethylated), but no products were 
obtained (data not shown). Bisulphite modification and methylation sensitive Jana Vavrova, 2008    Chapter 4, 119 
PCR method using the CpGenome
TM DNA Modification Kit (Chemicon
® 
International) was tried next. HeLa gDNA was used first for the bisulphite 
reaction, where all unmethylated cytosines are deaminated and converted to 
uracils, while methylated cytosines remain unaltered. Primers were then 
designed using CpGWare
TM Primer design Software (Millipore) to detect altered 
and unaltered Alu DNA. However, no products were detected in the PCR reaction 
(data not shown).  
As difficulties were encountered it was not possible to establish experimentally 
whether studied Alus are methylated or not.  Alu Jo was however one of human 
genomic fragments that bound strongly to a MBD column containing the MBD 
domain of MeCP2 (section 3.2.1), suggesting that it is methylated. For the other 
Alus it was necessary to rely on the evidence obtained from the literature and 
move on to establish whether Alus are bound by MBD proteins, which would also 




















































































































Figure   4-1 Southern blot analysis of Alu methylation. 
Southern blot hybridization of genomic DNA extracted from 5-azacytidine treated and 
untreated HeLa cells was performed on DNAs digested with BstUI/Tth111I (lanes 4 and 6) 
and Taq1/Tth111I (lanes 5 and 7). Alu Jo in pYES vector, Alu Jo fragment and undigested 
HeLa gDNA were used as positive controls. [α-
32P] dCTP-labelled Alu Jo was used as a 
probe. Marker sizes are indicated. 
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4.2.2 Presence of MBD proteins on Alus 
Methyl-CpG-binding domain proteins (MBD proteins) are the principle mediators 
of the repressive effect of DNA methylation (see Introduction). However, so far 
only MeCP2 has been shown to bind Alus and no repressive effect has been 
detected (Yu et al., 2001). The binding of MBD proteins was studied here using 
the chromatin immunoprecipitation assay, ChIP (Figure 4.2, 4.3). RNA 
polymerase III was used as a positive control. The previously described Alu Jo 
(see Chapter 3) and Alus on other chromosomes were examined. The 7SL gene 
was included as a negative control gene for MBD proteins and the Apolipoprotein 
E precursor (ApoE) gene, which is known to be bound by MBD1, MBD2 and MeCP2 
and silenced by DNA methylation, was included as a positive control (Ballestar et 
al., 2003).  ChIP analysis showed that MBD1 and MeCP2 (Figure 4.2) and MBD2 
(Figure 4.3) were detected on Alus.  MBD3 and Kaiso, other known contributors 
to DNA methylation-mediated silencing, were not tested here for lack of suitable 
antibodies. MeCP2 has been observed on Alus before and it indeed seemed to be 
giving the strongest signal on all the tested Alus. This is not due to a higher 
unspecific signal from the MeCP2 antibody, because it is not the strongest signal 
on the ApoE gene; ApoE seemed to be bound mainly by MBD1. MBD1 was also 










































Figure   4-2 ChIP analysis shows the presence of MBD1 and MeCP2 on Alus in HeLa cells. 
ApoE gene was used as a positive control gene for MBD proteins. 7SL was used as a 
positive control for RNA polymerase III antibody. Input DNA was diluted to 10%, 2% and 
0.4% to ensure quantitative PCR reactions. TFIIA antibody was used as a negative control 
antibody. Samples with beads only were used as a general negative control for ChIP 
analysis. Primers used in each PCR reaction are listed in Table 2-3 and indicated with letter 
C (ChIP) in the second column and H (human) in the third column of the table. Alu Jo was 
amplified using AluJogenomicF/R primers. PCR reactions contained [α-
32P] dCTP. 





































Figure   4-3 ChIP analysis shows the presence of MBD2 on Alus in HeLa cells. 
ApoE gene was used as a positive control gene for MBD2 antibody. 7SL was used as a 
positive control for RNA polymerase III antibody. Input DNA was diluted to 10%, 2% and 
0.4% to ensure quantitative PCR reactions. TFIIA antibody was used as a negative control 
antibody. Samples with beads-only were used as a general negative control for ChIP 
analysis. Primers used in each PCR reaction are listed in Table 2-3 and indicated with letter 
C (ChIP) in the second column and H (human) in the third column of the table. Alu Jo was 
amplified using AluJogenomicF/R primers. PCR reactions contained [α-
32P] dCTP. 
Autoradiograph. Marker sizes are indicated. 
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Two possible ways by which MBD proteins may repress transcription have been 
proposed. As they bind to methylated DNA they can directly prevent 
transcription factors from binding. In addition, they interact with repressor 
complexes which they recruit to the methylated DNA and establish 
transcriptional repression. 
In chapter 3, it was discovered that Alus are bound by RNA polymerase III, TFIIIB 
and TFIIIC, but RNA polymerase III cross-linked significantly less to Alus than to 
the active genes, suggesting that something may be obstructing better binding. 
In the above experiment, MBD1, MBD2 and MeCP2 and RNA polymerase III seem 
to be present together on the Alus and their presence could explain the lower 
cross-linking of RNA polymerase III to the DNA. However, due to the nature of 
ChIP analysis it is necessary to rule out that RNA polymerase III and MBD proteins 
are in fact present on different copies of the same Alus. ChIP analysis uses 
populations of cells; it is therefore possible that although both RNA polymerase 
III and MBD proteins are present on a gene within the population, RNA 
polymerase III may be present on Alus in some cells and MBD proteins may be 
present on Alus in other cells, and not together. Such a situation would appear 
as co-occupancy in a single ChIP analysis. A modified ChIP assay, called the 
sequential ChIP, was used to determine whether RNA polymerase III and MBD 
proteins could be present at the same time on the same gene. Briefly, a ChIP 
assay was performed using 10 plates of cells per antibody (10 x more than in a 
normal ChIP assay) and the obtained supernatant was immmunoprecipitated with 
TFIIIC antibody (Ab7). TFIIIC-immunoprecipitated material was then diluted 1:10 
and immunoprecipitated further with antibodies of interest. RNA polymerase III 
with TFIIIB were used here as positive controls as they co-occupy promoters 
together with TFIIIC. Signal from MBD proteins in the TFIIIC-immunoprecipitated 
material would mean that Alus are bound simultaneously by TFIIIC and MBD 












































Figure   4-4 MBD proteins co-occupy Alu genes with transcription factor TFIIIC in HeLa cells. 
Sequential ChIP analysis. TFIIIC Ab (Ab7) was used in the first step (ChIP analysis). 
Precipitated material was diluted 1:10 in 1xNET buffer and further precipitated with the 
antibodies listed at the top of the panel (sequential ChIP). TFIIA was a negative control 
antibody. Input DNA was diluted to 10%, and precipitated. Sequential input was then again 
diluted to 20%, 10% and 5% to ensure quantitative PCR reactions. Primers used in each PCR 
reaction are listed in Table 2-3 and indicated with letter C (ChIP) in the second column and H 
(human) in the third column of the table. Alu Jo was amplified using AluJogenomicF/R 
primers. PCR reactions contained [α-
32P] dCTP. Autoradiograph. Marker sizes are indicated. 
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Figure 4.4 shows sequential ChIP performed in HeLa cells. Three distinct Alus, 
Alu Jo, Alu19 and Alu 6 were tested. tRNA 
Tyr is shown as a RNA polymerase III-
transcribed active gene. Higher exposure was needed to detect its signal from 
sequential ChIP inputs, but it resulted in a background signal from MBD proteins 
showing at this exposure. It is considered a background signal as TFIIA (negative 
control antibody) is also showing at this exposure. Shorter exposure did not 
detect this signal (data not shown). As expected, TFIIIB and RNA polymerase III 
co-precipitated with TFIIIC on all tested genes, although the levels of TFIIIB and 
RNA polymerase III on Alus are lower than that on tRNA 
Tyr. As discussed in 
Chapter 3, there is significantly lower occupancy of RNA polymerase III on Alus 
then on actively transcribed genes (Figure 3.7 and 3.8). On contrary, higher 
occupancy of TFIIIB were observed on Alus than on actively transcribed genes. 
This was thought to be due to an epitope masking on TFIIIB when RNA 
polymerase III is present. This may not be the same if TFIIIB is co-precipitated by 
TFIIIC. 
All tested MBD proteins also precipitated from the TFIIIC-bound material. 
Interestingly, some differences from standard ChIP analysis were detected in 
MBD proteins’ occupancy. MBD1 rather than MeCP2 gave the strongest signal on 
Alu Jo and no MBD2 was detected. On Alu 6, MBD2 gave the strongest signal 
rather than MeCP2 (Figure 4.2, 4.3). This suggests selective occupancy of MBD 
proteins on Alus which are co-bound by TFIIIC. 
In conclusion, MBD proteins were detected at the same Alus as transcription 
factor TFIIIC; therefore, its recognition of Alu promoters and binding is not 
obstructed by the presence of MBD proteins. This is in agreement with the 
previous statistical analysis of TFIIIC occupancy (Chapter 3), where the TFIIIC 
was comparable at Alus and at active genes. Binding of TFIIIC is the first step in 
RNA polymerase III transcription complex assembly. Further sequential ChIP 
using TFIIIB and RNA polymerase III in the first ChIP step will be needed to assess 
the co-occupancy of these proteins with MBD proteins and to assess whether MBD 
proteins may prevent TFIIIB and RNA polymerase III from proper binding.  
Apart from direct inhibition, another major mechanism of repression by MBD 
proteins is through their cooperation with various repressor complexes. MBD Jana Vavrova, 2008    Chapter 4, 127 
proteins were shown to be part of different chromatin remodelling and 
corepressor complexes. MeCP2 was shown to be associated with mSin3a and 
HDACs (Jones et al., 1998; Nan et al., 1998), but also with normally a 
transcriptional activator complex SWI/SNF via Brahma (Harikrishnan et al., 
2005), although that was challenged by another study (Hu et al., 2006). MBD2 
was shown to be associated with mSin3a and HDACs alone or as part of the 
MeCP1 complex (Boeke et al., 2000; Ng et al., 1999) and to interact with the 
HDAC1/2-containing NuRD complex (Zhang et al., 1999). MBD1 was shown to 
interact with the histone H3K9 methylase SETDB1 (Hu et al., 2006), but 
recruitment of SETDB1 was not tested here. In figure 4.5, the possibility that 
MBD proteins also bring these complexes to Alus was investigated using ChIP 
analysis. Three distinct Alus were studied and additional genes were used as 
controls. Apolipoprotein E precursor (ApoE) is a methylated gene and although it 
is not known whether it is silenced by any of these protein complexes or whether 
they are present, it was used here for a comparison of different occupancies of 
the complexes between an inactive gene known to be bound by MBD1, MBD2 and 
MeCP2 and the active genes 7SL and tRNA 
Sec. tRNA 
Sec is a single copy gene and 
therefore it also ensures looking at occupancies at a single gene, comparable for 
each Alu, where primers used for the PCR analysis were designed to look at a 
single sequence. 7SL is also an active gene, but there are inactive 7SL 
pseudogenes also detected with the primers used. MeCP2 antibody was used as a 
positive control. Beads and TFIIA are negative control antibodies. Brm, Brahma, 
represents a component of a SWI/SNF2 complex (Wang et al., 1996), Mi2 is a 
component of the NuRD complex (Zhang et al., 1998) and mSin3a is a component 
of the SIN3A/HDAC complex (Zhang et al., 1997). HDAC2 is a component of both 
NuRD and SIN3A complexes.  
Figure 4.5 shows that of the proteins studied, Brm seems to be the protein only 
enriched on the genes associated with MBD proteins. It was not associated with 
the active genes. None of the other studied proteins – mi2, mSin3a and HDACs- 
were specifically associated with MBD proteins-bound genes. Mi-2 seems to be 
mainly enriched on the 7SL and Alu 6, with traces on all other studied genes. 
mSin3A was again mainly enriched on 7SL, with some signal detected on the Alu 
Jo, Alu 6 and ApoE. Although the occupancies of the proteins appear very low, it 
is important to regard them as present as they are all above the levels of 
negative control antibodies (TFIIA and beads). HDAC2 (and HDAC1, data not Jana Vavrova, 2008    Chapter 4, 128 
shown) were present on all tested genes, repressed or active. Given the 
acetylated levels of histones H3 and H4 on RNA polymerase III-transcribed genes 
and Alu Jo (Figure 3.8), presence of HDACs is surprising. The role of HDACs at 
acetylated RNA polymerase III-transcribed genes and Alus remains unknown. In 
general, HDACs are usually associated with corepressor complexes and proteins 
(reviewed in (Knoepfler and Eisenman, 1999; Ng and Bird, 2000), but new 
evidence suggests that they may also act as activators of transcription (Nusinzon 
and Horvath, 2005; Sakamoto et al., 2004; Zupkovitz et al., 2006). The 
mechanisms of such transcriptional activation of HDACs are also not known. 
The mSin3a and mi2 proteins were detected on the 7SL. However, they may be 
in fact associated with the 7SL pseudogenes, as they were not particularly 
enriched on the tRNA 
















































Figure   4-5 The occupancy of SWI/SNF2 and NuRD repressor complexes on Alus in HeLa 
cells. 
ChIP analysis shows that Brm is the only protein that is specifically enriched on the genes 
associated with MBD proteins. Other tested proteins do not show specific occupancy on 
Alus.  All antibodies used for the ChIP analysis are listed on the top of the first panel. 
Brm=Brahma, mi-2=helicase/ATP-ase, NuRD complex. Input DNA was diluted to 10%, 2% 
and 0.4% to ensure quantitative PCR reactions. TFIIA antibody was used as a negative 
control antibody. Samples with beads-only were used as a general negative control for ChIP 
analysis. Primers used in each PCR reaction are listed in Table 2-3 and indicated with letter 
C (ChIP) in the second column and H (human) in the third column of the table. Alu Jo was 
amplified using AluJogenomicF/R primers. PCR reactions contained [α-
32P] dCTP. 
Autoradiograph. Marker sizes are indicated. 
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In conclusion, Brahma (Brm) seems to be specifically associated with methylated 
genes. It is plausible that it is recruited via MeCP2, because Brahma has been 
shown to associate with MeCP2 before (Harikrishnan et al., 2005). It is a 
component of SWI/SNF2 chromatin remodelling complexes, which have been 
regarded for a long time as activators. New evidence shows that they can also be 
recruited as a part of repressive mechanisms to some genes (Watanabe et al., 
2006). Other complexes may contribute to the repression of methylated Alus, 
whether recruited via MeCP2 (SIN3A and HDACs) or MBD2 (NuRD and HDACs), or 
independently as in the case of RNA polymerase III-transcribed genes 7SL (SIN3A 
and NuRD) and tRNA 
Sec (HDACs). So, methylated Alus may be regulated via MBD 
proteins, which potentially directly inhibit access or assembly of RNA polymerase 
III and TFIIIB (after TFIIIC binding), or may inhibit via their association with 
corepressors, where a Brahma-containing SWI/SNF complex may be specific to 
MBD proteins-directed Alu repression. 
 
4.2.3 Alu activity in Saccharomyces cerevisiae 
 
Another approach for analysing the effect of methylation on Alu silencing is to 
remove or inhibit methylation and study Alu activity in a methylation-free 
environment. Previous studies used 5-azacytidine to reduce DNA methylation 
(Liu et al., 1994) or K562 cells with naturally hypomethylated DNA (Li et al., 
2000). 5-azacytidine treatment of HeLa cells was also tried here in order to 
demethylate DNA, but complete demethylation was never successfully achieved 
(tested with enzymatic methyl-sensitive restriction digests, data not shown). As 
no methylation-free human or mammalian cells were available at the time, an 
alternative in vivo system was searched for. It was known that yeasts as well as 
other fungi do not have endogenous DNA methylation (Antequera et al., 1984). 
Because yeasts have been routinely used as model systems to study gene 
transcription and its regulation, integrating Alu Jo into the yeast genome and 
studying its transcription in the yeast genomic environment was considered. This 
would bring a novel in vivo system for studying Alu element biology and it could 
be potentially very interesting for the following reasons. Not only do both S. 
cerevisiae and Schizosaccharomyces pombe have no detectable DNA methylation Jana Vavrova, 2008    Chapter 4, 131 
(Antequera et al., 1984; Hendrich and Tweedie, 2003), but S. cerevisiae also has 
no histone tail methylation connected with chromatin-mediated silencing (Sims 
et al., 2003). Also, the genome of S. cerevisiae is well characterised (Goffeau et 
al., 1996). Yeasts have no endogenous Alu elements. There are 5 retroelements 
in S. cerevisiae, Ty1-Ty5, but these are transcribed by RNA polymerase II (Bolton 
and Boeke, 2003). The yeast 7SL gene shows just 12% homology with human 7SL 
and this fact, together with no polymerase II-derived Alu RNAs normally present 
in the mammalian cells, avoids common cross hybridisation of probes with 7SL 
and RNA polymerase II-derived Alu transcripts. Also the RNA polymerase III 
transcriptome has been well studied (Roberts et al., 2003). It makes yeasts an 
interesting model system for studying Alu elements in a methylation-free 
system.   
The budding yeast S. cerevisiae strain used in this study was the GGBY 62 strain, 
his4-912Δ lys2-128Δ ura3-52 (collection of Dr McInerny). Cells were grown on a 
complete media with depleted uracil (Formedium LTD, England). Alu Jo was 
integrated using pYES2int vector (Invitrogen) which has the 2μORI fragment 
removed. GGBY 62 cells were transformed using the lithium acetate method, as 
described in Materials and Methods. Inserting the vector into the ura3 locus in 
budding yeast was facilitated by digestion with StuI, which linearised the vector 
within the ura3 gene. Homologous recombination between the URA3 gene in the 
pYES2int vector and mutated ura3 (ura3-52) on chromosome V replaced the 
deficient copy of this gene and enabled cells to grow on media with depleted 
uracil. This recombination process also integrated the Alu Jo element into the 
S. cerevisiae genome. It was further verified by PCR analysis using JoINF/JoINR 
primers designed to detect full-length Alu Jo (figure 4.6a). Untransformed GGBY 
cells (wt) and GGBY cells transformed with pYES2int only (empty pYES) were 
used as negative controls. Purified Alu Jo in pYES2int was used as a positive 
control for the PCR. Three different cell clones were obtained, Jo11, Jo13 and 
Jo15. Jo13 cells did not grow very well on media with depleted uracil and 
although some Alu Jo was detected by PCR, it is possible that it was an 




























































































Figure   4-6 Alu Jo integrated into the S. cerevisiae genome is active. 
(A) Agarose gel showing stable integration of Alu Jo into three S.cerevisiae lines. PCR used 
gDNA of each transformed cell line. gDNA of GGBY 62 wt and cells transformed with empty 
pYES were used as negative controls. Purified Alu Jo in pYES was used as a positive 
control. (B) Agarose gel shows equal loading of RNA used for Northern blot. Total RNA was 
extracted from each transformed S.cerevisiae line. Right hand side of the panel shows RNA 
treated with DNAseI to prevent contamination with gDNA (C) The Alu Jo transcript detected 
using Alu Jo fragment as probe in two yeast lines. Northern blot. (D) The Gal1 probe detects 
transcript driven by upstream Gal1 promoter. Northern blot. The right hand side of the panel 
shows RNA treated with DNaseI to prevent contamination with gDNA. GGBY 62 wt and cells 
transformed with empty pYES were used as negative controls. Marker sizes are indicated.  
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Total RNA was then extracted from the cells and separated on a formamide gel 
and figure 4.6b shows equal loading of samples. The activity of integrated Alu Jo 
was examined by Northern blot (figure 4.6c). Samples were treated with DNase I 
(Ambion) to ensure that signal is not due to DNA contamination. Jo11, Jo13 and 
Jo15 samples after DNAse I treatment are shown in duplicates. Samples not 
treated with DNAse I were also loaded and examined, as these included RNA 
from untransformed GGBY cells (wt) and cells transformed with empty pYES2int 
(empty pYES) as negative controls. Labelled purified Alu Jo fragment was used 
as a probe. Figure 4.6c shows that Alu Jo is expressed in both Jo11 and Jo15 
cells, but not in Jo13 cells. Weak signal detected in PCR reaction in figure 4.6a 
and lack of signal in the Northern blot analysis further suggests that pYES2int 
plasmid may not integrated properly in Jo13 cells. The possibility that it is 
present in these cells as a circular plasmid is unlikely, as the removed 2μORI 
fragment prevents it from being replicated.  
However, it was also noticed that when the Alu Jo signal was stripped (verified 
by exposure of film on the blot for several days) and reprobed with Gal1 probe, 
there was a weak signal. The Gal1 promoter is upstream of Alu Jo on the 
pYES2int plasmid (figure 4.6d). It is normally inactive in the presence of 2% 
glucose or absence of galactose (Flick and Johnston, 1990). Interestingly, Gal1 
promoter is only active where Alu Jo is active and it is inactive if inactive Alu Jo 
is near it (Jo13) or if present on empty pYES2int. It is therefore likely that Alu Jo 
is stimulating the activity of the Gal1 promoter, even in the absence of 
galactose. Such effects have been described previously for various RNA 
polymerase III-transcribed genes, such as tRNAs (see Discussion). In this 
experimental system it is, however, undesirable as it would complicate the 
experiment. 
Alu Jo activity in yeast cells was also verified by RT-PCR analysis (figure 4.7). 
Yeast actin was used as a loading control and full length Alu Jo was assayed 
using JoINF/JoINR primers. Samples where reverse transcriptase was omitted 
during cDNA synthesis were used as controls for genomic contamination. Figure 
4.7 again confirmed that Alu Jo was actively transcribed in Jo11 and Jo15 GGBY  
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transformed cells. Due to the unusual activity of the Gal1 promoter, this 
































































Figure   4-7 RT-PCR confirmed Alu Jo activity in S. cerevisiae. 
RT-PCR using gDNA of each transformed cell line. gDNA of GGBY 62 wt and cells 
transformed with empty pYES were used as negative controls. Samples where no reverse 
transcriptase (- Superscript) was added served as negative controls. Endogenous actin was 
used as a control for the RT-PCR. Alu Jo was amplified using AluJoINF/R primers. Actin was 
amplified using actin S.C. primers listed in Table 2-3. PCR reactions contained [α-
32P] dCTP. 
Autoradiograph. Marker sizes are indicated. Jana Vavrova, 2008    Chapter 4, 135 
 
 
4.2.4 HCT 116 DKO cells to study the effect of methylation on Alu 
silencing 
 
Later during the course of this study, the colorectal cancer cell line HCT-116, in 
which two major DNA methyltransferases, DNMT1 and DNMT3b have been 
genetically disrupted (DKO cells: HCTII6 Dnmt1-/Dnmt3b-), was obtained as a 
gift from Prof Bird and Dr Stancheva (Rhee et al., 2002). Global cytosine 
methylation patterns in mammalian genomes seem to be established by a 
complex interplay of at least three independently encoded DNA 
methyltransferases: Dnmt1, Dnmt3a and Dnmt3b. DNA methyltransferases are 
commonly classified as de novo  (DNMT3a and DNMT3b) and maintenance 
(DNMT1) enzymes (Bestor, 2000). While the lack of each individual enzyme has 
little effect on the DNA methylation patterns in human cells (Rhee et al., 2002; 
Rhee et al., 2000), in the DKO cells DNA methyltransferase activity is almost 
abolished and there is a 95% reduction in 5-methylcytosine content, including at 
repetitive sequences (Rhee et al., 2002). Figure 4.8 shows a map of the human 
Dnmt1 and Dnmt3b locus and target constructs. Deletions were verified by PCR 
(data not shown). These HCT-II6 DKO cells seemed to be the perfect system to 





Figure   4-8 HCT 116 cells – Map of the human Dnmt1 and Dnmt3b locus and target 
constructs. 
(adapted from Rhee et al, 2000 and Rhee et al, 2002). 
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Total RNA was extracted from both wt and DKO cells and Alu activity was 
studied by RT-PCR (figure 4.9). Duplicates of each RT-PCR are shown. In this 
experiment, consensus primers were used for the RT-PCR in order to look at 
activation of many closely related Alus. Other RNA polymerase III-transcribed 
genes were used as controls. 5S rRNA is a type1 promoter gene and 7SL and 
tRNAs are type2 RNA polymerase III-transcribed genes. GAPDH mRNA was used as 
a loading control, as it was shown previously that it is not affected in DKO cells 
(Paz et al., 2003). ARPPPO mRNA, which is used commonly as a loading control 
in our laboratory, was also included and it was shown to be negatively affected 
by loss of CpG methylation. Figure 4.9 shows an increase in Alu expression in the 
DKO cells. However, all other RNA polymerase III-transcribed genes were 
upregulated too. This was unexpected, because 5S rRNA, which is clearly 
affected here, was shown previously not to be influenced by CpG methylation 
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Figure   4-9 RT-PCR shows an increase in transcription of Alus in DKO HCT116. 
RT-PCR shows that in Dnmt1/Dnmt3b KO cells (DKO HCT116) there is an increase in Alu 
expression. There is also an increase in expression of all other tested RNA polymerase III-
transcribed genes. Samples are shown in duplicates. GAPDH was used as a loading control. 
Level of ARPP PO mRNA is decreased in HCTII6 DKO cells. Samples with no Superscript 
added during cDNA synthesis were used as a negative control for DNA contamination (data 
not shown). Primers used in each PCR reaction are listed in Table 2-3 and indicated with 
letter R (ChIP) in the second column and H (human) in the third column of the table. The Alu 
cons PCR used PV51/JoINR consensus primers. PCR reactions contained [α-
32P] dCTP. 
Autoradiograph. Marker sizes are indicated. 
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We therefore wanted to verify that some of the regulators of RNA polymerase III 
transcription were not affected in the DKO cells. An obvious candidate was p53, 
as it was shown to be a general repressor of RNA polymerase III activity (Cairns 
and White, 1998) and its inactivation was necessary in order to create the 
Dnmt1-/- viable mouse fibroblasts used in Chapter 5, which have similar DNA 
methylation levels as DKO HCT116 cells (Jackson-Grusby et al., 2001; Jorgensen 
et al., 2004).Total protein extracts were made from both wt and DKO HCT116 
cells and levels of p53 were verified using western blot analysis (figure 4.10). 
Actin was used here as a loading control. Samples were loaded in duplicates on a 
12% SDS gel. As figure 4.10 shows, levels of p53 protein are significantly reduced 
in DKO cells. HCT116 DKO cells are widely used in experiments studying effect of 
DNA methylation and it was surprising to find that the fact that p53 levels are 
reduced in the DKO cells has not been previously noticed. It could have been 
expected as the survival of the Dnmt1n/n KO mouse fibroblast requires presence 
of a homozygous p53 mutation (Jackson-Grusby et al., 2001). 
This poses an unfortunate problem for interpreting the data about Alu elements 
in these cells. Elevated levels of all RNA polymerase III transcripts in the DKO 
cells could be DNA methylation-dependent or, more likely, due to reduced levels 
of p53 (Cairns and White, 1998; Chesnokov et al., 1996). These cells therefore 
could not be used to study the effect of DNA methylation on Alus. Jana Vavrova, 2008    Chapter 4, 140 
 






Figure   4-10 Level of the p53 protein is decreased in DKO cells. 
Western blot. Total cell extracts of wt HCT116 and Dnmt1/Dnmt3b KO HCT116 (DKO) were 
used. Samples were loaded in duplicates. Actin used as a loading control. 12% SDS gel.  
Marker sizes are indicated on the left. 




There are two main mechanisms by which DNA methylation inhibits gene 
transcription. Methylated CpGs can directly inhibit binding of transcription 
factors to their cognate sequences (Watt and Molloy, 1988). Secondly, DNA 
methylation can inhibit gene activity indirectly via binding of methyl-CpG-
binding domain proteins (MBD proteins). MBD proteins recognise methylated DNA 
and bind to the sequences and can repress transcription via their transcriptional 
repression domains (TRDs) and also occlude target sequences and prevent 
transcription factors from binding (Nan et al., 1997; Ng et al., 2000). However, 
the main effect of MBD proteins is through recruitment of corepressor and 
chromatin remodelling complexes to silence gene expression (Boeke et al., 2000; 
Jones et al., 1998; Nan et al., 1998; Ng et al., 1999; Sarraf and Stancheva, 2004; 
Zhang et al., 1999). Apart from these mechanisms, it was recently discovered 
that also DNA methyltransferases themselves can establish silencing on genes via 
interaction with HDACs (Fuks et al., 2000; Fuks et al., 2001) or the histone 
methyltransferase SUV39H1 (Geiman et al., 2004). 
In this chapter, the effect of MBD proteins and MBD proteins-mediated silencing 
on Alu expression was studied. It was shown before that Alus are highly 
methylated and that removing methylation can increase their transcription in 
vitro and in vivo (Li et al., 2000; Liu et al., 1994; Liu and Schmid, 1993). The 
mechanisms of DNA methylation-mediated silencing in the case of Alus have not 
been studied in great detail. It was found that Alu sequences are amongst the 
preferential binding sites of MeCP2 (Koch and Stratling, 2004). The effect of 
MeCP2 on Alu silencing was investigated using a Gal4-linked transcription 
repression domain (TRD) of MeCP2, but it had no effect on transcription of an 
Alu reporter. In transient transfection assays, MeCP2 had no inhibiting effect on 
the AluSx reporter construct, although it was shown to inhibit an L1 (member of 
the long interspersed repeat elements) reporter construct in the same assay (Yu 
et al., 2001). 
Here, the occupancy of MBD proteins on Alus was investigated using ChIP 
analysis. Apolipoprotein E precursor was used as a positive control gene. Binding Jana Vavrova, 2008    Chapter 4, 142 
of MeCP2 to Alus was confirmed (Figure 4.2), together with MBD1 and MBD2 
(Figure 4.2, 4.3). MeCP2 seemed to be giving the strongest signal on all the 
tested Alus. MBD2 was detected on all of the tested Alus and MBD1 was detected 
on Alu Jo and Alu 6. To answer whether MBD proteins act alone or they act via 
recruitment of corepressors and chromatin remodelling complexes, another ChIP 
analysis was performed (Figure 4.5). The presence of SIN3A, NuRD, Brm-
containing SWI/SNF corepressor and chromatin remodelling complexes and 
HDACs alone were examined.  
Interestingly, Brm component of the SWI/SNF2 complex seemed to be associated 
specifically with methylated genes. Brm-containing SWI/SNF2 complex is usually 
associated with positive effect on genes’ activity (Muchardt and Yaniv, 1993). 
But it has also been reported to be involved in repression (Watanabe et al., 
2006). It has been shown to be recruited to methylated and repressed genes by 
MeCP2 via its component Brahma (Harikrishnan et al., 2005). Brahma was shown 
to associate with MeCP2 in vivo. Binding patterns of both proteins to methylated 
genes were similar and both of them were released from methylated genes upon 
treatment with methylation inhibitor. In agreement, this study confirms 
enrichment of SWI/SNF2 on the methylated genes, potentially recruited 
specifically by MeCP2.  
The association of HDACs, SIN3A or NuRD was not specific to methylated or 
active genes. HDACs were found on all tested genes. HDACs are associated with 
many corepressor complexes (reviewed in (Knoepfler and Eisenman, 1999; Ng 
and Bird, 2000), therefore it is not surprising to find them on all the repressed 
genes, regardless of whether SIN3A or NuRD components were detected. HDACs 
are known to repress RNA polymerase III-derived transcription (Sutcliffe et al., 
2000). HDACs could be recruited to methylated RNA polymerase III-transcribed 
genes via MeCP2 directly (Jones et al., 1998; Nan et al., 1998) or via SWI/SNF 
and mSin3a (Sif et al., 2001; Tong et al., 1998; Zhang et al., 1997), but they can 
be also recruited through mSin3a via p53 which was shown to interact with it 
(Murphy et al., 1999). P53 is a known repressor of RNA polymerase III-transcribed 
genes, including Alus (Cairns and White, 1998; Chesnokov et al., 1996). In the 
case of 7SL, both SIN3A and HDACs may in fact be present on the 7SL 
pseudogenes rather than the four active 7SL genes. The presence of HDACs at 
tRNA 
Sec is more surprising. Despite of HDACs being best known for their Jana Vavrova, 2008    Chapter 4, 143 
participation in transcriptional repression, HDACs were recently also shown to 
enhance activation of transcription of certain genes (Zupkovitz et al., 2006). A 
genome-wide study using HDAC1-deficient cells showed that the transcription of 
only 7% of genes is deregulated (partially due to the compensatory effect of 
HDAC2). Expression of some of the genes (about two fifths) was downregulated 
in the absence of HDACs. Some of them increased after TSA treatment, 
suggesting that they are repressed by compensating HDACs. Some of them, 
however, such as interferon responsive genes, displayed a negative response to 
TSA treatment, supporting previous studies (Nusinzon and Horvath, 2005; 
Sakamoto et al., 2004) Such a positive effect has not yet been shown for any 
RNA polymerase III transcribed gene. There is also an obvious discrepancy 
between HDACs occupancy and acetylated H3 and H4 on both RNA polymerase 
III-transcribed genes and Alus. Acetylated histones H3 and H4 were observed on 
Alus in other studies (Hakimi et al., 2002; Johnson et al., 1998), but the 
presence of HDACs have never been described before. Significance of the co-
occupancy of acetylated histones and HDACs on Alus remains to be determined. 
Despite the low transcriptional activity of Alus, histone acetylation may be 
linked to the transcriptional activation potential of Alus, such as the rapid 
activation of Alus expression after exposure to cell stress (Liu et al., 1995).  
NuRD complex seemed to be present on both methylated and active genes. Its 
specificity is not clear. It was shown to interact with MBD2 and be recruited to 
methyl DNA in vitro (Zhang et al., 1999); however, in itself, mi2/NuRD does not 
seem to have a significant affinity for methylated DNA in vitro (Hendrich and 
Bird, 1998; Zhang et al., 1999). In the case of 7SL, it may be in fact present on 
7SL pseudogenes rather than active 7SL genes.  
In summary, SWI/SNF2 complex seems to be specifically enriched on methylated 
genes, however, other complexes may also contribute to the repression of 
methylated Alus, whether recruited via MeCP2 (SIN3A and HDACs) or MBD2 (NuRD 
and HDACs), or independently. 
MBD1, detected on Alus here, is not known to recruit the studied complexes. It 
is, however, known to form a stable complex with the histone H3K9 methylase 
SETDB1 (Sarraf and Stancheva, 2004), which may be maintaining H3K9 
methylation present on Alus (Kondo and Issa, 2003). Jana Vavrova, 2008    Chapter 4, 144 
MBD proteins could also silence transcription via their TRD domains or by 
obstructing transcription factors from binding to Alus. It was shown in the 
previous chapter that although TFIIIB and TFIIIC occupancy levels seem to be 
indistinguishable on Alus and active RNA polymerase III genes, RNA polymerase III 
levels were significantly lower suggesting that something may prevent RNA 
polymerase III from better binding. MBD proteins were potential candidates. 
Sequential ChIP analysis was performed to verify that MBD proteins and RNA 
polymerase III machinery are indeed present on the same Alus at the same time. 
TFIIIC, which is the component associating first with promoters during RNA 
polymerase III complex assembly, was used in the first step of sequential ChIP 
analysis. As figure 4.4 shows, MBD proteins indeed co-precipitate with TFIIIC, 
suggesting that TFIIIC binding is not prevented by their presence. However, 
whether TFIIIB or RNA polymerase III binding may be inhibited remains to be 
established. Using TFIIIB and RNA polymerase III in the first step of sequential 
ChIP analysis would address that. Interestingly, some differences from standard 
ChIP analysis were detected in MBD proteins’ occupancy. MBD1 rather than 
MeCP2 gave the strongest signal on Alu Jo and no MBD2 was detected. On Alu 6, 
MBD2 gave the strongest signal rather than MeCP2 (compare figure 4.4 and figure 
4.2, 4.3). A possible explanation could be that sequential ChIP analysis only 
detects Alus bound simultaneously by TFIIIC and MBD proteins, and not the Alu 
copies only bound by MBD proteins. Therefore, there could be different 
occupancy of MBD proteins present on the Alu Jo and Alu 6 when these are 
simultaneously bound by TFIIIC or possible MBD epitope masking may occur in 
the presence of TFIIIC.  
Overall, the detected MBD proteins may act both via inhibition of RNA 
polymerase III machinery from proper binding (namely RNA polymerase III) and 
recruitment of corepressor complexes, specifically SWI/SNF. 
DNA methylation is regarded as a global repressor of Alus. On the other hand, 
treatment of cells with adenovirus type 2 (Russanova et al., 1995) or heat shock 
or cycloheximide (Li et al., 2000) leads to an increase in Alu RNA without 
altering methylation of their DNA. Despite DNA methylation and DNA 
methylation-mediated silencing being widely recognised, in certain genes and 
promoters it is established as a secondary ‘lock’ on sequences which first 
became transcriptionally inactive (reviewed in (Clark and Melki, 2002; Turker, Jana Vavrova, 2008    Chapter 4, 145 
2002) resulting in further and deeper repression. Transfected PV Alu remains 
transcriptionally silenced without becoming methylated (Leeflang et al., 1992). 
So, perhaps Alu sequences are only co-silenced by DNA methylation and their 
silencing depends on individual circumstances, such as promoter structure, 
flanking sequences and chromatin situation, that can supersede global regulation 
(Li and Schmid, 2001). 
The effect of DNA methylation on Alu transcription has so far been studied using 
5-azacytidine treatment (Liu et al., 1994) or in naturally hypomethylated K562 
cells (Li et al., 2000). Here, an attempt was made to study ‘methylation-free’ 
environments.  
The budding yeast S.cerevisiae was first used as a model system to study Alu 
expression as the organism has no endogenous methylation (Antequera et al., 
1984). An Alu Jo element was integrated into the yeast genome and its activity 
assayed using Northern blot analysis. Alu Jo was expressed in two different cell 
lines (figure 4.6, 4.7). However, it was also revealed that the Gal1 promoter, 
which is normally inactive in the presence of glucose and absence of galactose, 
was active. Since the Gal1 promoter is only active where Alu Jo is active (figure 
4.6), it is possible that Alu Jo is stimulating the activity of the Gal1 promoter 
even in the absence of galactose. The ability to influence transcription of nearby 
genes has been described previously for tRNAs and Ty1 elements in budding 
yeast (Bolton and Boeke, 2003; Hull et al., 1994). tRNA genes have been shown 
to strongly inhibit transcription from nearby RNA polymerase II promoters and 
this inhibition was dependent on the active transcription of the tRNA gene (Hull 
et al., 1994). Ty1 element, on the other hand, was shown to stimulate 
transcription of nearby tRNAs (Bolton and Boeke, 2003). Despite such a capacity 
being an interesting property of Alu Jo, it was undesirable in this experimental 
system. Future experiments would require using a different integrating vector, 
where no other promoter is present. 
HCT 116 cells, where deletion of Dnmt1 and Dnmt3b led to loss of more than 95% 
of genomic methylation, were used next to study Alu elements in a virtually 
‘methylation-free’ environment. Alu transcriptional activity was increased in the 
DKO cells upon CpG methylation removal (figure 4.9). However, all other RNA 
polymerase III-transcribed genes were affected too. An upstream regulator of Jana Vavrova, 2008    Chapter 4, 146 
RNA polymerase III activity was suspected and, indeed, levels of p53 protein 
were shown to be decreased in DKO cells (figure 4.10). Alus are known targets of 
p53 in vitro and in vivo (Chesnokov et al., 1996) and due to this fact, this system 
could not be used for further analysis. 
Because of difficulties finding a good DNA methylation-free system, the 
significance of MBD proteins that were found to associate with tested Alus and 
their repressive effect could not be further studied. Alus, however, have 
homologous sequences in rodent genomes, the B1 SINEs (see Chapter5) and the 
next focus was on them. The closely related B2 family (another RNA polymerase 
III-transcribed SINE family) was also studied and mouse fibroblasts with Dnmt1 
deletion resulting in 95% reduction in 5-methylcytosine content (Jackson-Grusby 





5  Chapter 5 - B1 and B2 transcription is not 
silenced by DNA methylation 
5.1 Introduction 
Except for rodents and primates, SINEs from all other animals examined are 
unrelated to the 7SL RNA but are instead homologous to tRNAs. Rodents have 
both- the 7SL-derived B1 family and tRNA-derived B2 family (Kramerov et al., 
1979). Sequence analysis indicates that B1 is a homologue to the Alu left 
monomer. B1s and B2s are expressed at very low levels under normal 
circumstances, although B2s’ expression levels appear somewhat higher than 
that of B1s (Carey et al., 1986). B1 and B2 elements often respond in a similar 
manner to a number of activating stimuli such as cell stress (Fornace et al., 
1989; Kalkkila et al., 2004; Li et al., 1999; Liu et al., 1995; Price and 
Calderwood, 1992), DNA-damage (Rudin and Thompson, 2001), cell growth 
(Lania et al., 1987; Singh et al., 1985) and viral infections (Carey et al., 1986; 
Lania et al., 1987; Scott et al., 1983; Singh et al., 1985). On the other hand, 
their activity decreases during differentiation of embryonal carcinoma cells 
(White et al., 1989). 
Both B2 and B1 elements contain an RNA polymerase III promoter and are 
transcribed by RNA polymerase III (Carey et al., 1986; Krayev et al., 1982; Singh 
et al., 1985). Like Alus, they are common in hnRNA as part of RNA polymerase II 
derived mRNAs (Ryskov et al., 1983). Given the number of copies, 564 000 of B1 
and 348 000 of B2 in the mouse genome (Waterston et al., 2002), their very low 
transcription rate signifies that they are subject to repression. While 
methylation was thought to be the main repressive mechanism for human Alus it 
has never been studied for B1 and B2 sequences, which are also methylated 
(Jeong and Lee, 2005; Yates et al., 1999). For B2, unlike Alus, global repression 
was alleviated by depleting linker histone H1 from chromatin (Carey and Singh, 
1988; Russanova et al., 1995).  
In this chapter, the hypothesis that DNA methylation-mediated silencing or 
chromatin silencing inhibit transcription of B1 and B2 was investigated.  Jana Vavrova, 2008    Chapter 5, 148 
 
5.2 Results 
5.2.1 RNA polymerase III components are present on B1 and B2 
Alus and B1 and B2 respond to stimuli in a similar manner. Previous studies 
proposed that Alu promoters get masked by chromatin proteins and are 
inaccessible to the RNA polymerase III transcriptional machinery (Kim et al., 
2001; Russanova et al., 1995), suggesting that B1s and B2s may be similarly 
affected. To find out whether the repressive mechanism acting on B1s and B2s 
inhibits access of the RNA polymerase III machinery, the occupancy of RNA 
polymerase III components at B1 and B2 promoters was investigated in vivo. The 
A31 mouse fibroblast cell line was used for the in vivo analysis. RNA polymerase 
III, TFIIIB and TFIIIC were tested as they were shown to be necessary and 
sufficient for transcription of SINEs in vitro (Singh et al., 1985). Prior to the 
analysis it was necessary to verify B1 and B2 expression levels in these cells. 
Total RNA was extracted and cDNA made. Samples where no reverse 
transcriptase was used during cDNA preparing were used as controls for genomic 
DNA contamination. RT-PCR was then performed and levels of B1 and B2 activity 
compared to the levels of 7SL as a RNA polymerase III transcribed active gene 
(Figure 5.1). Consensus primers were used for both B1 and B2 RT-PCR. Figure 5.1 
shows that both B1 and B2 RNA were detected. Although direct comparison with 
7SL is not possible here (the strength of the signal depends on number of cycles 
of amplification and the annealing capacity of each primer), it can be estimated 
that RNA levels from four active 7SL genes are higher than RNA levels produced 
from approximately a hundred B1 and B2 sequences detected by these primers 











Figure   5-1 Low levels of B1 and B2 transcripts were detected in A31 cells. 
RT-PCR. B1 and B2 are consensus primers detecting a subgroup of about a hundred B1 and 
B2 sequences each. 7SL is a positive control gene. The primers used for RT-PCR reaction 
are listed in Table 2-3, with letter R (RT-PCR) in the second column and letter M (mouse) in 
the third column of the table. Samples are shown in duplicates. NS is a sample with no 
Superscript added during cDNA synthesis, used as a negative control for DNA 
contamination (data not shown). Marker sizes are indicated. Autoradiograph. 
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Having verified that both families are indeed expressed at low levels in A31 
cells, chromatin immunoprecipitation assay was performed in order to determine 
RNA polymerase III machinery levels on both SINEs families (Figure 5.2). 
Antibodies against TFIIIB, TFIIIC and RNA polymerase III were used, together with 
antibodies for acetylated histone H3 (directed against acetylated lysine 9 and 
14) and H4 (directed against acetylated lysine 5, 8, 12, 16), both often 
associated with transcriptionally active genes (Kuo et al., 1996). TFIIA was used 
as a negative control antibody. Beads were used as an additional negative 
control.  Set1 and Set2 were genomic primers for B1 and B2 SINEs on 
chromosome 9, designed to detect two sites of this unique region, which is 
surrounded within 3 kb distance by other SINEs only. B1 and B2 are consensus 
primers detecting a subgroup of about a hundred B1 and B2 sequences each. 
tRNA 
Leu was used as a positive control gene. H19 is a RNA polymerase II-
transcribed gene known to be repressed by DNA methylation in the mouse 
genome (Fuks et al., 2003) and it was used here as a negative control. As figure 
5.2 shows, RNA polymerase III transcriptional machinery and both acetylated H3 
and H4 were detected on all B1 and B2 genes studied, whether present scattered 
within RNA polymerase II-transcribed regions (B1 and B2) or in the middle of a 
cluster of other B1 and B2s (Set1 and Set2). 
Lower level of TFIIIC was also detected on the H19 gene. There are two possible 
explanations. Firstly, there may be a TFIIIC binding site in the H19 sequence. As 
described in sections 1.2.1 and 1.2.2, TFIIIC is the first step of RNA polymerase 
III transcription machinery assembly and it is the main DNA binding protein. 
Secondly, it is possible that the H19 sequence contains SINEs or their remnants 
and TFIIIC binds to those sequences. SINEs are located throughout the genome, 
and they tend to be enriched in gene-rich regions (Korenberg and Rykowski, 
1988). In the past, SINEs inserted and became part of many genes, spreading 
RNA polymerase II promoters (Ferrigno et al., 2001) and alternative splice sites 
(Sorek et al., 2002; Sorek et al., 2004). H19 gene was used here as a negative 
control gene as it is RNA polymerase II-transcribed. It is an imprinted gene that 
is expressed, although exclusively from the maternal allele (Bartolomei et al., 
1991). Acetylated histones H3 and H4 may therefore be present on the maternal Jana Vavrova, 2008    Chapter 5, 151 
allele and their association with H19 gene was observed before (Huang et al., 
2004).  
It is surprising to find that many B1s and B2s are occupied by RNA polymerase III 
machinery in A31 cells, considering that the level of expression of both families 
is very low. It seems that there is no obvious problem with RNA polymerase III 
machinery assembly- TFIIIC binding followed by TFIIIB recruitment and 
recruitment of RNA polymerase III. However, the RNA polymerase III occupancy 
appears to be lower on all B1/B2 SINEs when compared to tRNA
Leu or 7SL (figure 






















































Figure   5-2 ChIP analysis shows the occupancy of the RNA polymerase III machinery and 
acetylated histones on B1 and B2 in A31 cells. 
Set1 and Set2 were genomic primers for B1 and B2 SINEs on chromosome 9, designed to 
detect two sites of this unique region, which is surrounded within a 3 kb distance by other 
SINEs only. B1 and B2 are consensus primers detecting a subgroup of about a hundred B1 
and B2 sequences each. All antibodies used for the ChIP analysis are listed on top of the 
first panel. TFIIA was used as a control antibody. Samples with beads-only were used as a 
general negative control. Input DNA was diluted to 10%, 2% and 0.4% to ensure quantitative 
PCR reactions. Primers used in each PCR reaction are listed in Table 2-3 and indicated with 
letter C (ChIP) in the second column and M (mouse) in the third column of the table. PCR 
reactions contained [α-
32P] dCTP. Autoradiograph. Marker sizes are indicated. Jana Vavrova, 2008    Chapter 5, 153 
 
To determine whether levels of RNA polymerase III on B1 and B2 families are 
significantly different from active RNA polymerase III-transcribed genes, mouse 
fibroblasts were subjected to more ChIP assays and statistical analysis of the 
occupancy signals of the RNA polymerase III transcription complex (TFIIIC-TFIIIB- 
RNA polymerase III) was performed. The occupancy signals of TFIIIB, TFIIIC and 
RNA polymerase III at 7SL and B1 and B2 families were quantified and the ratios 
of TFIIIB/TFIIIC, RNA polymerase III/TFIIIB and RNA polymerase III/TFIIIC were 
calculated. Six different ChIP analyses were used and 7SL, B1 and B2 were 
tested. Both two-tailed t-test analysis and student t-test analysis were 
performed to correct the analysis for small sample sets (Table 5.1). 
As table 5.1 shows, both B1 and B2 families are co-ordinately affected. There 
was no significant difference in occupancy ratio of IIIB/IIIC between 7SL and B1 
or B2. However, there was significant difference (p<0.05) of occupancy ratios of 
RIII/IIIB and RIII/IIIC between B1 and B2 and 7SL (see table).  
 
 
 Mean  St dev  T test P  Student t test P 
7SL IIIB/IIIC  0.9862  0.5181  0.274  0.270 
B1 IIIB/IIIC  0.6896  0.3477 
7SL IIIB/IIIC  0.9862  0.5181  0.174  0.150 
B2 IIIB/IIIC  0.6409  0.1813 
7SL RIII/IIIB  3.1287  1.3859  0.015  0.008 
B1 RIII/IIIB  1.1029  0.5384 
7SL RIII/IIIB  3.1287  1.3859  0.017  0.012 
B2 RIII/IIIB  1.2352  0.5823 
7SL RIII/IIIC  2.6594  1.1585  0.008  0.002 
B1 RIII/IIIC  0.6414  0.1800 
7SL RIII/IIIC  2.6594  1.1585  0.007  0.003 
B2 RIII/IIIC  0.727  0.2760 
Table   5-1 Statistics of 7SL and B1 and B2 genes’ occupancy by RNA polymerase III (RIII), 
TFIIIB (IIIB) and TFIIIC (IIIC). 
 
Box and whisker plots show graphic representation of the samples’ descriptive 
statistical values (Figure 5.3). Chart shows that there are higher occupancy 
ratios of all RNA polymerase III components on the 7SL. While for TFIIIB to TFIIIC 
it is not significantly higher, the ratios of RNA polymerase III to TFIIIB and RNA 
polymerase III to TFIIIC are significantly higher on the 7SL gene then on B1 or B2, Jana Vavrova, 2008    Chapter 5, 154 
showing that there is lower amount of cross-linked RNA polymerase III on both B1 
and B2. This implies that there is a problem with RNA polymerase III recruitment 
or its access to the SINE promoter, which would then result in lower 
transcription or lack of transcription from the majority of the B1s and B2s. Or 
perhaps, RNA polymerase III is present but its epitopes are masked by other 
molecules present on B1 and B2, possibly impeding its proper function.  Jana Vavrova, 2008    Chapter 5, 155 
 




























Figure   5-3 Ratios of RNA polymerase III machinery components on 7SL and B1 and B2. 
Box and whisker plots chart shows graphic representations of descriptive statistical values 
found for each sample set. Six ChIP analyses were included. Ratios of TFIIIB/TFIIIC, RNA 
polymerase III/TFIIIB and RNA polymerase III/TFIIIC occupancies were measured by ImageJ. 
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5.2.2 B1 and B2 and methylation – presence of MBD proteins 
There is not much evidence about B1 or B2 and methylation and its effect on B1 
and B2 activity. It is known that they are methylated (Jeong and Lee, 2005; 
Yates et al., 1999). Also, B1 and B2 were amongst mouse genomic fragments 
that bound strongly to the MBD column containing MBD domain of MeCP2 (A 
Hever, M Bailey, personal communication). Because of difficulties determining 
Alu methylation in section 4.2.1, B1 and B2 methylation status was not 
determined. Establishing whether B1 and B2 are bound by MBD proteins would 
therefore indicate whether B1 and B2 are methylated.  
To find out whether MBD proteins bind to B1 and B2 and could therefore inhibit 
RNA polymerase III access to their promoters or its function, ChIP analysis was 
performed to look at their occupancy. Antibodies against MBD1, MeCP2 and 
MBD2 were used. Acetylated H4 was used as a positive control antibody. 
H3K9me3 is also known to associate with methylated DNA and so it was also 
studied here using antibody against it. tRNA 
Leu and 7SL are encoded by actively 
transcribed RNA polymerase III genes and were used here as negative controls. 
Apolipoprotein E  precursor (ApoE) is methylated in different cells at different 
levels, heavily in rat liver, less in other tested tissues (Driscoll and Getz, 1984). 
It was used as it was shown in human cells to be bound by all MBD proteins. 
Whether that is the case in rodent fibroblasts was unknown.  
ChIP analysis revealed that B1 and B2 genes are indeed bound by all MBD 
proteins studied here, MBD2, MeCP2, and MBD1 (figure 5.4, 5.5). ApoE is also 
bound by all MBD proteins, as is its human homologue (Ballestar et al., 2003). 
Both B1 and B2 were also bound by trimethylated H3K9 (figure 5.4), which has 
previously been reported for human Alus (Kondo and Issa, 2003). This is despite 
the fact that B1 and B2 are also occupied by AcH4. It is possible that acetylated 
H4 and H3K9me3 are in fact present on different copies of B1 and B2. B1 and B2 
primers are consensus primers detecting a subgroup of about a hundred B1 and 
B2 sequences each, some of which could have H3K9me3 and other AcH4. Also, 
ChIP analysis uses populations of cells; it is therefore possible that although both 
H3K9me3 and AcH4 are present on a gene within the population, H3K9me3 may 
be present on B1 and B2 in some cells and AcH4 may be present on B1 and B2 in  Jana Vavrova, 2008    Chapter 5, 157 
other cells, and not together. Such a situation would appear as co-occupancy in 









































Figure   5-4 MBD2, MeCP2 and H3K9me3 were detected on B1 and B2 genes in A31 cells. 
ChIP analysis. B1 and B2 are consensus primers detecting a subgroup of about a hundred 
B1 and B2 sequences each. ApoE gene was used as a positive control gene for MBD 
proteins. tRNA Leu was used as a negative control gene for MBD proteins. All antibodies 
used for the ChIP analysis are listed on top of the first panel. TFIIA was used as a control 
antibody. Samples with beads-only were used as a general negative control for the ChIP. 
Input DNA was diluted to 10%, 2% and 0.4% to ensure quantitative PCR reactions. Primers 
used in each PCR reaction are listed in Table 2-3 and indicated with letter C (ChIP) in the 
second column and M (mouse) in the third column of the table. PCR reactions contained [α-
32P] dCTP. Autoradiograph. Marker sizes are indicated. 































Figure   5-5 MBD1 occupies B1 and B2 genes in A31 cells. 
ChIP analysis. B1 and B2 are consensus primers detecting a subgroup of about a hundred 
B1 and B2 sequences each. The ApoE gene was used as a positive control gene for MBD1. 
7SL was used as a negative control gene for MBD1. TFIIA and beads were used as control 
antibodies. Input DNA was diluted to 10%, 2% and 0.4% to ensure quantitative PCR 
reactions. PCR reactions contained [α-
32P] dCTP. Autoradiograph. Marker sizes are 
indicated. 
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These data confirmed that MBD proteins are associated with B1 and B2 
sequences. A sequential ChIP was used to determine whether RNA polymerase III 
and MBD proteins could be present at the same time on the same gene. Briefly, a 
ChIP assay was performed using 10 plates of cells per antibody (10 x more than 
in a normal ChIP assay) and the obtained supernatant was immmunoprecipitated 
with RNA polymerase III antibody (1900). RNA polymerase III-immunoprecipitated 
material was then diluted 1:10 and immunoprecipitated further with antibodies 
of interest. TFIIIC with TFIIIB were used here as positive controls as they co-
occupy promoters together with RNA polymerase III. If MBD proteins are 
detected on B1 and B2 in RNA polymerase III-immunoprecipitated material, it is 
considered that they co-occupy the same B1 and B2 sequences. Figure 5.6 shows 
sequential ChIP performed in A31 cells. Antibodies against TFIIIB, TFIIIC together 
with MBD1, MBD2 and MeCP2 were used. TFIIA was a negative control antibody. 
B1, B2, Set1 and Set2 are the same sequences used in previous simple ChIP 
analysis. tRNA 
Tyr is shown as an active RNA polymerase III-transcribed active 
gene. TFIIIB and TFIIIC co-precipitated on all tested genes. MBD2 and MeCP2 
were found on all tested B1 and B2 sequences. MBD1 was found on B1 and B2 
when detected with consensus primers, providing evidence that some B1s and 
B2s are indeed targets of MBD1. It was not detected on Set1 and Set2 suggesting 
that MBD1 does not co-occupy these sequences with RNA polymerase III 
machinery. MBD proteins were also detected on the tRNA 
Tyr gene. Higher 
exposure was needed to detect its signal from sequential ChIP inputs, but it 













































Figure   5-6 Sequential ChIP shows the co-occupancy of the RNA polymerase III and MBD 
proteins on B2 and B1 in A31 cells. 
RNA polymerase III antibody (1900) was used in the first step (ChIP analysis). Precipitated 
material was diluted 1:10 in 1xNET buffer and further precipitated with the antibodies listed 
at the top of the panel (sequential ChIP). TFIIA was a negative control antibody. Input DNA 
was diluted to 10%, and precipitated. Sequential input was then again diluted to 20%, 10% 
and 5% to ensure quantitative PCR reactions. Primers used in each PCR reaction are listed 
in Table 2-3 and indicated with letter C (ChIP) in the second column and M (mouse) in the 
third column of the table. Set1 and Set2 were genomic primers for B1 and B2 SINEs on 
chromosome 9, designed to detect two sites of this unique region, which is surrounded 
within 3 kb distance by other SINEs only. B1 and B2 are consensus primers detecting a 
subgroup of about a hundred B1 and B2 sequences each.  PCR reactions contained [α-
32P] 
dCTP. Autoradiograph. Marker sizes are indicated. Jana Vavrova, 2008    Chapter 5, 161 
 
In the above experiment, it was shown that RNA polymerase III and MBD proteins 
occupy B1s and B2s together. It is now a question whether MBD proteins inhibit 
B1s and B2s’ transcription and whether they inhibit it directly or via recruitment 
of corepressors and chromatin remodelling complexes. MBD2 and MeCP2 studied 
here are known to interact with corepressor and chromatin remodelling 
complexes. MeCP2 has been the most studied in mice. While other MBD proteins 
seem to be partially redundant in their action, MeCP2 is essential for normal 
post-natal neurological development in mice (Chen et al., 2001; Guy et al., 
2001). It has been shown to interact with a number of cofactors, including 
mSin3a and HDACs (Jones et al., 1998; Nan et al., 1998) and the SWI/SNF2 
complex via Brahma (Harikrishnan et al., 2005). In mice, MeCP2 is a known 
repressor of the H19 gene (Drewell et al., 2002; Fuks et al., 2003).  It represses 
H19 through its TRD domain and this repression is almost entirely (>95%) 
dependent on recruitment of HDACs (Drewell et al., 2002). MBD2 was also shown 
to interact with HDACs (Ng et al., 1999; Zhang et al., 1999). MBD1 is not known 
to interact with HDACs or SWI/SNF2 and its partners were not tested here. ChIP 
analysis was performed to establish whether HDACs are present, perhaps 
recruited via MeCP2 or possibly other MBD proteins. Brahma (Brm) was also 
studied, as it was shown to interact with MeCP2 (Harikrishnan et al., 2005) and 
HDACs (Watanabe et al., 2006). The MeCP2 antibody was used as a positive 
control. ApoE was used here as it was shown in previous experiment to be bound 
by MeCP2. tRNA 
Sec is an actively-transcribed RNA polymerase III gene. As figure 
5.7 shows, MeCP2 is enriched on methylated genes compared to the tRNA 
Sec 
gene. HDAC1 and HDAC2 are, however, present on all these genes, suggesting 
that they can be recruited independently of MBD proteins. Brm was only 
enriched on B1, B2 and ApoE genes. Brm is recruited to methylated genes by 
MeCP2 in some cell lines (Harikrishnan et al., 2005). These and our finding 
suggest that Brm could be recruited to B1 and B2 and ApoE via its interaction 
with MeCP2. However, direct protein-protein interactions have not been 








































Figure   5-7 ChIP analysis shows that Brm is specifically enriched on genes associated with 
MBD proteins.  
Other tested proteins, namely HDAC1, HDAC2 do not show specific occupancy on B1, B2. 
All antibodies used for the ChIP analysis are listed on the top of the first panel. 
Brm=Brahma. Input DNA was diluted to 10%, 2% and 0.4% to ensure quantitative PCR 
reactions. TFIIA antibody was used as a negative control antibody. Samples with beads-only 
were used as a general negative control for ChIP. Primers used in each PCR reaction are 
listed in Table 2-3 and indicated with letter C (ChIP) in the second column and M (mouse) in 
the third column of the table. PCR reactions contained [α-
32P] dCTP. Autoradiograph. Marker 
sizes are indicated. 
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5.2.3 B1 and B2 RNA levels are not upregulated in MeCP2 null 
mice 
The above experiment suggests that HDACs and Brm, which is part of the 
SWI/SNF2 remodelling complex, are present at B1 and B2 sequences. It is not 
clear whether these are recruited via MeCP2 and whether MeCP2 directly or via 
these proteins inhibits B1 and B2 activity. One way to establish MeCP2 
importance is to study B1 and B2 expression upon MeCP2 removal. MeCP2 null 
mice were generated by cre/lox deletion of exons 3 and 4 of the MeCP2 gene 
(Guy et al., 2001). MeCP2 null males and females are viable and appear normal 
until about 6 weeks of age. A period of rapid regression follows, when they 
develop a number of defects including hind limb clasping, irregular breathing, 
uneven wearing of teeth and various behavioural changes. Progression of 
symptoms leads to weight loss and death at approximately 8 weeks (Guy et al., 
2001). MeCP2
+/- heterozygotes did not exhibit this rapid deteriorating effect. 
Instead, symptoms appeared at about 9 months, suggesting that the condition 
was long-term stable. 
Frozen kidneys of two matching pairs of mice were obtained from M. Bailey (gift 
from A. Bird). Two months old MeCP2 null male C57/Balb/6 (b13) and age 
matched wild type C57/Balb/6 (b14) and nine months old MeCP2 heterozygote 
female (672) and aged matched wild type female (671). Another wild type male 
is also included (771). All of the mutants were symptomatic (Guy, personal 
communication). Total RNA was extracted from the kidney tissue and cDNA 
made. Samples where no reverse transcriptase was added during cDNA synthesis 
were used as negative control for genomic contamination (data not shown). If 
MeCP2 is critical in repression of B1 and B2, their expression should increase in 
mice tissue lacking MeCP2. Samples were normalised for ARPPPO mRNA 
expression and expression of B1 and B2 in those samples assayed (Figure 5.8). 
Samples from both kidneys of each mouse are shown. Samples were also 
quantified and the values are displayed in the chart below. Comparison of MeCP2 
-/y male (b13) and MeCP2 +/y male (b14) shows no increase in B1 and B2 
expression in MeCP2 null mouse kidneys. As expected from the result of the Jana Vavrova, 2008    Chapter 5, 164 
MeCP2 null male, there is also no increase in B1 and B2 expression in the MeCP2 
heterozygote female (672) relative to the wild type female (671). There seem to 
be quite significant variation between the two kidneys of each animal. It is also 
interesting that the additional MeCP2 wild type male expresses more B1 and B2 
in its kidneys than the studied mutants. It is clear from this experiment that 
removing MeCP2 from B1 and B2 does not result in increased levels of B1 and B2. 
MeCP2 binds to B1s and B2s, but, as found in case of Alus (Yu et al., 2001), it 
does not seem to repress them. Jana Vavrova, 2008    Chapter 5, 165 
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Figure   5-8 RT-PCR shows that the B1 and B2 RNA is not upregulated in kidneys of the 
MeCP2 KO mouse. 
B13 KO and b14 wt are a matched pair, and 671 wt and 672 KO are a matched pair, whilst 
771 is an additional wt mouse. The two cDNAs were isolated separately from each kidney.  
B1 and B2 expression was quantified for both kidneys of each animal and plotted in the bar 
graph. Auradiographs. Marker sizes are indicated. 
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5.2.4 Effect of removing DNA methylation on B1 and B2 
expression  
MBD proteins were shown to bind to methylated B1 and B2 genes, but their role 
in regulation of these sequences is not clear. B1 and B2 expression did not 
increase upon MeCP2 removal, suggesting that MeCP2 is not critical for B1 and 
B2 repression. It remains possible that other MBD proteins compensate for lack 
of MeCP2 in these mice. A different approach was therefore adopted. Instead of 
removing MBD proteins one by one, removing DNA methylation would result in 
releasing MBD proteins from B1 and B2 promoters and alleviating DNA 
methylation-mediated silencing if it acts on B1 and B2 sequences. 
Li et al. (1992) made Dnmt1 
-/- mouse embryonic stem cells (Dnmt1 
n/n) by 
deleting the first exon of the Dnmt1 gene with neo and hyg expression cassettes 
in two rounds of targeting. Deleting of Dnmt1 led to a substantial demethylation 
of about 80% of total cytosines (Li et al., 1992). This is mainly because these 
cells retained de novo methylation activity (Lei et al., 1996), which is performed 
by Dnmt3a and Dnmt3b (Okano et al., 1999). Studies of deletions of DNA 
methyltransferases showed that only Dnmt1 mutants manifest marked loss of 
genomic cytosine methylation (Li et al., 1992; Okano et al., 1999; Okano et al., 
1998).  
In Dnmt1 
n/n mouse embryonic stem cells, methylation of B1 was reduced to 43% 
of the levels of wt ES cells (Yates et al., 1999). This compares with the H19 
region, which had less than 1.4% of its original methylation. Dnmt1 is a 
maintaining DNA methyltransferase and these cells lack the enzymatic activity 
responsible for spreading and maintaining methylation, however de novo 
methylation still remains in these cells (Lei et al., 1996). This suggested that B1s 
are target of de novo methylation.  
The cells used here were mouse embryonic fibroblasts derived from 9.5 days old 
embryos (I.Ben-Porath and H.Cedar, unpublished data). They were Dnmt1 
n/n 
knock out, as described (Li et al., 1992), with introduced mutational inactivation 
of Trp53, resulting in Dnmt1
n/n p53
-/- cells and control Dnmt1
+/+ p53
-/- cells. The Jana Vavrova, 2008    Chapter 5, 167 
presence of a homozygous p53 mutation allows survival of this somatic cell line, 
which otherwise succumbs to apoptotic death (Jackson-Grusby et al., 2001). 
These cells have less than 5%  of the normal level of DNA methylation (Jorgensen 
et al., 2004). 
To study the effect of methylation on MBD proteins’ binding to B1 and B2, 
binding of MBD2 and MeCP2 in Dnmt1
n/n p53
-/- fibroblast was compared to 
binding in Dnmt1
+/+ p53
-/- fibroblasts using ChIP analysis (figure 5.9). MBD1 was 
not studied here due to lack of a suitable antibody. The MBD1 (Imgenex) 
antibody used previously in A31 cells did not detect MBD1 in Dnmt1
+/+ p53
-/-  
cells in ChIP or Western blot (data not shown). Immunoprecipitated DNA was 
first normalised using input DNA ensuring equal input of material from each cell 
line. Apart from MBD2 and MeCP2 antibodies, acetylated H4 antibody was used 
as a positive control and TFIIA antibody and beads as negative controls. Levels of 
trimethylated H3K9 in the two cell lines were also studied using H3K9me3 
antibody. B1 and B2 families were studied using consensus primers, and Set1 
primers were used to look at individual B1 and B2 genes on chromosome 9, 
remote from any RNA polymerase II-transcribed genes. ApoE was used here as a 
positive control gene, as it was shown previously to be bound by both MBD2 and 
MeCP2. tRNA 
Leu was used as a negative control gene. As figure 5.9a shows, MBD2 
and MeCP2 occupy all tested methylated genes in control fibroblasts. In Dnmt1
n/n 
p53
-/- embryonic fibroblasts, where levels of DNA methylation are significantly 
reduced, there is a reduction in both MBD2 and MeCP2 binding to the methylated 
promoters. Levels of both proteins were not reduced in the Dnmt1
n/n p53
-/- 
fibroblasts (figure 5.9b), suggesting that lower occupancy on the B1 and B2 
promoters is due to a lower affinity of MBD proteins. In fact, the abundance of 
both MBD2 and MeCP2 is increased in Dnmt1
n/n p53
-/- cell extracts, possibly due 
to their release from chromatin and consequent higher extractability. Further to 
the ChIP analysis, it was also interesting that levels of trimethylated H3K9 were 
only mildly reduced on the ApoE gene, with no reduction on B1 or B2. 
Unfortunately, due to lack of suitable antibody, MBD1 was not included in these 
studies. As it binds to both methylated and unmethylated CpG (Jorgensen et al., 
2004), it is possible that it remains bound to B1 and B2 and through its 
interaction with Suv39h1 or SETDB1 maintains histone methylation (Fujita et al., 






















































Figure   5-9 MBD2 and MeCP2 occupy methylated genes in DNA methylation-dependent 
manner. 





-/- cells. All antibodies used for the ChIP analysis are listed on the top of the first panel. 
Input DNA was diluted to 10%, 2% and 0.4% to ensure quantitative PCR reactions. TFIIA 
antibody was used as a negative control antibody. Samples with beads-only were used as a 
general negative control for ChIP analysis. Primers used in each PCR reaction are listed in 
Table 2-3 and indicated with letter C (ChIP) in the second column and M (mouse) in the third 
column of the table. PCR reactions contained [α-
32P] dCTP. Autoradiograph. Marker sizes 
are indicated. (B) Western analysis of MBD2 and MeCP2 shows that levels of both proteins 
were not reduced in the Dnmt1
n/n p53
-/- fibroblasts. Actin was used as a loading control. 
Total cell extracts were used.  
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Cells were than examined for expression of B1 and B2 in order to find whether 
reducing DNA methylation and removing MBD proteins from B1 and B2 genes 
leads to an increase in their expression. Total RNA was extracted and cDNA 




-/- fibroblasts (figure 5.10). 
Samples where no reverse transcriptase was added during cDNA synthesis were 
used as a negative control for genomic DNA contamination (data not shown). 
Consensus B1 and B2 primers were used to detect B1 and B2 RNAs. 5S and 7SL 
are RNA polymerase III-transcribed genes and their RNA levels serve as controls 
for RNA polymerase III activity in the two cell lines. The p53BP2 gene encodes 
p53 binding protein 2 and was identified as a target of MBD1. In HeLa cells, it 
has a methylated promoter and it is silenced both by DNA methylation and 
methylated H3K9 (Sarraf and Stancheva, 2004). Demethylation of DNA with 5-
azacytidine led to an increase of its activity. It was therefore used here as a 
positive control, together with ApoE. GAPDH was a loading control for equal 
cDNA levels. Figure 5.10 shows that there was no increase in RNA polymerase III 
transcript expression in Dnmt1
n/n p53
-/- cells. Notably, there was no increase in 
B1 or B2 expression. In contrast, expression of the two DNA methylation-silenced 
genes, p53BP2 and ApoE, increases in the Dnmt1
n/n p53

























Consensus B1 and B2 primers were used to detect B1 and B2 RNAs. 5S and 7SL are RNA 
polymerase III-transcribed genes and their RNA levels serve as controls for RNA 
polymerase III activity in the two cell lines. The p53BP2 is silenced by DNA methylation. 
Level of its mRNA together with ApoE mRNAs were used as positive controls. Pol II – genes 
transcribed by RNA polymerase II; Pol III - genes transcribed by RNA polymerase III. 
Samples are shown in duplicates. GAPDH was used as a loading control. Samples with no 
Superscript added during cDNA synthesis were used as a negative control for DNA 
contamination (data not shown). Primers used in each PCR reaction are listed in Table 2-3 
and indicated with letter R (RT-PCR) in the second column and M (mouse) in the third 
column of the table. PCR reactions contained [α-32P] dCTP. Autoradiograph. Marker sizes 
are indicated. 
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RT-PCR cannot distinguish between newly transcribed RNA and steady state 
levels. It cannot be excluded that some minor changes happen at the 
transcriptional levels. However, if methylation-mediated silencing was the main 
mechanism for controlling expression, an increase in overall B1 and B2 RNA 
levels would be expected. 
One way to gain a further insight into changes in transcriptional activity is to 
look at promoter occupancy by the RNA polymerase III transcriptional machinery. 
In previous experiments, it was established that RNA polymerase III levels on B1 
and B2 genes are reduced when compared to actively transcribed genes (figure 
5.2; figure 5.3). If MBD proteins prevent RNA polymerase III from access to B1 
and B2 promoters, removing MBD proteins from the promoters should lead to an 
increase in occupancy of RNA polymerase III on B1 and B2. ChIP analysis was 




-/- cell lines (figure 5.11). 
Input material was first normalised. Antibodies against TFIIIB, TFIIIC, RNA 
polymerase III and acetylated H3 and acetylated H4 were used to investigate 
differences in occupancy of transcription machinery and marks of active genes. 
TFIIA and beads were used as negative controls. 7SL was a positive control gene; 
the RNA polymerase II-transcribed H19 gene was used as a negative control. 
Figure 5.11 shows that, as in A31 fibroblasts, transcription machinery is present 





fibroblasts. Notably, the levels of occupancy remain constant; there is no 
increase in the occupancies of individual components in the Dnmt1
n/n p53
-/- 
cells. This is consistent with the absence of change in B1 and B2 expression. 
There were traces of RNA polymerase III machinery also detected on the H19 
gene. It is possible that the H19 sequence contains SINEs or their remnants.  
Overall, this experiment argues against the possibility that an increase in 
transcription was compensated by increased degradation of B1 and B2 RNA and 
suggests that the unchanged levels of B1 and B2 RNA in the RT-PCR analysis truly 
reflect a lack of increase at the level of transcription. The data also suggests 
that DNA methylation-dependent MBD proteins are not responsible for 
preventing (or not exclusively) RNA polymerase III recruitment to B1 and B2 



























































-/- cell lines. Antibodies 
against TFIIIB, TFIIIC, RNA polymerase III and acetylated H3 and H4 were used to investigate 
differences in the occupancy of the transcription machinery and the marks of active genes. 
Input material was first normalised to allow direct comparison between the two sets. It was 
then diluted to 10%, 2% and 0.4% to ensure quantitative PCR reactions. TFIIA and beads 
were used as negative controls. 7SL was a positive control gene; the RNA polymerase II-
transcribed H19 gene was used as a negative control. Autoradiograph. Marker sizes are 
indicated.Jana Vavrova, 2008    Chapter 5, 173 
 
MBD proteins associate with corepressor complexes. To investigate their 
recruitment to B1s and B2s in these cells and whether there is a change upon 
methylation removal, ChIP analysis was performed. The occupancy of Brm, 




-/- fibroblasts was 
compared (figure 5.12). B1, B2 and set1 were studied together with methylated 
ApoE and the active RNA polymerase III gene tRNA 
Sec. Samples were first 
normalised for equal inputs. As an additional control, acetylated H4 was used, as 
it was shown in the previous experiment that its occupancy is not changing. 
TFIIA and beads were negative controls.  
MeCP2 showed reduction in occupancy in the Dnmt1
n/n p53
-/- fibroblasts, as 
before (figure 5.9). Surprisingly, no other proteins were detected in the 
Dnmt1
+/+ p53
-/- fibroblasts, apart from HDAC1 at tRNA
Sec (figure 5.12). There is 
also an increase in occupancy of HDAC2 on B1 and B2 and ApoE in Dnmt1
n/n p53
-/- 
cells. Unfortunately, it is not known whether ApoE gene (used here as a positive 
control) is occupied by the studied complexes in these cells. 
This result was unexpected, as it is in striking contrast to the ChIP analysis 
performed in A31 cells (figure 5.7), where these proteins were detected on all 
tested active and silent genes. This discrepancy could be due to differences 
between the two cell lines. However, it is more likely to be related to 
inactivation of p53. p53 is a strong regulator of transcription and its deletion can 
result in a number of changes. It can affect levels of B1 and B2 expression in 





fibroblasts, it is not affecting the relative change in B1 and B2 activities. Any 
increase in B1s and B2s due to lack of p53 would be constant in the two cell 
lines. It is likely to affect the binding of corepressors with which it is known to 
interact. P53 was shown to interact both with HDACs and mSin3a (Murphy et al., 
1999) and SWI/SNF (Lee et al., 2002). Better positive control used in future 















































Figure   5-12 ChIP analysis of the occupancy of the components of corepressor complexes, 
namely Brm, HDAC1, HDAC2 on B1 and B2 in Dnmt1
+/+ p53
-/-  cells and Dnmt1
n/n p53
-/-  cells. 
MeCP2 showed reduction in occupancy in the Dnmt1
n/n p53
-/- fibroblasts, as before (figure 
5.9). Surprisingly, no other proteins were detected in the Dnmt1
+/+ p53
-/- fibroblasts, apart 
from HDAC1 at tRNA
Sec . Increased occupancy of HDAC2 on B1, B2 and ApoE was detected 
in Dnmt1
n/n p53
-/- cells. Input DNA was first normalized and then diluted to 10%, 2% and 0.4% 
to ensure quantitative PCR reactions. TFIIA antibody was used as a negative control 
antibody. Samples with beads-only were used as a general negative control for ChIP 
analysis. Primers used in each PCR reaction are listed in Table 2-3 and indicated with letter 
C (ChIP) in the second column and M (mouse) in the third column of the table. PCR 
reactions contained [α-
32P] dCTP. Autoradiograph. Marker sizes are indicated.Jana Vavrova, 2008    Chapter 5, 175 
 
The lack of proteins bound to the promoters could also simply be due to altered 
expression of these proteins in the cells. To confirm that the proteins are 




-/- cells, total cell extracts 
were made and Western blot analysis performed (figure 5.13). Actin served as a 
loading control. It was confirmed that Brm, HDAC1 and HDAC2 are all expressed 
in Dnmt1
+/+ p53
-/- cells. They are also expressed in Dnmt1
n/n p53
-/- cells, and 
their levels seem to increase in these cells. This may be due to higher solubility 
of these proteins in the total cell extract, as their presence on chromatin may 
be reduced.   
In conclusion, this study provides the first evidence that DNA methylation and 
DNA methylation-mediated repression alone may not be silencing these SINE 
families. MBD proteins were found to be bound on methylated B1s and B2s, but 
when removed, no increase in transcriptional activity was observed. Their sole 
involvement in B1 and B2 repression is therefore unlikely. HDACs and Brm were 
detected in A31 cells, but when their dependence on DNA methylation and MBD 




-/- fibroblasts, ChIP 
analysis failed to detect them, possibly due to the absence of p53. Their 
involvement stays therefore unclear. If these complexes are involved in B1 and 
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-/-  cells. 
Western analysis shows that levels of both proteins were not reduced in the Dnmt1
n/n p53
-/- 
fibroblasts. Total cell extracts were used. Actin was used as a loading control. Jana Vavrova, 2008    Chapter 5, 177 
 
 
5.2.5 Histone H1 is not responsible for silencing B1 and B2 
transcription 
Functional assays suggested that viral infections stimulate SINE transcription in 
transformed cells by unmasking their chromatin structure and making them more 
accessible for in vitro transcription (Carey and Singh, 1988; Russanova et al., 
1995). Adenovirus also unmasks a subset of Alus in HeLa chromatin (Li et al., 
2000). Accessibility of Alus for restriction cleavage increases after heat shock 
treatment or cycloheximide treatment of HeLa and 293 cells (Li et al., 2000). So 
these studies indicate that there is a tight correlation between Alu transcription 
and chromatin accessibility. Adenoviral infection in HeLa cells also results in a 
slight increase of nucleosome spacing, suggesting that linker histone H1, which 
influences the length of linker DNA between nucleosomes, may be involved in 
SINE repression. However, when Bio-Rex 70 ion-exchange resin was used to 
deplete H1 from HeLa cells, it resulted in a very mild 2-to 2.5-fold increase of 
Alu expression (Russanova et al., 1995). Alus were further shown to possess a 
nucleosome positioning signal in vitro and in vivo (Englander and Howard, 1995; 
Englander et al., 1993). Assembling a methylated Alu template with histone 
tetramers leads to complete transcriptional repression compared to only 2- to 3-
fold reduction of naked Alu DNA by methylation alone; however, assembling the 
Alu template with histone octamers was methylation insensitive (Englander et 
al., 1993). In contrast to Alu, ion-exchange resin-mediated depletion of linker 
histone H1 had a major effect on alleviating B2 repression (Carey and Singh, 
1988; Russanova et al., 1995). The effect of linker histone H1 on B1 repression 
has not yet been established. 
H1 was long considered as a global repressor of gene activity through its 
compaction of chromatin, because it is often depleted on active chromatin and 
can cause inhibition of transcription in vitro (Bresnick et al., 1992; Shimamura 
et al., 1989; Smith and Hager, 1997). However, new evidence showed that cells 
and tissues can tolerate very low levels of H1 and that only a small percentage 
of genes are effected in their expression (Fan et al., 2003; Fan et al., 2005).  Jana Vavrova, 2008    Chapter 5, 178 
Fan et al. (2003) prepared mouse embryonic stem cells with three out of six H1 
subtypes (H1c, H1d, H1e) deleted. That led to about 50% reduction in linker H1 
content in these cells. This resulted in dramatic global changes in chromatin 
structure, involving decreased global nucleosome spacing and reduced chromatin 
compaction. Surprisingly, expression of only few genes was affected as shown by 
microarray analysis, some with positive and some with negative effects. The 
largest group of effected genes were imprinted or repressed by methylation. B1 
and B2 expression was not studied.  
RNA from two H1cde triple knock-out ES cell lines together with wild type ES cell 
line (derived from littermate embryos) was obtained (Y.Fan, gift) and analysed 
here for B1 and B2 expression using RT-PCR. ARPPPO mRNA was used as a loading 
control. Imprinted H19 gene, whose RNA levels were shown to be upregulated in 
KO ES cells served as a positive control. RT-PCR confirmed that H19 mRNA 
increases in both triple KO ES cell line when compared to the wild type ES cell 
line, but surprisingly, neither B2 nor B1 expression increased in the triple KO ES 
cells (figure 5.14). This is in striking contrast with previous studies which 
suggested that B2 was derepressed by H1 depletion. Several explanations are 
possible. Firstly, because the reduction in H1 content is only 50%, the remaining 
H1 may still be maintaining repression of SINEs in the ES cells. However, 
considering the substantial overall relaxation of the chromatin structure, if 
linker H1 was the major repressor some changes would be expected. The results 
are consistent with those of Fan et al (2005) that despite large changes in 
chromatin structure, only small numbers of genes were affected, some of them 
even with lower expression. Secondly, the previous data which showed 
derepression of B2 when H1 was removed from chromatin using ion-exchange 
columns could have depleted other important components which resulted in the 
observed derepression. The lack of increase in activity is in agreement with 
evidence that increased nucleosome spacing has a positive effect on Alus 
accessibility for RNA polymerase III (Li et al., 2000). Here, the nucleosome 
spacing is actually reduced upon H1 removal which together with unchanged 
methylation of B1 and B2 may still keep B1 and B2 repressed. In conclusion, Alus 













Figure   5-14 RT-PCR shows that H1 depletion does not increase B1 and B2 expression in ES 
cells. 
Consensus B1 and B2 primers were used to detect B1 and B2 RNAs. ARPPPO was used as 
a loading control. H19 was used as a positive control. Samples are shown in duplicates. 
Samples with no Superscript added during cDNA synthesis were used as a negative control 
for DNA contamination (data not shown). Primers used in each PCR reaction are listed in 
Table 2-3 and indicated with letter R (RT-PCR) in the second column and M (mouse) in the 
third column of the table. PCR reactions contained [α-32P] dCTP. Autoradiograph. Marker 




B1 and B2 are rodent SINEs which are present each in about half a million copies 
in the mouse genome. Despite their abundance, relatively few B2 transcripts and 
even fewer B1 transcripts (Carey et al., 1986; Maraia, 1991) can be detected in 
cultured cells or mouse tissues, indicating that like human Alus, expression of 
these repetitive elements is repressed. Compared to Alus, mechanisms of 
repression of B1s and B2s have not yet been studied much. Numerous studies, 
however, showed that both B1 and B2 expression increases as a response to 
various stimuli and that led to hypotheses about how they may be repressed. 
In cells infected with various viruses, the increase is thought to be mediated 
through activity of TFIIIC and/or TFIIIB (Larminie et al., 1999; White et al., 1990; 
Yoshinaga et al., 1986). Strikingly, it was revealed in this study that RNA 
polymerase III machinery is present on many B1 and B2 sequences. Data 
presented here showed that both TFIIIB and TFIIIC are present on tested B1s and 
B2s at comparable levels with active genes. Increased availability of additional 
TFIIIB and TFIIIC might therefore activate those B1s and B2s which were 
previously unoccupied.  
More global changes in chromatin not dedicated to RNA polymerase III 
components were observed previously (Li et al., 2000; Russanova et al., 1995). 
Cell stress conditions increase transcription of both B1 and B2 (Liu et al., 1995; 
Schmid, 1998). It is not known how this is mediated, but in the case of Alus, it is 
believed to be via chromatin and template availability.  
Observations here suggest that at least some B1 and B2 genes avoid being 
sequestered by chromatin proteins and maintain their promoters accessible to 
RNA polymerase III machinery, arguing against the general template masking 
that has been suggested before (Li et al., 2000; Russanova et al., 1995). 
Chromatin remodelling following stimuli such as viral infection and cell stress 
may, however, unmask other B1 and B2 genes which are normally inaccessible 
and unoccupied by RNA polymerase III components. It is reasonable to consider 
that to mount a quick response resulting in the increase of B1 and B2 expression Jana Vavrova, 2008    Chapter 5, 181 
which is observed within half an hour of stimulation, preassembled complexes 
would be a key. In vitro, RNA polymerase III transcription complex can assemble 
in less than 15 minutes (R.White, personal communication), the rate of the in 
vivo assembly is not known. 
However, as the very low levels of transcripts detected in uninduced cells and 
tissues imply, these preassembled complexes are somehow inactive. The 
observed low occupancy of detected RNA polymerase III may be a sign of a 
repression. RNA polymerase III access and function was thought to be inhibited 
by chromatin proteins or by mediators of DNA methylation-derived repression, 
the MBD proteins. ChIP analysis in A31 cells and in mouse embryonic fibroblasts 
showed that MBD1, MeCP2 and MBD2 are present on both B1 and B2 sequences, 
potentially mediating repression of the RNA polymerase III complex. HDAC1, 
HDAC2 and Brm were detected on B1 and B2 sequences in A31 cells. It is not 
clear whether these are recruited via MBD proteins or independently and 
whether they can establish repression of B1 and B2 transcription. RT-PCR 
analysis of B1 and B2 RNA in MeCP2 null mice, however, showed no increase, 
suggesting that MeCP2 may not play a non-redundant role in their repression. 
This would agree with a previous study showing that human Alus are bound by 
MeCP2, but MeCP2 does not seem to repress them (Yu et al., 2001). More MeCP2 
null individuals and wild type mice and tissues should however be examined to 
avoid individual differences. Tissue-specific cofactors might allow regulation in 
other cell types.  
B1 and B2 were then studied in Dnmt1
n/n p53
-/- embryonic fibroblasts, which 
have less than 5% of the normal DNA methylation level. ChIP analysis showed a 
significant reduction in tested MBD proteins MBD2 and MeCP2 binding to 





-/- cells, however, failed to detect any increase in B1 or 
B2 expression. This suggested that DNA methylation-dependent MBD proteins do 
not mediate the repression of B1 and B2 genes. Occupancy of RNA polymerase III 
factors in the two cell lines was also studied, but no increase in occupancy of 
any of the RNA polymerase III components was seen when DNA methylation was 
reduced. Occupancy of RNA polymerase III remained reduced compared to active 
genes, suggesting a MeCP2 and MBD2 independent effect. MBD1 that was not 
included in the study due to technical difficulties may still mediate repression as Jana Vavrova, 2008    Chapter 5, 182 
it also binds unmethylated as well as methylated sequences (Jorgensen et al., 
2004). Its effect could be DNA methylation-independent. MBD1 was shown to 
interact with H3K9 HMTs and the persistent level of methylated H3K9 in 
Dnmt1
n/n p53
-/- cells is in support of this possibility.  
The binding of HDAC1, HDAC2 and Brm was studied in this system and was not 
detected in either of the cell lines. This was unexpected, as these proteins were 
detected on B1 and B2 in A31 cells. Careful interpretation about the significance 
of lack of these proteins on genes is needed here, as the most obvious difference 
between A31s and these cells is the lack of p53 protein. P53 is a global repressor 
of RNA polymerase III transcription and is known to interact with various 
chromatin repressor and chromatin remodelling complexes such as HDACs and 
mSin3a (Murphy et al., 1999) and SWI/SNF (Lee et al., 2002). It is likely to cause 
changes in the binding of these proteins to their target sequences.  
Chromatin was suggested as a possible major repressor of template availability 
and activity. B2 activity was reported to increase upon removal of linker histone 
H1 (Carey and Singh, 1988; Russanova et al., 1995). Triple null mutant cells were 
created, resulting in a 50% decrease in H1 content (Fan et al., 2003). This led to 
significant changes in chromatin structure. However, a surprisingly small number 
of  genes were affected, resulting in increased expression of some and 
decreased expression of others (Fan et al., 2005). RNA from these cells was used 
to re-investigate the effect of H1 on activity of B2s and establish the effect of 
H1 on B1 activity. The RNA level of the control H19 gene increased in both triple 
KO ES cells when compared to the wild type ES cells, but surprisingly neither B2 
nor B1 expression increased in triple KO ES cells. H1 was also shown to have 
little effect on Alus in human cells (Russanova et al., 1995). It is possible that 
during the ion-exchange resin removal of H1, another important component is 
removed, resulting in the B2 increase. Deletion of the H1 genes provides a better 
control of specificity.  





-/- cells suggest that DNA methylation and DNA methylation-
dependent MBD proteins are not responsible for B1 and B2 repression, although 
further studies are necessary. A better system for assessing the role of DNA 
methylation in B1 and B2 silencing would be to use the Dnmt3
- cells (Okano et Jana Vavrova, 2008    Chapter 5, 183 
al., 1999), which, through prolonged passage in culture established virtually no 
detectable CpG methylation (0.6%) and p53 levels were not deliberately altered 
(Gilbert et al., 2007). 
DNA methylation-mediated silencing may also act in concert with histone 
deacetylation. It was shown recently that there are two distinct classes of 
methylated genes (Lande-Diner et al., 2007). One category is automatically 
induced following the removal of DNA methylation. In the other group, 
methylated genes could not be activated by demethylation. However, they 
underwent strong induction when cells were subjected to combination of 
demethylation and TSA treatment (Lande-Diner et al., 2007). TSA is a histone 
deacetylase inhibitor and its treatment prevents deacetylation of histones. 
Future study should therefore determine whether this is not the case of SINE 
repression by treating Dnmt1
n/n p53
-/- cells with TSA. 
Future studies should also include another chromatin remodelling protein, Lsh. 
Lsh is a member of SNF2  of chromatin remodelling complexes (Jarvis et al., 
1996) that was previously mainly associated with pericentromeric chromatin 
(Yan et al., 2003). However, its deletion was found to result in global loss of DNA 
methylation in mouse cells, comparable to that of Dnmt1
n/n (Dennis et al., 
2001).  Mainly repetitive sequences were shown to be demethylated (Dennis et 
al., 2001). SINEs were amongst sequences found to be deregulated in Lsh
-/- cells 
(Huang et al., 2004), however, this deregulation was not determined further as 
the study focused mostly on LTR repeats. Slight enrichment of Lsh at SINEs was 
observed by ChIP analysis (Huang et al., 2004). mRNA and protein levels of 
Dnmt1 and Dnmt 3a/3b were unchanged in the Lsh
-/- cells, as was their 
methyltransferase activity. It was therefore suggested that based on its 
chromatin remodelling activity, Lsh may regulate chromatin accessibility for DNA 
methyltransferases. Lsh’s homologue DDM1 (Dennis et al., 2001) also cooperates 
with DNA methyltransferases and  contributes to transcriptional silencing of 
transposons in plants (Lippman et al., 2004). Lsh cooperation with Dnmts may be 
similar in mammalian cells. Despite the fact that Dnmt1 deletion did not result 
in increased expression of SINEs in this study, Lsh may be involved in additional, 
independent way. As its plant homologue DDM1, it could involve SINE-derived 
double stranded RNA to maintain their silenced status (Lippman et al., 2004). 184 
6  Chapter 6 - Final discussion 
6.1 Introduction 
Despite the abundance of the templates, both human and rodent SINEs are 
normally expressed at a very low level. There are several reasons why it may be 
important to suppress their transcription. Firstly, they could present a burden 
for limited cell resources. Secondly, their activity could result in undesired 
amplification, which can be potentially very harmful (Deininger and Batzer, 
1999). Thirdly, taken from a view that they may be merely DNA parasites, in 
order for them to amplify, they have to get to the next generation. Such 
amplification is only possible for retroelements in germ lines, where they are 
indeed more active (Li et al., 1999). In somatic cells, it is therefore not to their 
advantage. Taken together, there is no incentive for the host cell to keep SINEs 
constitutively active or for SINEs themselves to be constitutively active. 
Exposure to various cell stress stimuli increase this activity many folds. One view 
is that this increase simply disrupts normal SINE regulation, inadvertently 
causing a transient, non-specific increase in dormant SINE activity. However, as 
more and more functions are being described, whether original or acquired, it is 
clear that using the vast potential they represent might be beneficial to a host 
cell in certain situations (see Chapter 1).  
 
6.2 The effect of DNA methylation and chromatin on the 
activity of SINEs 
Expression of both human and rodent SINEs was studied here in physiological 
conditions with respect to its regulation by DNA methylation and other 
chromatin factors, including the mechanisms by which such regulation may be 
achieved. Both human and rodent SINEs were shown here to be bound by the 
MBD proteins MeCP2, MBD1 and MBD2, which suggested that the effect of DNA 
methylation may be mediated via these proteins. Whether MBD proteins mediate 
repression of SINEs was then investigated. Their involvement in recruitment of 
chromatin remodeling and corepressor complexes was studied. In addition, the Jana Vavrova, 2008    Chapter 6, 185 
importance of their presence was studied using systems with low or near absent 
DNA methylation or systems where the MBD was removed.  
HDAC1/2 and components of chromatin remodeling and corepressor complexes 
were detected on SINEs in this study. Brahma was specifically enriched only on 
both human and rodent SINEs and a control methylated gene. It is a component 
of a SWI/SNF2 remodeling complex. In this case, it may be recruited via MeCP2, 
which was shown before to interact with Brahma, resulting in repression 
(Harikrishnan et al., 2005). Other proteins detected in this study on human Alus 
were components of the NuRD and SIN3 complexes. HDAC1/2, NuRD and SIN3 
were shown to associate with MBD proteins before and they may therefore be 
recruited by MBD proteins to the SINE’s methylated DNA. Yet, they could also be 
recruited independently, for example via p53 (Murphy et al., 1999) or H3K9me3 
(Stewart et al., 2005).  
Apart from SINEs, some of the NuRD and SIN3 components were also detected on 
some actively transcribed genes. HDACs on the other hand, were detected on all 
of the tested genes. That was surprising, but given the complexity of their 
action, these complexes are no longer regarded as solely connected to 
transcriptionally silenced genes. It may be that there is an intricate 'dance' of 
associations, with these changing places over time. The positive-acting 
complexes may be recruited during initiation or elongation, followed by 
recruitment of negative-acting complexes (Sin3-HDAC) during attenuation of 
transcription. As an example could serve transcriptional regulation by oestrogen-
receptor-α (ERα) at the pS2 gene. Once bound by oestradiol and recruited to 
target DNA containing oestrogen responsive elements, ERα induces an ordered 
and cyclical recruitment of coactivator and corepressor complexes containing 
HAT, HMT or ATP-dependent remodelling activities (Metivier et al., 2003).  
The importance of the observed occupancy of MBD proteins and corepressor 
complexes on SINEs was then investigated by studying their effect in near 
methylation-free systems or, in the case of MeCP2, by its direct removal. The 
effect of the absence of MBD proteins and corepressor complexes was, however, 
only investigated with regards to rodent SINEs, because of the lack of a suitable 
‘methylation-free’ system for Alu research. Human methylation-free cells 
(HCT116 DKO) were shown in this study to have decreased levels of p53, which is Jana Vavrova, 2008    Chapter 6, 186 
a known RNA polymerase III repressor. The observed increase in SINE RNA levels 
and all other tested RNA polymerase III transcripts were probably affected by 
this. Support for a p53 effect came from the observed increase in levels of 5S 
rRNA. Expression of 5S rRNA was shown before not to be affected by DNA 
methylation (Besser et al., 1990). Because its RNA levels were upregulated in 
HCT116 DKO cells, it was likely an effect of decreased levels of p53, rather than 
of the lack of DNA methylation. Saccharomyces cerevisiae, a DNA methylation-
free organism, was also used to study an integrated Alu element, but problems 
were encountered with the chosen Alu construct, as it appeared to affect a 
nearby RNA polymerase II promoter. Although this is very interesting, it was not 
ideal in this study. 
Whether MBD proteins’ absence will affect the activity of rodent SINEs was 





-/- cells. RT-PCR analysis of B1 and B2 expression in MeCP2 null mice kidneys 
showed no increase in B1 and B2 RNA levels. This suggested that MeCP2 may not 
play a non-redundant role in their repression, at least in kidney tissue. If it plays 
any, it is well compensated by other mechanism(s). B1 and B2 were also studied 
in Dnmt1
n/n p53
-/- embryonic fibroblasts, which have less than 5% of the normal 
DNA methylation level. ChIP analysis showed a significant reduction of MeCP2 
and MBD2 binding to SINEs, showing that their presence is DNA methylation-





however, detected no increase in B1 or B2 RNA levels. This is consistent with 
results obtained from MeCP2 KO mice, where lack of MeCP2 did not result in 
increased B1 and B2 expression. This is also consistent with a previous study 
showing that human Alus are a major binding target of MeCP2, but that MeCP2 
does not seem to repress them (Yu et al., 2001). MBD2 also does not seem to 
repress rodent SINE activity, as its removal did not result in increased SINE RNA 
levels. SINE expression remained at comparable level in DNA methylation-free 
cells (Dnmt1
n/n p53




How is SINE repression mediated in Dnmt1
n/n p53
-/- cells? Attempts were made to 
detect occupancy of components of corepressor and chromatin remodeling 
complexes, that were found to occupy SINEs in other mouse cells (A31); 
however, these failed to be detected even in Dnmt1
+/+ p53
-/-, making Jana Vavrova, 2008    Chapter 6, 187 
interpretation of their absence in Dnmt1
n/n p53
-/- difficult. A potential 
explanation for the absence of the complexes in both cell lines is the lack of 
p53. p53 is known to interact with HDACs, which were shown both in HeLa cells 
and in A31 cells to be present on SINEs (Murphy et al., 1999). The extent of the 
p53 effect is, however, not known. Because p53 is known to repress SINEs, levels 
of SINE RNA in Dnmt1
+/+ p53
-/- may already be partially elevated compared to 
levels in other cells, disguising the potential effect of any DNA methylation-
independent action of corepressor complexes. 
SINE repression could also be mediated by MBD1. MBD1 can bind both 
methylated and unmethylated DNA through its different domains and it was 
detected here on Alus in HeLa cells and on both B1 and B2 in A31 cells. Due to 





cells. It is likely to occupy B1 and B2 in Dnmt1
+/+ p53
-/- cells and it is possible 
that it remains bound to unmethylated SINEs in Dnmt1
n/n p53
-/- cells. It is not 
known to interact with HDAC1/2 or SIN3 and NuRD, but it is known to establish 
repression via different partners. It is known to interact with HMTs Suv39h1 and 
SETDB1 (Fujita et al., 2003b; Sarraf and Stancheva, 2004), which specifically 





-/- cells, suggesting that MBD1 may still be present 
on SINEs. MBD1 further associates with MCAF/AM-related proteins (Ichimura et 
al., 2005; Sarraf and Stancheva, 2004) and together with SETDB1 establishes 
transcriptional repression. H3K9 methylation was also shown to be connected to 
an RNAi mechanism and Alus were shown to be sources of miRNAs and to match 
certain miRNAs as targets (Borchert et al., 2006; Smalheiser and Torvik, 2006). 
However, this repressive effect of MBD1 has only been shown for RNA 
polymerase II transcription and H3K9 methylation has never been connected to 
repression of RNA polymerase III transcription. 
Overall, SINEs repression was not found to be mediated by DNA methylation or 
the DNA methylation-dependent MBD proteins, MeCP2 and MBD2. If MBD1 and/or 
corepressor and chromatin remodelling complexes bound to SINEs regulate SINE 
transcriptional activity, it is via DNA methylation-independent mechanism(s). 
Future study should include TSA treatment to determine whether DNA 
methylation-mediated silencing does not act in concert with histone Jana Vavrova, 2008    Chapter 6, 188 
deacetylation. Some methylated genes could not be activated by demethylation, 
but they undergo strong induction when cells are subjected to combination of 
demethylation and TSA treatment (Lande-Diner et al., 2007). SINEs may be 
similarly regulated. 
As mentioned earlier, future studies should also include the chromatin 
remodelling protein Lsh. Its deletion was found to result in global loss of DNA 
methylation in mouse cells, comparable to that of Dnmt1
n/n (Dennis et al., 
2001).  Mainly repetitive sequences were shown to be demethylated (Dennis et 
al., 2001) and SINEs were amongst deregulated sequences found to be in Lsh
-/- 
cells (Huang et al., 2004), however, this deregulation was not determined 
further as the study focused mostly on LTR repeats. Slight enrichment of Lsh at 
SINEs was observed by ChIP analysis (Huang et al., 2004). Lsh was suggested to 
regulate chromatin accessibility for DNA methyltransferases. Despite the fact 
that Dnmt1 deletion did not result in increased expression of SINEs in this study, 
Lsh may be involved in additional, independent way. As its plant homologue 
DDM1, it could involve SINE-derived double stranded RNA to maintain their 
silenced status (Lippman et al., 2004). 
 
NuRD complex binding to Alus should be also further examined with respect to 
its association with cohesin on Alus. ChIP analysis demonstrated specific 
association of hRAD21, SNF2 and mi2 with DNA elements containing Alu element 
(Hakimi et al., 2002). This binding depended on DNA methylation status of Alu 
elements. Binding of the cohesin complex to Alu containing DNA was stronger 
after 5-azacytidine treatment. Chromatin remodelling activity of SNF2h was 
shown to be important, as transfection of cells with SNF2h mutant containing 
mutation in the nucleotide-binding motif that abrogates ATP hydrolysis resulted 
in disruption of hRAD21 binding to DNA elements containing Alus (Hakimi et al., 
2002). It may be that SNF2h/NuRD-mediated binding of hRAD21 to Alus plays a 
role in their transcriptional regulation. 
  
Another aspect of chromatin that was also considered is the linker histone H1. 
H1 is connected to chromatin-mediated repression (Laybourn and Kadonaga, 
1991; Shimamura et al., 1989). It is often more abundant on silent genes and 
regions of chromosomes (heterochromatin) which are less transcriptionally 
active. Its removal was shown to result in major changes in chromatin Jana Vavrova, 2008    Chapter 6, 189 
compaction (Fan et al., 2005). It was reported previously that is has an effect on 
B2 transcription (Carey and Singh, 1988; Russanova et al., 1995), but not on Alu 
(Russanova et al., 1995). It was reexamined here after its removal was shown to 
have little effect on general RNA polymerase II activity (Fan et al., 2005), and a 
great proportion of the few genes upregulated were normally repressed by DNA 
methylation. RT-PCR from RNA extracted from triple H1 KO mouse embryonic 
fibroblasts was used here to study B1 and B2 activity. No increase in B1 or B2 
RNA levels was detected, as compared to wild type cells, suggesting that H1 is 
not the main or single mediator of repression. This is in agreement with the 
work of Fan et al. (2005), showing that only small percentage of RNA polymerase 
II genes and their activity is affected by H1.  
Histone H1 was not itself found to be repressing SINEs. However, it has been 
suggested that chromatin may act through positioning of nucleosomes over SINE 
promoters (Englander and Howard, 1995). This seems unlikely, because all SINEs 
studied here have preassembled transcriptional complexes, which suggests that 
H1 or nucleosomes do not cause an obstruction for their assembly. Furthermore, 
it was shown that yeast RNA polymerase III can transit during its transcriptional 
activity through nucleosomal DNA by mobilising histones along the templates 
(Studitsky et al., 1997).  
A striking discovery in this work was the detection of preassembled RNA 
polymerase III transcription complexes on all tested human and rodent SINEs. 
These were present both in wild type cells (HeLa, A31) and Dnmt1
+/+ p53
-/- cells 
and their occupancy did not increase in Dnmt1
n/n p53
-/- cells. This suggests that 
occupancy is not affected by methylated DNA or perhaps chromatin in general. 
The occupancy of TFIIIC and TFIIIB on SINEs was equivalent to their occupancy on 
active RNA polymerase III transcribed genes, while the occupancy of the RNA 
polymerase III was significantly lower on SINEs then on active genes, suggesting a 
deficiency in RNA polymerase III loading. Since levels of SINE RNAs in the cells 
are low and the occupancy of RNA polymerase III is lower on SINEs, these 
complexes may be regarded as inactive. The nature of the defect in RNA 
polymerase III loading onto SINEs is not known. A direct effect of DNA 
methylation or MBD proteins can, however, be excluded. Also, an unprecedented 
insight into the number of RNA polymerase III transcription factors present in the 
cell is presented here. If it is the case that all SINEs capable of recruiting Jana Vavrova, 2008    Chapter 6, 190 
transcription complexes to their promoters (excluding those with inactive 
promoters) can be occupied by transcription complexes, there must be a high 
number of transcription complexes present in the cell. Recent preliminary data 
show that indeed there are far more TFIIIB molecules than originally thought 
(White, personal communication).  
 
6.3 Conclusions 
To conclude this work, MBD1, MeCP2 and MBD2 and components of chromatin 
remodelling and corepressor complexes were detected on both human and 
rodent SINEs, while SIN3 and NuRD were also detected on human SINEs. Removal 
of DNA methylation and DNA methylation-dependant MBD proteins did not result 
in increased B1 and B2 transcriptional activity, showing that repression of SINE 
activity is still maintained.  
It was shown here that despite their low transcriptional activity, SINEs are 
occupied by RNA polymerase III transcription factors TFIIIB and TFIIIC. There is 
also a low level of RNA polymerase III present on SINEs, suggesting that SINEs 
have a defect in its loading. Occupancy of the RNA polymerase III does not 
increase at DNA methylation-‘free’ SINEs, suggesting that this defect is DNA 
methylation-independent. This contradicts the common belief, that SINEs do not 
bind the RNA polymerase III transcription machinery in vivo and that their 
promoters are masked by chromatin, or MBD proteins. It also brings a new insight 
into the number of RNA polymerase III transcription factors present in the cell. 
How the repression of SINEs is mediated is not clear, but data in this study show 
that it is likely to be DNA methylation-independent. TSA studies will need to 
exclude that histone deacetylation is not required in addition to DNA 
demethylation. Repression may be mediated via chromatin remodelling 
complexes, which were shown to bind SINEs. However, these would be recruited 
and maintained via DNA methylation-independent mechanisms, such as p53 and 
H3K9 methylation. So far, involvement of chromatin remodelling complexes in 
SINEs repression has not been shown except for Lsh (Huang et al., 2004), which 
was not studied here and will need to be addressed in future experiment. 
Brahma, which was shown to be recruited by MeCP2 and result in repression 
(Harikrishnan et al., 2005) is otherwise a ‘neutral’ component of SWI/SNF2 Jana Vavrova, 2008    Chapter 6, 191 
remodelling complexes and it is used by both activating and repressing 
complexes to remodel chromatin. Brahma was also shown to be present together 
with MeCP2 on actively transcribed genes during natural cycles of methylation 
and demethylation after RNA polymerase II transit (Metivier et al., 2008). The 
DNA methylation-independent repression of SINEs is likely to be at multiple 
levels. Depending on the stimuli and the function they perform, a certain 
amount of SINE RNA may be needed. It is therefore desirable that a cell could 
control these at many levels, which could be used individually or in a 
compounded manner in order to achieve a certain magnitude of response. Many 
mechanisms of control would be expected and, when needed, some of these 
mechanisms are alleviated in order to obtain the required levels of SINE RNA.  
The significance of the presence of DNA methylation on SINEs also remains 
unknown. It was speculated that DNA methylation only silences genes that are 
inactive and does not affect genes that may be active (Bird, 2002). Potentially 
active SINEs with preassembled RNA polymerase III complexes may therefore be 
‘immune’ to repressive effect of DNA methylation. Evidence that DNA 
methylation does not repress actively transcribed genes was given recently. 
Completion of genome-wide microarray analysis of DNA methylation in 
Arabidopsis indicated that, in addition to its expected distribution in silenced 
heterochromatin, DNA methylation is also common across ORFs. Even more 
unanticipated is the presence of DNA methylation in the ORFs of many actively 
transcribed genes (Zhang et al., 2006; Zilberman et al., 2007). Further example 
of DNA methylation on active genes was given by study of ERα-controlled genes 
(Kangaspeska et al., 2008; Metivier et al., 2008). Actively transcribed genes 
were showed to be exposed to cycles of DNA methylation/demethylation, where 
DNA methylation occurs after the cyclical occupancy of ERα and RNA polymerase 
II (Kangaspeska et al., 2008). DNA methyltransferases were shown to be involved 
in the methylation and active demethylation of CpGs (Metivier et al., 2008). 
DNA methylation on SINEs could be useful to cells in other ways, such as 
reduction of non-homologous recombination by introducing CpG to TpG 
mutations (Bird, 1980). These mutations can also silence retrotransposition, as 
shown with a B1 element where a single base mutation is responsible for a many-
fold decrease in transpositional activity (Dewannieux and Heidmann, 2005). 
However, a primary function of DNA methylation as a mechanism of introduction Jana Vavrova, 2008    Chapter 6, 192 
of these mutations seems unlikely, as most of the preserved CpGs (apart from 
CpG islands) are present in SINE DNA. It was also speculated that methylated 
SINEs contribute to genomic imprinting as they are highly methylated in somatic 
tissues and female germ cells, but methylation in male germ cells is restricted 
(Hellmann-Blumberg et al., 1993; Rubin et al., 1994). However the fact, that 
imprinted regions are usually poor in SINEs (Greally, 2002), does not support 
that.  
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